Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3047826	s-amh	ug/l (ug/l)	7054	9165	0.45%
3047826	s-amh	— (—)	902	1418	100.00%	Distribution not available
3047826	s-amh	µg/l (ug/l)	176	177	0.00%
3047826	s-amh	ug/l______ (ug/l)	58	68	0.00%
3047826	s-amh	UG/L (ug/l)	27	27	0.00%
3047826	s-amh	µg/L (ug/l)	16	18	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Female infertility, associated with anovulation

1155

566

28.18

307.65

1.3

6.10

3.08

ug/l

22.56

1128

514

Female infertility, cervical, vaginal, other or unspecified origin

3595

896

33.80

307.65

1.3

1.4

3.00

4.08

ug/l

0.79

3463

766

Endometriosis of ovary

603

506

12.01

307.65

1.4

1.7

2.24

4.86

ug/l

1.09

571

392

Polycystic ovarian syndrome, broad definition

1289

2924

5.45

307.65

1.3

6.46

2.70

ug/l

33.51

1256

2771

Procreative management

1220

1593

6.68

307.65

1.4

3.26

3.59

ug/l

0.61

1134

1340

Noninflammatory disorders of female genital tract

1673

1071

8.35

307.65

1.4

1.5

3.92

4.01

ug/l

0.04

1591

923

Endometriosis diagnosis and infertility diagnosis occurring together

853

1186

8.52

307.65

1.4

2.49

3.39

ug/l

1.63

818

1053

Female infertility

3729

936

30.93

307.65

1.3

1.4

3.59

4.12

ug/l

0.32

3597

804

Amenorrhoea

496

418

13.74

307.65

1.3

4.46

3.32

ug/l

2.48

443

376

Endometriosis of pelvic peritoneum

523

553

9.12

307.65

1.3

1.6

2.16

4.69

ug/l

1.26

493

447

Endometriosis

1041

893

7.12

307.65

1.4

1.5

2.43

4.03

ug/l

1.40

976

760

Unspecified/other endometriosis

458

469

10.49

307.65

1.4

1.3

2.24

3.05

ug/l

2.02

431

401

Medical treatment for female infertility

2602

3328

9.97

307.65

1.4

1.3

3.05

3.17

ug/l

0.33

2509

3004

Female infertility, tubal origin

269

130

23.42

307.65

1.4

1.5

2.90

3.62

ug/l

0.28

253

Pain and other conditions associated with female genital organs and menstrual cycle

638

1030

5.42

293.71

1.4

3.02

3.97

ug/l

0.61

615

899

Ovarian cyst

796

966

4.87

281.96

1.5

3.33

4.05

ug/l

0.36

714

825

Excessive, frequent and irregular menstruation

868

1065

4.49

272.81

1.3

1.5

3.92

4.01

ug/l

0.04

806

919

Complications associated with artificial fertilization

196

27.79

271.06

1.3

1.2

4.57

3.94

ug/l

0.20

191

Malignant neoplasm of ovary, including Hilmo

224

146

16.70

260.99

5.1

1.2

21.47

2.92

ug/l

2.31

121

122

Genitourinary diseases

711

690

5.24

258.14

1.4

1.6

3.90

5.52

ug/l

0.86

661

594

Ovarian dysfunction

730

1937

4.45

251.81

1.3

7.54

3.13

ug/l

15.22

634

1855

Endometriosis of rectovaginal septum and vagina

220

182

12.85

222.75

1.5

2.05

3.38

ug/l

1.03

206

142

Malignant neoplasm of ovary

176

107

17.99

212.66

5.8

1.2

25.42

2.94

ug/l

2.25

Polyp of the female genital tract

473

462

5.94

204.15

1.4

1.7

2.50

5.21

ug/l

0.94

407

344

Medicines for HER+ breast cancer

551

1244

4.22

199.21

2.1

1.5

4.28

4.97

ug/l

0.35

424

952

Uterine polyps

423

406

6.24

193.72

1.4

1.8

2.50

5.59

ug/l

0.90

359

293

Disorders of other endocrine glands

1051

3911

2.72

188.59

1.4

6.48

3.21

ug/l

12.65

920

3597

Dysplasia of cervi uteri

520

838

4.50

184.01

1.3

1.4

3.41

4.07

ug/l

0.28

482

716

L02BG Aromatase inhibitors

433

930

4.71

183.15

2.1

1.5

4.82

5.59

ug/l

0.31

339

688

Polycystic ovarian syndrome

557

1617

4.08

169.48

1.2

1.3

8.57

3.05

ug/l

18.59

545

1558

Pregnancy examination and test

749

1465

3.39

167.11

1.3

4.33

3.25

ug/l

1.60

719

1300

Adenomyosis (Endometriosis of uterus)

218

275

8.16

161.21

1.5

1.9

2.24

3.50

ug/l

1.24

196

194

malignant neoplasm of female genital organs, including Hilmo

280

449

6.12

155.98

4.3

1.2

17.04

3.08

ug/l

2.23

158

371

Endometriosis of intestine

118

22.64

154.36

1.5

1.3

2.02

4.62

ug/l

0.71

110

Oligomenorrhoea

160

149

11.83

151.01

1.5

1.4

4.51

3.77

ug/l

0.40

150

131

Endometriosis ASRM stages 3,4

713

2522

2.96

147.69

1.4

2.27

3.49

ug/l

5.40

672

2241

malignant neoplasm of female genital organs

229

360

6.40

134.92

4.8

1.2

20.25

2.89

ug/l

2.27

128

294

Irregular menses

1497

5921

1.95

115.11

1.3

3.89

3.07

ug/l

2.35

1352

5407

Polycystic ovarian syndrome, consortium definition

1872

5995

1.83

112.43

1.3

1.4

4.73

3.09

ug/l

9.66

1704

5436

Supervision of high-risk pregnancy

635

1481

2.68

96.97

1.3

1.4

3.93

3.25

ug/l

1.29

592

1284

Primary_lymphoid and hematopoietic malignant neoplasms

213

459

4.71

91.52

2.0

1.6

3.38

4.23

ug/l

0.43

172

381

Liquid cancers

233

526

4.24

86.44

1.9

1.2

3.33

3.38

ug/l

0.03

183

454

Liquid cancers, including Hilmo

270

633

3.80

84.53

1.8

1.2

3.11

3.23

ug/l

0.07

200

537

Persons encountering health services in circumstances related to reproduction

627

1748

2.43

84.00

1.5

4.51

4.42

ug/l

0.05

560

1442

Personal history of malignant neoplasm

178

361

5.12

82.93

2.1

1.6

2.42

4.51

ug/l

1.67

148

288

Primary ovarian failure

141

254

6.55

77.64

1.5

1.06

2.87

ug/l

3.26

234

Other noninflammatory disorders of vulva and perineum

166

335

5.10

77.57

1.5

1.7

2.97

3.54

ug/l

0.59

156

274

Spontaneous abortion

1255

4729

1.82

76.65

1.3

3.07

3.61

ug/l

1.74

1172

4253

Neoplasms

1673

5270

1.69

75.99

1.5

1.2

3.54

3.52

ug/l

0.03

1548

5034

Deep endometriosis

315

1034

3.22

75.29

1.5

1.4

2.09

3.71

ug/l

3.38

298

931

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

140

256

5.56

72.79

1.9

1.2

2.86

2.94

ug/l

0.03

107

218

Other abnormal products of conception

1187

4477

1.79

68.00

1.3

3.14

3.34

ug/l

0.31

1125

4077

Endometriosis ASRM stages 1,2

530

2386

2.30

66.40

1.3

1.4

2.18

3.38

ug/l

7.36

500

2142

Other menopausal disorders

219

295

4.19

66.16

1.3

2.0

1.37

6.64

ug/l

1.03

162

188

Malignant neoplasm of breast, HER-positive

248

533

3.50

65.67

1.7

1.1

1.89

2.17

ug/l

0.32

132

394

Malignant neoplasm of breast, ER-positive, including Hilmo

249

537

3.48

65.46

1.7

1.1

1.93

2.17

ug/l

0.27

133

398

Menorrhagia

368

719

2.89

65.21

1.3

1.5

2.45

4.30

ug/l

1.17

331

591

Secondary uncertain malignant neoplasm

118

211

5.68

62.89

2.0

1.2

3.11

3.04

ug/l

0.03

182

Other abnormal uterine and vaginal bleeding

227

461

3.59

61.40

1.2

1.7

3.19

5.47

ug/l

0.76

199

357

Malignant neoplasm

906

2878

1.86

59.43

2.1

1.2

4.24

2.85

ug/l

1.32

653

2583

Malignant neoplasm

906

2895

1.85

58.35

2.1

1.2

4.23

2.85

ug/l

1.30

652

2600

Secondary and unspecified malignant neoplasm of lymph nodes

106

189

5.74

56.85

2.1

1.2

3.20

3.11

ug/l

0.03

166

Hypothyroidism, levothyroxine purchases

811

2431

1.91

56.10

1.4

1.2

3.40

3.28

ug/l

0.24

758

2326

Hypothyroidism and >3 levothyroxin purchases

811

2431

1.91

56.10

1.4

1.2

3.40

3.28

ug/l

0.24

758

2326

Other noninflammatory disorders of uterus, except cervix

136

179

5.12

55.72

2.0

2.5

7.82

10.66

ug/l

0.17

Special screening examination for infectious and parasitic diseases

758

2958

1.91

55.52

1.3

3.08

3.49

ug/l

2.10

715

2776

Endocrine, nutritional and metabolic diseases

1459

4624

1.61

55.22

1.4

1.3

4.44

3.16

ug/l

4.85

1321

4283

Other noninflammatory disorders of vagina

110

211

5.34

54.52

1.6

1.7

2.86

3.52

ug/l

0.44

167

Hypothyroidism (congenital or acquired)

806

2432

1.90

54.47

1.4

1.2

3.40

3.28

ug/l

0.25

753

2327

Solid cancers

830

2650

1.85

53.81

2.1

1.2

4.23

2.83

ug/l

1.17

590

2362

Disorders of the thyroid gland

1491

6234

1.56

53.10

1.3

3.05

3.61

ug/l

2.43

1357

5678

Hodgkin lymphoma, hilmo

178

5.87

51.24

1.9

1.3

2.39

2.91

ug/l

0.74

162

Malignant neoplasm, including Hilmo

962

3241

1.74

51.08

2.1

1.2

3.92

2.87

ug/l

1.04

711

2934

Malignant neoplasm, wide definition

955

3210

1.74

51.01

2.1

1.2

3.95

2.87

ug/l

1.08

705

2903

Postpartum care and examination

480

1427

2.19

48.32

1.3

3.50

3.12

ug/l

0.97

454

1276

L02BA Anti-estrogens

166

478

3.53

48.30

2.5

1.6

2.57

4.86

ug/l

0.90

107

340

Cervical polyps

151

5.86

47.94

1.6

2.2

2.27

4.35

ug/l

0.89

Solid cancers, including Hilmo

883

2997

1.73

45.82

2.1

1.2

4.09

2.84

ug/l

1.14

650

2698

Rare circulating lymphoid malignancy, including Hilmo

7.81

45.30

2.1

1.3

3.87

3.28

ug/l

0.17

Malignant neoplasm of breast

346

942

2.39

44.75

1.5

1.2

3.29

2.38

ug/l

0.22

207

759

Malignant neoplasm of breast, HER2-negative

344

937

2.39

44.47

1.5

1.2

3.29

2.38

ug/l

0.22

205

755

Hypothyroidism, other/unspecified

1404

6147

1.51

43.33

1.4

1.3

3.03

3.60

ug/l

2.38

1278

5597

Dentofacial anomalies [including malocclusion]

1245

6391

1.54

42.63

1.4

2.95

3.60

ug/l

3.23

1147

5767

Antenatal screening

542

1554

2.00

42.63

1.3

1.4

4.36

3.32

ug/l

2.13

504

1355

Benign neoplasm of ovary

202

712

2.89

41.99

2.3

1.6

3.94

4.53

ug/l

0.24

128

593

Malignant neoplasm of breast, HER2-negative, including Hilmo

356

1006

2.29

41.72

1.5

1.2

3.25

2.37

ug/l

0.22

217

822

Malignant neoplasm of breast, including Hilmo

356

1006

2.29

41.71

1.5

1.2

3.25

2.37

ug/l

0.22

217

822

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

7.72

40.13

1.5

1.3

2.25

4.69

ug/l

0.80

Finngen Rheumatological endpoints

691

6619

0.59

39.95

1.4

1.3

3.45

3.49

ug/l

0.04

604

6028

Hypothyreosis and Thyroxine purchase for inclusion criteria

1416

6294

1.48

39.88

1.4

1.3

3.02

3.58

ug/l

2.38

1286

5714

Torsion of ovary, ovarian pedicle and fallopian tube

8.39

39.13

1.7

1.3

2.44

4.64

ug/l

0.61

Outcome of delivery

457

1413

2.04

38.84

1.3

4.49

3.22

ug/l

2.21

432

1239

Caries of enamel

1293

5664

1.50

38.83

1.4

3.32

3.58

ug/l

0.60

1176

5061

Exclusions for E4_PCOS_BROAD

288

1283

2.29

36.73

1.4

3.49

4.22

ug/l

0.54

259

1150

Hypopituitarism

113

305

3.80

36.49

1.6

1.5

4.51

3.73

ug/l

0.21

102

277

Other symptoms and signs involving the digestive system and abdomen

234

957

2.48

36.23

1.8

1.4

4.38

3.61

ug/l

0.31

158

834

All anxiety disorders

1161

6035

1.51

36.14

1.3

3.32

3.58

ug/l

0.67

1076

5490

Other obstetric conditions, not elsewhere classified

1291

5589

1.49

35.54

1.3

3.29

3.34

ug/l

0.12

1228

5188

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1289

5572

1.49

35.46

1.3

3.28

3.34

ug/l

0.16

1228

5182

Gestational diabetes (for exclusion)

1258

5990

1.47

33.40

1.3

3.36

3.27

ug/l

0.30

1190

5506

Lymphoid leukaemia

119

5.51

32.95

2.1

1.5

3.93

3.30

ug/l

0.18

Diseases of oesophagus, stomach and duodenum

605

5923

0.60

32.76

1.4

4.05

3.43

ug/l

0.41

522

5307

Anxiety (asthma-related co-morbidities)

1098

5639

1.49

32.72

1.3

3.30

3.64

ug/l

0.88

1015

5115

Ovarian dysfunction, other/unspecified

7.99

32.53

1.6

1.2

2.22

2.65

ug/l

0.30

Hypothyroidism, strict autoimmune

1211

5459

1.47

32.29

1.4

3.15

3.67

ug/l

1.76

1105

4968

Diabetes, insulin treatment (Kela reimbursement)

329

3821

0.51

31.94

1.5

1.4

5.39

3.59

ug/l

0.39

263

3274

Other complications of labour and delivery, not elsewhere classified

661

3631

1.69

31.50

1.3

3.65

3.25

ug/l

1.26

641

3439

Behavioural syndromes associated with physiological disturbances and physical factors

1283

6080

1.44

30.91

1.3

1.4

3.34

3.65

ug/l

0.76

1178

5461

Statin medication

354

3764

0.53

30.90

1.3

1.4

2.82

3.21

ug/l

0.84

284

3356

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

327

3697

0.52

29.47

1.5

1.4

5.39

3.45

ug/l

0.43

263

3176

Periodontitis

426

4782

0.56

29.42

1.6

1.4

3.23

3.44

ug/l

0.13

346

4206

Chronic periodontitis, including avohilmo

424

4762

0.56

29.22

1.6

1.4

3.22

3.44

ug/l

0.14

345

4187

Insomnia

1271

6265

1.42

28.94

1.3

1.4

3.09

3.59

ug/l

2.38

1169

5641

Other heart diseases, wide

592

5787

0.61

28.91

1.4

2.70

3.57

ug/l

5.41

496

5189

Serous carcinoma of ovary, including Hilmo

9.92

27.74

3.4

1.2

8.70

3.17

ug/l

0.50

Any gastric operation

1344

4825

1.41

27.27

1.5

1.2

3.77

3.49

ug/l

0.36

1224

4524

GASTRO-related operations

1344

4825

1.41

27.27

1.5

1.2

3.77

3.49

ug/l

0.36

1224

4524

Salpingitis and oophoritis

202

881

2.33

27.23

1.6

1.5

3.16

4.04

ug/l

0.31

175

703

Sleep disorders

1226

6035

1.41

26.54

1.3

1.4

3.13

3.59

ug/l

1.67

1124

5421

Neurotic, stress-related and somatoform disorders

1240

6127

1.40

26.31

1.4

3.43

3.63

ug/l

0.35

1125

5511

Sleep apnoea, including avohilmo

411

4278

0.58

25.99

1.5

1.4

3.39

3.44

ug/l

0.03

319

3730

All pneumoniae

682

6758

0.65

25.86

1.4

2.97

3.63

ug/l

2.77

590

6102

Postpartum haemorrhage

760

4160

1.54

25.80

1.3

3.77

3.24

ug/l

0.49

711

3802

Polyarthropathies

341

3946

0.55

25.72

1.4

4.15

3.58

ug/l

0.44

303

3538

Anxiety disorders

1240

6126

1.40

25.70

1.4

3.43

3.63

ug/l

0.34

1125

5509

Pneumonias (Asthma/COPD co-morbidities)

672

6703

0.65

25.67

1.4

2.96

3.63

ug/l

2.82

582

6047

Pain in throat and chest

589

5456

0.63

25.00

1.3

1.4

2.91

3.67

ug/l

2.56

519

4947

Influenza and pneumonia

792

7174

0.68

24.64

1.4

3.10

3.64

ug/l

2.27

688

6517

Nerve, nerve root and plexus disorders

639

5854

0.65

24.07

1.4

3.10

3.40

ug/l

0.44

542

5248

Ectopic pregnancy

332

1825

1.85

24.01

1.4

3.00

4.09

ug/l

1.61

309

1610

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

636

6431

0.65

23.71

1.4

2.95

3.62

ug/l

2.82

547

5784

Artrosis, including avohilmo

328

3200

0.56

23.44

1.5

1.4

2.79

3.41

ug/l

0.58

265

2764

Exclusions for E4_PCOS_CONSORTIUM

1284

5909

1.37

22.88

1.7

1.2

4.19

3.24

ug/l

1.10

1074

5475

Postmenopausal bleeding

121

3.74

22.45

2.3

3.3

2.28

27.62

ug/l

0.87

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1268

4968

1.36

21.73

1.5

1.3

4.02

3.58

ug/l

0.33

1116

4484

Routine general health check-up of defined subpopulation

197

3.74

21.72

2.4

1.3

2.46

4.29

ug/l

1.87

184

Congenital malformations of genital organs

278

1495

1.91

21.47

1.5

1.4

4.21

3.74

ug/l

0.23

254

1391

Symptoms and signs involving cognition, perception, emotional state and behaviour

587

5905

0.66

21.04

1.4

3.12

3.56

ug/l

1.13

504

5280

Cardiac arrhythmias

430

4436

0.62

21.03

1.4

1.3

2.81

3.39

ug/l

1.92

372

3995

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1253

5980

1.35

20.99

1.4

3.10

3.72

ug/l

2.39

1136

5383

Benign leiomyoma with endometriosis

125

497

2.54

20.75

1.4

1.6

1.90

3.76

ug/l

1.76

106

357

Donors of organs and tissues

111

4.71

20.47

1.3

1.4

3.05

3.33

ug/l

0.34

104

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1029

6865

1.37

20.32

1.4

1.3

3.61

3.51

ug/l

0.12

938

6261

Tonsillectomy and adenotomy

1190

6174

1.35

20.26

1.3

3.38

3.44

ug/l

0.11

1112

5678

Disorders of tooth development and eruption

324

1501

1.78

20.16

1.5

1.3

3.24

3.34

ug/l

0.14

304

1378

Other intervertebral disc disorders

460

4312

0.63

20.08

1.3

1.4

3.74

3.42

ug/l

0.15

377

3874

Hypothyroidism, strict autoimmune, 3 medication purchases required

1225

6184

1.34

19.53

1.4

1.3

3.13

3.54

ug/l

1.33

1102

5606

All kidney diseases

732

6981

0.70

19.51

1.5

1.3

4.23

3.50

ug/l

0.95

618

6344

Migraine, single triptan purchase ok & required. ICD-code if available is included

1182

6000

1.34

19.24

1.4

3.62

3.56

ug/l

0.05

1082

5421

Triptan medication for migraine, single purchase ok

1182

6000

1.34

19.24

1.4

3.62

3.56

ug/l

0.05

1082

5421

Non-Hodgkin lymphoma, all, including Hilmo

128

4.09

19.13

2.2

1.1

3.84

3.00

ug/l

0.14

107

Chronic apical periodontitis

893

6881

0.72

18.85

1.4

1.3

3.53

3.49

ug/l

0.04

783

6266

Perineal laceration during delivery

707

4014

1.46

18.30

1.2

1.3

3.53

3.23

ug/l

0.89

672

3765

Pneumonia, organism unspecified

552

5602

0.67

18.27

1.4

3.12

3.68

ug/l

1.19

474

5018

Sleep apnoea

306

3252

0.59

18.10

1.5

3.56

3.63

ug/l

0.03

227

2732

Disorders of gallbladder, biliary tract and pancreas

490

4614

0.66

17.96

1.3

1.4

2.75

3.49

ug/l

2.23

392

4064

Autoimmune diseases excluding thyroid diseases, strict definition

751

5716

0.71

17.70

1.2

1.4

3.19

3.80

ug/l

2.26

677

5200

Malignant neoplasm of breast, HER-negative

104

393

2.56

17.52

1.5

1.1

6.28

2.55

ug/l

0.36

307

Congenital malformations of uterus and cervix

104

424

2.65

17.27

1.3

3.45

3.19

ug/l

0.34

397

Postpartum hemorraghe, parous women as controls

760

4573

1.41

17.11

1.3

3.77

3.47

ug/l

0.25

711

4236

Other anxiety disorders

938

5922

1.36

17.09

1.3

3.42

3.47

ug/l

0.10

879

5452

Benign neoplasms

1432

6066

1.29

17.07

1.4

1.3

3.25

3.55

ug/l

0.67

1303

5647

Atopic dermatitis

1050

6298

1.34

17.06

1.4

1.3

3.40

3.57

ug/l

0.31

975

5735

Autoimmune diseases excluding thyroid diseases

780

5836

0.72

16.93

1.2

1.4

3.15

3.77

ug/l

2.43

704

5300

Hypertensive diseases

302

2832

0.60

16.78

1.7

1.4

3.61

3.49

ug/l

0.07

223

2383

Hypertension

301

2820

0.60

16.67

1.7

1.4

3.60

3.49

ug/l

0.06

222

2372

Cardiovascular diseases (excluding rheumatic etc)

828

6442

0.73

16.61

1.4

1.3

2.99

3.44

ug/l

1.30

726

6005

Diabetes mellitus in pregnancy

1046

5018

1.34

16.59

1.3

3.57

3.23

ug/l

1.24

993

4607

Chromosomal abnormalities, not elsewhere classified

245

3.11

16.58

1.5

4.55

3.75

ug/l

0.17

226

Fall on same level

986

6983

0.75

16.53

1.4

1.3

3.52

3.61

ug/l

0.13

865

6362

Long labour

656

3930

1.44

16.35

1.3

3.31

3.19

ug/l

0.20

618

3589

Arthrosis

208

2079

0.55

16.35

1.6

1.4

3.20

3.57

ug/l

0.17

157

1727

Hypertensive diseases (excluding secondary)

273

2673

0.59

16.07

1.7

1.4

3.57

3.28

ug/l

0.19

220

2350

Substance abuse, excluding more controls

273

3812

0.59

16.06

1.3

4.21

3.52

ug/l

0.24

244

3468

Abnormalities of breathing

791

6164

0.73

15.94

1.4

1.3

3.07

3.67

ug/l

1.74

693

5636

Oral corticosteroids

792

6316

0.73

15.83

1.4

2.74

3.57

ug/l

3.22

700

5690

Any event in cancer register

1175

5268

1.31

15.79

1.9

1.2

3.64

3.08

ug/l

0.63

929

4899

Intracranial trauma

518

5085

0.68

15.70

1.4

1.3

3.86

3.69

ug/l

0.10

472

4677

Other maternal disorders predominantly related to pregnancy

1104

5288

1.32

15.55

1.3

1.4

3.91

3.49

ug/l

0.62

1016

4746

Malignant neoplasm of breast, ER-negative, including Hilmo

115

469

2.31

15.47

1.5

1.2

5.75

2.55

ug/l

0.35

371

Spondylopathies

229

2360

0.57

15.41

1.4

1.5

3.08

3.77

ug/l

0.42

171

1995

Maternal care for known or suspected fetal abnormality and damage

571

3392

1.46

15.13

1.3

3.08

3.03

ug/l

0.11

549

3148

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

672

5419

0.72

14.77

1.4

2.91

3.66

ug/l

3.21

581

4901

672

5419

0.72

14.77

1.4

2.91

3.66

ug/l

3.21

581

4901

Family history of malignant neoplasm

197

1077

1.86

14.73

1.5

1.4

2.49

3.80

ug/l

2.25

160

951

Supervision of normal pregnancy

413

1532

1.56

14.52

1.4

4.64

3.28

ug/l

2.34

380

1334

Acute upper respiratory infections of multiple and unspecified sites

1039

5821

1.31

14.51

1.4

3.15

3.62

ug/l

1.72

958

5264

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

101

4.00

14.33

2.8

1.2

27.22

3.21

ug/l

0.48

Persons encountering health services in other circumstances, wide

1236

4968

1.28

14.12

1.4

1.3

3.46

3.58

ug/l

0.14

1091

4484

Complications of labour and delivery

1071

4585

1.31

14.10

1.4

3.92

3.48

ug/l

0.50

970

4098

Pain in limb

727

6234

0.74

14.02

1.4

3.45

3.63

ug/l

0.14

635

5716

Injuries to the shoulder and upper arm

397

4568

0.67

13.95

1.3

1.4

3.16

3.90

ug/l

2.12

343

4035

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

225

2.85

13.92

1.8

1.1

1.74

2.53

ug/l

1.10

166

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

422

3922

0.68

13.54

1.7

1.4

3.21

3.40

ug/l

0.14

317

3408

Cholelithiasis, broad definition with cholecystitis

422

4121

0.68

13.47

1.3

1.4

2.77

3.49

ug/l

1.80

341

3590

Cystitis

1197

5604

1.28

13.42

1.4

3.44

3.51

ug/l

0.10

1087

5079

Hernia

417

4061

0.68

13.22

1.7

1.4

3.17

3.60

ug/l

0.65

340

3518

Hypertension, essential

276

2498

0.62

13.21

1.8

1.4

3.58

3.42

ug/l

0.08

192

2070

Use of hypnotics and sedatives

659

5116

0.73

13.11

1.5

1.4

2.74

3.43

ug/l

2.24

561

4541

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1033

6262

1.29

13.04

1.3

3.12

3.44

ug/l

0.44

942

5679

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

561

5248

0.72

12.96

1.5

1.4

3.33

3.70

ug/l

0.75

488

4699

Anxiety disorders, excluding more controls

1014

5029

1.29

12.85

1.4

1.3

3.35

3.64

ug/l

0.52

913

4515

Cholelithiasis

405

4035

0.68

12.64

1.3

1.4

2.83

3.50

ug/l

1.48

324

3506

Persons encountering health services for specific procedures and health care

892

6806

0.77

12.52

1.6

1.3

3.32

3.61

ug/l

0.30

762

6202

Headache

946

5670

1.29

12.46

1.4

1.3

3.86

3.61

ug/l

0.24

844

5174

Recurrent or chronic depression

532

2621

1.42

12.39

1.3

3.00

3.85

ug/l

1.87

488

2346

Inflammatory diseases of female pelvic organs

1212

6632

1.26

12.35

1.4

1.3

3.31

3.50

ug/l

0.21

1089

6018

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

10.67

12.29

5.2

1.1

5.79

3.26

ug/l

—

Malignant neoplasm of urinary organs

5.36

12.28

1.9

1.2

2.59

3.51

ug/l

0.42

248

3439

0.62

12.15

1.3

3.09

3.68

ug/l

1.43

226

3115

463

2.26

12.04

1.4

1.3

6.15

3.65

ug/l

0.37

439

Hypertrichosis

418

2.33

12.00

1.3

4.39

3.19

ug/l

2.06

392

Female genital prolapse

121

319

2.12

11.90

1.6

2.0

4.73

6.69

ug/l

0.26

211

Malignant neoplasm of urinary organs, including Hilmo

4.67

11.87

1.8

1.1

2.54

3.49

ug/l

0.52

Depression

1178

6298

1.25

11.82

1.3

1.4

3.03

3.64

ug/l

3.04

1069

5685

Shoulder lesions

261

2467

0.63

11.82

1.5

2.31

3.66

ug/l

3.06

192

2081

Malignant neoplasm of kidney, except renal pelvis

5.37

11.81

1.9

1.2

2.59

3.25

ug/l

0.28

Renal tubulo-interstitial diseases

612

6029

0.74

11.77

1.5

1.4

3.62

3.65

ug/l

0.03

517

5441

Congenital malformations, deformations and chromosomal abnormalities

923

6847

1.28

11.74

1.4

1.3

3.66

3.43

ug/l

0.30

835

6281

Asthma/COPD (KELA code 203)

787

6833

0.77

11.69

1.4

3.55

3.64

ug/l

0.11

706

6190

Agranulocytosis

416

2.23

11.68

2.1

1.6

2.57

4.08

ug/l

1.12

347

Labour and delivery complicated by fetal stress [distress]

816

4082

1.32

11.64

1.3

3.28

3.25

ug/l

0.07

773

3783

Congenital ovarian cysts

137

728

1.95

11.57

1.6

1.3

4.38

3.39

ug/l

0.26

121

677

Low back pain

685

6104

0.75

11.51

1.4

3.29

3.54

ug/l

0.21

601

5602

Tramadol

452

3831

0.71

11.50

1.7

1.3

3.42

3.43

ug/l

0.00

385

3397

Hirsutism in women

388

2.36

11.47

1.2

1.3

4.48

3.21

ug/l

2.09

366

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

4.66

11.40

1.8

1.1

2.54

3.52

ug/l

0.53

Transplanted organ and tissue status

278

2.51

11.36

1.9

1.6

3.49

4.85

ug/l

0.35

241

Mental and behavioural disorders due to psychoactive substance use

287

3994

0.65

11.35

1.3

4.14

3.54

ug/l

0.22

257

3636

Mycoses, including avohilmo

1121

6835

1.25

11.33

1.4

3.35

3.56

ug/l

0.28

1021

6175

Dyspnoea

537

5281

0.73

11.28

1.5

1.4

3.10

3.61

ug/l

0.85

448

4700

Non-invasive ventilation

105

1785

0.50

11.27

1.4

3.54

3.48

ug/l

0.02

1595

Conjunctivitis

1071

6884

1.26

11.26

1.3

1.4

3.33

3.65

ug/l

0.74

971

6228

Other disorders of ear

408

3761

0.70

11.21

1.6

1.4

3.39

3.84

ug/l

0.47

344

3244

Other arrhythmias

331

3640

0.68

11.02

1.4

2.78

3.56

ug/l

2.35

282

3178

Lower back pain or/and sciatica

887

7009

0.78

11.01

1.3

1.4

3.32

3.50

ug/l

0.17

770

6372

Melanocytic naevi

434

3072

1.42

11.01

1.3

3.34

3.44

ug/l

0.13

385

2789

Premature rupture of membranes

691

3735

1.34

10.97

1.3

3.70

3.12

ug/l

0.58

647

3449

Postprocedural endocrine and metabolic disorders, not elsewhere classified

167

958

1.76

10.74

2.1

1.4

4.17

3.45

ug/l

0.12

125

838

Substance abuse

273

3838

0.66

10.63

1.3

4.21

3.51

ug/l

0.25

244

3494

Inflammatory bowel disease treatment related agents

992

6885

0.80

10.60

1.4

1.3

2.86

3.68

ug/l

4.00

889

6241

Conjunctivitis (acute, non atopic), including avohilmo

1129

5486

1.25

10.59

1.3

1.4

3.13

3.78

ug/l

2.57

1013

4939

Enlarged lymph nodes

172

998

1.74

10.58

1.7

1.3

3.34

3.83

ug/l

0.45

147

892

231

3227

0.64

10.50

1.3

1.4

3.06

3.73

ug/l

1.68

211

2931

Malignant neoplasm of mesothelium and soft tissue

4.52

10.50

2.0

1.2

1.74

3.78

ug/l

1.53

Contraceptive management

342

1615

1.49

10.46

1.4

4.27

3.80

ug/l

0.17

291

1346

Non-follicular lymphoma

106

3.42

10.40

2.1

1.6

1.34

5.92

ug/l

1.09

Disorders of conjunctiva

1100

6887

1.24

10.36

1.3

1.4

3.30

3.65

ug/l

0.88

997

6229

Pregnancy with abortive outcome

1210

5121

1.24

10.30

1.4

1.3

3.59

3.68

ug/l

0.11

1123

4615

Infections with a predominantly sexual mode of transmission, including avohilmo

914

6657

1.27

10.24

1.3

3.26

3.32

ug/l

0.16

860

6194

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

164

2.88

10.24

2.7

1.1

2.05

2.56

ug/l

0.51

120

ILD medications: prednisolone, methylprednisolone, prednisone

950

6605

0.80

10.15

1.4

1.3

2.80

3.67

ug/l

3.68

847

6000

Single delivery by caesarean section

590

2521

1.36

10.04

1.3

3.69

2.99

ug/l

1.86

557

2304

Condition for Implicit Sepsis (Organ dysfunction codes)

440

4197

0.72

9.92

1.6

1.4

3.43

3.83

ug/l

0.61

372

3726

Obstructed labour due to malposition and malpresentation of fetus

535

3702

1.35

9.83

1.3

3.22

3.11

ug/l

0.19

499

3353

Postmenopausal atrophic vaginitis

158

2.46

9.79

1.3

2.8

1.82

16.48

ug/l

0.91

Triptan medication for migraine, min. 3 purchases

1101

6700

1.24

9.76

1.3

3.12

3.53

ug/l

1.41

1009

6122

Chronic diseases of tonsils and adenoids

1056

5383

1.24

9.69

1.4

3.42

3.73

ug/l

0.71

966

4870

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

436

5169

0.73

9.60

1.3

3.83

3.68

ug/l

0.18

412

4941

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

277

2591

0.67

9.57

1.6

1.4

3.43

3.33

ug/l

0.05

213

2285

Medical abortion

732

5057

0.78

9.40

1.3

3.33

3.68

ug/l

0.32

662

4553

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

332

2307

1.45

9.37

1.4

3.19

3.81

ug/l

0.54

290

2006

Haemorrhage in early pregnancy

578

4284

1.32

9.22

1.3

2.98

3.15

ug/l

0.45

535

3864

Migraine

994

6275

1.24

9.21

1.3

3.31

3.61

ug/l

0.67

906

5760

Other disorders of urethra and urinary system

575

5230

0.76

9.15

1.4

1.3

3.17

3.54

ug/l

0.64

510

4720

Disorders of puberty

213

2.62

9.13

1.8

1.4

7.85

3.50

ug/l

1.32

205

Malignant neoplasm of other connective and soft tissue, including Hilmo

4.01

9.06

2.8

1.2

1.72

3.90

ug/l

1.87

Follow-up examination after treatment for malignant neoplasms

159

2.78

9.05

2.8

1.8

2.61

7.70

ug/l

0.77

105

Other metabolic disorders

171

1038

1.66

9.01

2.2

1.4

4.16

3.45

ug/l

0.12

129

910

Disorders of puberty, all

283

2.39

8.98

1.8

1.5

7.10

3.98

ug/l

1.10

268

Other bacterial diseases, including avohilmo

672

5372

0.78

8.97

1.6

1.4

3.36

3.68

ug/l

0.40

533

4818

Factors influencing health status and contact with health services

151

429

1.77

8.85

1.4

3.05

4.88

ug/l

0.98

133

357

Congenital malformations of ovaries, fallopian tubes and broad ligaments

146

860

1.74

8.82

1.5

1.4

4.28

3.77

ug/l

0.12

129

795

Other diseases of blood and blood-forming organs, wide

149

877

1.71

8.77

1.8

1.5

2.57

3.84

ug/l

2.01

110

747

Hard cardiovascular diseases

148

1462

0.60

8.73

1.9

1.6

3.57

4.95

ug/l

0.59

100

1066

Mood [affective] disorders

1188

6300

1.21

8.66

1.3

1.4

3.01

3.64

ug/l

3.24

1066

5685

Mood disorders

1189

6301

1.21

8.58

1.3

1.4

3.01

3.64

ug/l

3.26

1067

5685

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1078

6915

1.22

8.51

1.4

3.72

3.58

ug/l

0.14

954

6276

Malignant neoplasm of corpus uteri

4.17

8.45

2.0

1.1

0.45

2.55

ug/l

—

Colorectal cancer

153

2.70

8.35

1.8

1.1

2.41

2.65

ug/l

0.11

107

Metabolic disorders

463

3699

0.75

8.31

1.8

1.4

3.32

3.70

ug/l

0.18

362

3194

Malignant neoplasm of corpus uteri, including Hilmo

3.63

8.27

1.8

1.1

4.27

2.32

ug/l

0.21

Complications of the puerperium, not elsewhere classified

140

837

1.73

8.14

1.3

3.31

3.82

ug/l

0.45

134

780

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1027

6235

1.22

8.13

1.3

3.10

3.44

ug/l

0.46

937

5662

Maternal care related to the fetus and amniotic cavity and possible delivery problems

877

4161

1.24

8.08

1.3

1.4

4.25

3.38

ug/l

1.19

803

3751

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

495

3686

1.32

8.08

1.5

1.4

2.80

3.65

ug/l

1.35

418

3208

Ischemic heart diseases

118

1218

0.58

8.07

1.8

1.7

1.86

5.06

ug/l

3.17

848

Failed induction of labour

254

1747

1.50

8.07

1.2

1.3

3.01

3.32

ug/l

0.59

238

1661

Major coronary heart disease event

1033

0.54

7.94

1.7

1.8

1.84

5.44

ug/l

2.73

684

Concussion

477

4847

0.76

7.91

1.4

1.3

3.85

3.72

ug/l

0.07

437

4453

Examination and observation for other reasons

695

3092

1.27

7.87

1.4

1.3

3.15

3.98

ug/l

1.74

620

2824

Colorectal cancer, including Hilmo

175

2.51

7.85

2.1

1.1

2.30

2.53

ug/l

0.12

125

Necrosis of pulp, including avohilmo

430

5622

0.75

7.79

1.4

3.39

3.51

ug/l

0.13

385

5048

Other septicaemia

192

1169

1.55

7.74

1.7

1.5

3.97

4.54

ug/l

0.25

149

1011

Drug-induced neutropenia

198

2.45

7.66

2.2

1.7

1.41

4.28

ug/l

1.33

161

Other septicaemia, including avohilmo

197

1204

1.54

7.65

1.7

1.5

3.94

4.49

ug/l

0.25

153

1045

Other heart diseases

333

2980

0.72

7.63

1.4

2.46

3.73

ug/l

7.00

274

2670

Implicit Sepsis, including avohilmo

424

4019

0.75

7.62

1.6

1.4

3.50

3.84

ug/l

0.48

358

3566

Pregnancy, childbirth and the puerperium

477

1881

1.33

7.49

1.3

1.4

3.88

3.16

ug/l

2.58

448

1690

Disorders of lipoprotein metabolism and other lipidaemias

165

1570

0.64

7.43

1.8

1.6

2.86

4.31

ug/l

1.44

110

1195

Artificial joint operation, meniscal resection

205

1959

0.67

7.42

1.8

1.5

3.92

4.19

ug/l

0.11

154

1533

Alcohol use disorder, Swedish definition

193

2634

0.66

7.39

1.3

1.4

3.08

3.69

ug/l

1.10

176

2351

Used for control exclusion in common control thyroid runs

1307

5574

1.19

7.34

1.3

1.4

3.33

3.79

ug/l

1.48

1197

5079

Hyperkinetic disorders

252

3473

0.70

7.26

1.3

3.96

3.83

ug/l

0.09

241

3319

Type 2 diabetes, wide definition

179

1723

0.65

7.22

1.5

2.38

3.78

ug/l

2.34

127

1348

Lumbar disc prolapse

355

3544

0.74

7.18

1.4

4.15

3.47

ug/l

0.27

291

3135

Intestinal infectious diseases, including avohilmo, including avohilmo

1245

5860

1.19

7.17

1.4

3.08

3.74

ug/l

3.12

1118

5275

Dizziness and giddiness

427

4355

0.76

7.14

1.4

3.15

3.63

ug/l

1.05

366

3827

Disturbance of activity and attention

246

3396

0.70

7.14

1.3

3.94

3.77

ug/l

0.12

235

3252

Suicide or other Intentional self-harm

163

2493

0.65

6.97

1.3

1.4

2.91

3.59

ug/l

1.55

147

2277

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

445

3400

1.31

6.93

1.4

2.76

3.65

ug/l

1.26

377

2944

Diabetic retinopathy, excluding more controls

759

0.52

6.92

1.3

1.5

3.80

5.84

ug/l

1.36

683

Disorders of choroid and retina

218

2217

0.69

6.91

1.7

1.5

6.97

3.78

ug/l

0.51

183

1828

Mental and behavioural disorders due to alcohol

212

2930

0.69

6.86

1.2

1.4

3.05

3.47

ug/l

0.99

192

2652

Colorectal adenocarcinoma

3.17

6.79

2.2

1.1

2.91

2.63

ug/l

0.06

Short stature, not elsewhere classified

299

2.09

6.79

1.9

1.4

10.54

4.13

ug/l

1.20

288

Asthma, unspecified (mode), excluding more controls

376

3563

0.75

6.75

1.5

1.3

2.78

3.62

ug/l

3.82

338

3206

Emergency coronary revascularization (for ACS)

968

0.57

6.71

1.4

1.9

1.52

5.70

ug/l

3.29

632

Intestinal infectious diseases

1095

6875

1.19

6.70

1.4

3.17

3.63

ug/l

2.04

984

6234

Other nutritional deficiencies

900

6846

1.20

6.65

1.3

3.34

3.51

ug/l

0.35

824

6203

Molar incisor enamel hypoplasia

111

630

1.73

6.61

1.8

1.4

5.62

4.60

ug/l

0.31

598

Gonarthrosis

123

1131

0.61

6.60

1.9

1.6

3.88

4.40

ug/l

0.13

836

Kela-code for severe mental illness

208

2998

0.69

6.55

1.4

1.3

3.43

3.60

ug/l

0.19

177

2724

Coronary revascularization (ANGIO or CABG)

951

0.57

6.55

1.4

1.8

1.52

5.72

ug/l

3.26

625

Other specific joint derangements/joint disorders

834

6264

0.83

6.53

1.3

3.60

3.59

ug/l

0.00

740

5777

Asthma, unspecified (mode)

376

3575

0.76

6.53

1.5

1.3

2.78

3.79

ug/l

3.48

338

3208

Gonarthrosis [arthrosis of knee](FG)

131

1205

0.62

6.52

1.9

1.7

3.80

4.29

ug/l

0.12

841

Schizophrenia or delusion, excluding more controls

173

2543

0.67

6.48

1.5

1.3

3.64

3.58

ug/l

0.06

149

2322

Melanocytic naevi of trunk

152

977

1.57

6.48

1.3

1.4

3.09

4.07

ug/l

1.20

132

894

Injuries to the head

995

6999

0.84

6.42

1.4

1.3

3.61

3.59

ug/l

0.02

898

6332

Intestinal stricture

114

683

1.67

6.40

1.2

1.6

1.93

4.43

ug/l

2.38

546

Hypoplasia of dental enamel , including avohilmo

105

597

1.74

6.37

1.8

1.4

5.79

4.60

ug/l

0.36

565

Hyperkinetic disorders, excluding more controls

251

3233

0.71

6.33

1.3

1.2

3.53

3.64

ug/l

0.13

240

3096

Postpartum hemorraghe, all women as controls

760

6132

1.22

6.33

1.3

3.77

3.23

ug/l

0.51

711

5706

Malignant neoplasm of colon

2.89

6.29

1.5

1.1

2.88

2.93

ug/l

0.02

Percutaneous Coronary Intervention

949

0.58

6.29

1.4

1.8

1.52

5.73

ug/l

3.26

624

Rheumatoid arthritis

1414

0.59

6.28

1.3

1.4

2.70

4.17

ug/l

1.47

1180

Unspecified mental disorder

280

3806

0.73

6.24

1.4

1.3

3.23

3.51

ug/l

0.49

245

3477

Appendectomy

787

6204

1.21

6.23

1.7

1.3

4.90

3.20

ug/l

0.93

671

5620

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

199

2.28

6.21

2.0

1.2

2.97

2.98

ug/l

0.01

178

Diseases of middle ear and mastoid

960

6607

1.19

6.21

1.3

3.66

3.38

ug/l

0.36

896

6133

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

133

2.60

6.16

1.9

1.4

4.64

2.73

ug/l

0.34

118

Erysipelas, including avohilmo

211

2224

0.70

6.05

1.5

3.38

4.07

ug/l

0.37

154

1867

Septicaemia

212

1347

1.44

5.98

1.8

1.5

3.92

4.57

ug/l

0.33

165

1165

Malignant melanoma, including Hilmo

268

2.06

5.96

1.2

2.25

2.77

ug/l

0.77

224

Gonarthrosis,primary

104

1032

0.61

5.94

2.1

1.8

4.49

5.11

ug/l

0.11

635

Malignant neoplasm of endocrine gland, including Hilmo

331

1.95

5.92

1.6

1.2

2.38

2.96

ug/l

0.60

293

Undescended testicle

15.23

5.91

1.9

1.2

13.28

36.44

ug/l

—

Other disorders involving the immune mechanism, not elsewhere classified

142

2.51

5.90

1.9

1.5

4.56

2.70

ug/l

0.34

124

Schizophrenia, schizotypal and delusional disorders

173

2525

0.68

5.89

1.5

1.4

3.64

3.54

ug/l

0.10

149

2292

Other other unspecified disorders of the circulatory system

3.55

5.89

2.2

1.9

2.63

5.24

ug/l

—

Schizophrenia or delusion

173

2524

0.68

5.88

1.5

1.4

3.64

3.54

ug/l

0.10

149

2292

Insulin medication

249

2835

0.73

5.82

1.3

1.4

3.59

3.62

ug/l

0.03

217

2503

Autoimmune diseases

1339

5879

1.16

5.79

1.3

1.4

3.43

3.78

ug/l

0.96

1225

5342

Diseases of pulp and periapical tissues, including avohilmo

1005

6109

0.85

5.78

1.4

1.3

3.82

3.64

ug/l

0.23

916

5569

Conductive and sensorineural hearing loss

212

1983

0.71

5.71

1.7

1.5

3.73

4.34

ug/l

0.31

164

1605

Benzodiazepine use

855

6844

0.84

5.69

1.4

2.88

3.51

ug/l

2.90

740

6208

Diabetic retinopathy

827

0.57

5.63

1.3

1.5

3.80

5.59

ug/l

1.24

735

Other diseases of intestines

1056

6861

0.85

5.59

1.4

3.00

3.69

ug/l

3.76

941

6280

Varicose veins

1210

0.61

5.59

2.4

1.6

5.23

4.82

ug/l

0.05

866

Other bacterial intestinal infections, including avohilmo

190

1325

1.44

5.49

1.5

1.4

3.29

3.95

ug/l

0.47

166

1173

Other and unspecified iron deficiency

300

2252

1.33

5.46

1.3

1.4

3.86

3.73

ug/l

0.07

278

1996

Malignant melanoma

237

2.07

5.45

1.1

1.2

2.30

2.75

ug/l

0.60

204

Placenta praevia

138

912

1.55

5.43

1.3

2.60

3.08

ug/l

0.76

131

841

Certain disorders involving the immune mechanism

118

747

1.59

5.41

1.8

1.4

4.78

3.65

ug/l

0.31

103

625

Maternal care for known or suspected malpresentation of fetus

593

3459

1.24

5.41

1.3

3.33

3.05

ug/l

0.75

565

3195

Other degenerative diseases of the nervous system

1003

0.59

5.40

1.2

1.5

2.59

3.81

ug/l

1.36

868

Infections of genitourinary tract in pregnancy

114

1762

0.64

5.36

1.2

1.3

3.25

3.20

ug/l

0.06

102

1649

Zoster [herpes zoster], including avohilmo

341

2525

1.31

5.35

1.5

3.26

3.94

ug/l

0.59

284

2170

Anaemias

465

2368

1.27

5.31

1.4

1.2

3.31

3.34

ug/l

0.03

422

2263

Other diseases of urinary system

1159

5616

1.16

5.30

1.4

3.64

3.55

ug/l

0.09

1049

5085

ILD medications

1087

6787

0.86

5.27

1.4

1.3

2.92

3.70

ug/l

3.49

975

6176

L04AD Calcineurin inhibitors

492

1.72

5.24

1.6

3.40

4.54

ug/l

0.45

428

Schizophrenia

823

0.48

5.20

1.3

1.4

2.59

3.68

ug/l

1.05

730

Inguinal hernia

145

1427

0.67

5.20

1.3

1.4

3.80

3.85

ug/l

0.03

128

1265

Leiomyoma of uterus

554

2515

1.24

5.20

1.6

1.4

4.35

3.16

ug/l

0.53

422

2078

Malignant neoplasm of digestive organs, including Hilmo

292

1.81

5.18

2.2

1.1

2.03

2.47

ug/l

0.43

208

Dermatitis and eczema

1238

6374

1.15

5.16

1.4

3.33

3.59

ug/l

0.53

1121

5747

Other retinal disorders

156

1722

0.69

5.13

1.6

1.5

4.24

3.84

ug/l

0.20

127

1426

Meniscus derangement

144

1412

0.67

5.12

1.3

1.5

2.89

4.10

ug/l

0.93

106

1127

Other congenital malformations

149

1009

1.49

5.11

1.6

1.3

4.95

3.90

ug/l

0.46

139

942

Malignant neoplasm of digestive organs

246

1.90

5.09

1.6

1.1

2.30

2.51

ug/l

0.14

168

Insulin, fast-acting (human)

1280

0.59

5.08

1.3

4.20

3.64

ug/l

0.39

1185

Malignant neoplasm of colon, including Hilmo

127

2.43

5.06

1.5

1.1

2.53

2.70

ug/l

0.06

Other endocrine disorders

492

1.70

5.04

1.8

1.4

8.39

3.77

ug/l

1.09

467

Malignant neoplasm of rectum, including Hilmo

3.28

5.02

3.1

1.1

1.37

3.01

ug/l

—

Temporomandibular joint disorders, including avohilmo

839

6922

1.18

5.01

1.3

2.92

3.44

ug/l

2.36

779

6345

Malignant neoplasm of respiratory system and intrathoracic organs

2.70

5.00

2.1

1.1

2.40

3.24

ug/l

0.43

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

114

2.38

4.96

2.0

1.2

2.18

3.30

ug/l

0.89

Other and unspecified nonorganic psychotic disorders

134

1978

0.67

4.96

1.5

1.4

3.83

3.64

ug/l

0.16

120

1818

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

139

2032

0.68

4.91

1.3

1.4

2.54

3.69

ug/l

3.83

125

1877

Constipation

455

3823

0.80

4.89

1.4

3.36

3.92

ug/l

0.70

365

3309

Iron deficiency anaemia

336

2560

1.29

4.87

1.4

3.75

3.66

ug/l

0.05

304

2252

Other surgical follow-up care

321

1.87

4.82

1.3

1.4

3.71

3.73

ug/l

0.01

300

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

780

6348

1.18

4.78

1.4

3.47

3.58

ug/l

0.15

712

5721

Parasetamol

1028

4481

1.16

4.76

1.4

1.3

4.19

3.77

ug/l

0.42

927

4169

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

3.58

4.76

2.3

1.1

1.20

3.14

ug/l

—

Carpal tunnel syndrome

267

3040

0.76

4.76

1.4

1.5

2.44

3.65

ug/l

2.95

213

2546

Allergic conjunctivitis

811

6656

1.18

4.74

1.4

1.3

3.47

3.56

ug/l

0.14

735

6004

Diabetes medication

890

6050

0.86

4.70

1.4

5.59

3.23

ug/l

2.89

801

5421

Other and unspecified immunodeficiencies with predominantly antibody defects

3.19

4.68

2.8

1.3

13.85

3.23

ug/l

0.73

Mental and behavioural disorders due to alcohol, excluding acute intoxication

149

2115

0.70

4.66

1.2

1.4

3.04

3.60

ug/l

0.88

134

1892

Malignant melanoma of skin, including Hilmo

225

2.01

4.64

1.1

2.24

2.73

ug/l

0.60

192

Malignant neoplasm of brain, including Hilmo

159

2.22

4.63

2.1

1.2

3.16

3.01

ug/l

0.08

147

Cardiovascular diseases

1046

6379

0.87

4.63

1.4

1.3

3.19

3.55

ug/l

1.16

948

5981

Colectomy operation

310

1.85

4.59

1.9

1.7

4.23

4.02

ug/l

0.04

245

Depression medications

587

2438

1.22

4.54

1.4

1.2

3.34

ug/l

0.00

553

2333

Disorders of adult personality and behaviour

338

4269

0.79

4.52

1.3

3.31

3.50

ug/l

0.23

313

3984

Poisoning by drugs, medicaments and biological substances

210

2822

0.74

4.50

1.3

2.88

3.59

ug/l

2.28

191

2600

Fever of other and unknown origin

588

4247

1.20

4.44

1.6

1.3

3.34

3.76

ug/l

0.62

505

3855

Personality disorders

310

3944

0.78

4.42

1.4

1.3

2.96

3.49

ug/l

1.96

288

3670

Pain in joint

672

3472

1.19

4.40

1.3

1.4

3.74

3.80

ug/l

0.04

595

3183

Chronic lower respiratory diseases

1140

6838

0.88

4.40

1.4

3.19

3.64

ug/l

1.51

1033

6194

Benign neoplasm of other and unspecified female genital organs

203

2.05

4.40

1.7

1.6

2.34

4.36

ug/l

0.87

175

Benign neoplasm of other and unspecified endocrine glands

488

1.65

4.36

1.3

1.6

2.40

4.10

ug/l

1.82

410

Delivery, wide proxy

555

2434

1.22

4.35

1.3

1.4

4.33

3.04

ug/l

4.92

517

2201

Injuries to the knee and lower leg

1115

6867

0.88

4.35

1.4

1.3

3.68

3.58

ug/l

0.15

982

6245

Implicit Sepsis

348

3221

0.79

4.31

1.6

1.4

3.63

3.95

ug/l

0.34

292

2833

Diabetes mellitus

912

6072

0.86

4.28

1.5

1.4

5.48

3.25

ug/l

2.76

825

5446

Other anaemias

168

1124

1.40

4.26

1.7

1.5

3.49

4.30

ug/l

0.44

136

930

Seropositive rheumatoid arthritis

979

0.58

4.24

1.2

1.6

2.89

4.10

ug/l

0.82

777

Artificial opening status

108

2.42

4.22

1.3

1.5

2.52

3.60

ug/l

1.10

Aplastic and other anaemias

191

1278

1.37

4.22

1.8

1.5

3.37

4.15

ug/l

0.50

159

1066

Myeloid leukaemia

3.29

4.20

1.3

1.6

3.09

3.28

ug/l

—

Codeine or tramadol medication

1069

6611

0.88

4.15

1.4

1.3

3.46

3.47

ug/l

0.01

975

5987

Other and unspecified anaemias

165

1112

1.39

4.10

1.8

1.5

3.51

4.33

ug/l

0.44

135

919

Acute posthaemorrhagic anaemia

2.73

4.09

1.6

1.4

2.77

3.36

ug/l

0.35

Disorders of eyelid, lacrimal system and orbit

582

5059

0.84

4.07

1.3

1.4

2.93

3.58

ug/l

1.39

489

4478

Pure hypercholesterolaemia

134

1217

0.70

4.07

1.8

1.6

3.15

4.80

ug/l

1.15

894

Sub-endpoint used in defining T1D endpoints

154

2100

0.72

4.05

1.3

1.4

3.93

3.85

ug/l

0.06

141

1924

Poisoning by medicine

197

2626

0.75

4.05

1.2

1.3

2.90

3.61

ug/l

2.07

181

2422

Personality disorders, excluding more controls

310

3886

0.79

4.03

1.4

1.3

2.96

3.40

ug/l

1.70

288

3622

Insulin, intermediate and long-acting

187

2426

0.74

4.03

1.3

1.5

3.83

3.90

ug/l

0.05

159

2133

Insulin, combination of fast acting with intermediate-acting or long-acting

249

2921

0.77

4.03

1.3

1.4

3.59

3.75

ug/l

0.18

217

2593

Rotator cuff syndrome

158

1508

0.72

4.02

1.5

1.6

2.43

4.17

ug/l

2.00

110

1181

Schizoaffective disorder

603

0.48

4.02

1.1

1.4

3.14

3.77

ug/l

0.42

555

Mood disorders, excluding more controls

980

5025

1.15

4.02

1.3

3.03

3.62

ug/l

2.26

875

4510

Bronchitis

1236

6568

1.13

4.02

1.4

1.3

3.14

3.60

ug/l

1.69

1125

5925

Specific personality disorders

280

3553

0.78

3.97

1.4

1.3

2.97

3.53

ug/l

1.96

259

3314

Acute tubulo-interstitial nephritis

485

4911

0.83

3.93

1.4

3.66

3.74

ug/l

0.07

412

4455

Dental caries

205

1450

1.34

3.93

1.6

1.4

3.79

4.23

ug/l

0.18

170

1294

Gastro-oesophageal reflux disease

332

3490

0.80

3.92

1.5

1.4

3.74

3.67

ug/l

0.03

279

2994

Benign neoplasm of bone and articular cartilage

511

1.60

3.91

1.8

1.4

4.94

3.81

ug/l

0.30

462

Rheumatoid arthritis, including avohilmo

126

1795

0.70

3.91

1.3

1.5

2.50

3.78

ug/l

2.38

112

1489

Malignant neoplasm of rectum

3.26

3.90

2.4

1.1

1.20

3.01

ug/l

—

Diabetes, varying definitions

905

6005

0.87

3.87

1.5

1.4

5.50

3.25

ug/l

2.78

819

5382

Other disorders of adrenal gland

249

1.87

3.86

1.5

2.47

3.63

ug/l

0.63

224

STROKE

121

1172

0.69

3.85

2.1

1.6

3.75

5.11

ug/l

0.47

894

Symptoms and signs involving the digestive system and abdomen

1011

4440

1.14

3.81

1.4

1.3

4.21

3.67

ug/l

0.56

891

4061

Other congenital malformations, including avohilmo

205

1549

1.33

3.81

1.5

1.4

4.17

4.05

ug/l

0.05

194

1431

Other bacterial intestinal infections

110

747

1.48

3.79

1.6

1.5

3.90

3.98

ug/l

0.03

659

Other and unspecified coagulation defects

454

1.63

3.78

1.4

3.36

3.29

ug/l

0.04

415

Persons encountering health services in other circumstances

492

4069

1.20

3.77

1.3

3.31

3.68

ug/l

0.96

448

3729

Candidiasis, including avohilmo

436

3610

1.21

3.74

1.4

1.3

3.19

3.48

ug/l

0.63

408

3315

Alcohol use disorder, ICD-based

145

1998

0.72

3.70

1.2

1.4

3.03

3.63

ug/l

0.93

130

1789

Seropositive rheumatoid arthritis, wide

947

0.60

3.70

1.2

1.6

2.89

4.25

ug/l

0.94

765

Complications of medical and surgical care

628

4819

1.17

3.68

1.5

1.4

2.74

3.53

ug/l

1.75

526

4257

Nutritional anaemias

351

2711

1.24

3.66

1.4

3.70

3.63

ug/l

0.04

315

2371

Other/unspecified seropositive rheumatoid arthritis

931

0.60

3.65

1.3

1.6

2.92

4.26

ug/l

0.89

753

Other disorders of lacrimal gland

280

2216

1.27

3.64

1.4

1.5

2.45

4.06

ug/l

3.46

229

1894

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

929

0.60

3.63

1.3

1.6

2.92

4.26

ug/l

0.89

753

Caries of dentine, including avohilmo

549

3322

0.84

3.62

1.5

1.4

3.88

3.81

ug/l

0.04

488

2974

Zoster [herpes zoster]

617

1.51

3.60

1.8

1.5

2.50

4.05

ug/l

2.09

527

Maternal care for other known or suspected fetal problems

721

3909

1.17

3.60

1.2

1.3

3.53

3.22

ug/l

1.11

679

3613

Adenocarcinoma and papilloma adenocarcinoma of rectum

3.51

3.60

2.4

1.1

1.20

3.24

ug/l

—

Periapical abscess

204

2659

0.77

3.57

1.7

1.4

3.26

4.05

ug/l

0.94

179

2307

Family history of certain disabilities and chronic diseases leading to disablement

112

777

1.46

3.57

1.4

1.3

2.78

4.04

ug/l

1.74

102

731

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

394

4759

0.82

3.56

1.3

3.00

3.39

ug/l

1.46

367

4434

199

2585

0.76

3.56

1.3

2.61

3.27

ug/l

2.75

189

2426

Emotionally unstable personality disorder

185

2431

0.75

3.55

1.3

3.20

3.66

ug/l

0.92

171

2285

Single delivery by forceps and vacuum extractor

489

2449

1.20

3.52

1.3

4.30

2.95

ug/l

1.37

460

2254

Leiomyosarcoma

10.18

3.51

1.0

1.3

—

1.02

—

Disorders of lens

787

0.66

3.47

1.7

1.8

16.31

4.18

ug/l

0.45

531

Other diseases of intestine

287

1.75

3.47

1.4

1.9

2.02

4.79

ug/l

1.61

215

Other disorders of the genitourinary system

280

1.76

3.46

2.0

1.8

5.51

4.59

ug/l

0.09

206

Foreign body on external eye

535

1.54

3.45

1.4

2.90

3.55

ug/l

0.80

488

Type 1 diabetes, wide definition

139

1898

0.73

3.44

1.3

1.4

4.19

3.70

ug/l

0.45

127

1737

Other soft tissue disorders, not elsewhere classified

977

6273

0.88

3.43

1.3

1.4

3.33

3.68

ug/l

0.41

873

5754

Coxarthrosis

546

0.59

3.41

1.4

1.8

2.92

6.88

ug/l

1.13

336

Sensorineural hearing loss

172

1525

0.75

3.40

1.7

1.6

2.72

4.77

ug/l

2.31

126

1189

L01XE Protein kinase inhibitors

2.84

3.36

1.2

1.9

11.53

2.92

ug/l

—

Reimbursement for rheumatic diseases

306

3745

0.81

3.35

1.3

1.4

3.28

3.70

ug/l

0.37

262

3246

Haemorrhage from respiratory passages

153

998

1.36

3.31

1.6

4.05

4.88

ug/l

0.35

130

841

Acute upper respiratory infections

1097

5860

1.12

3.31

1.4

3.30

3.63

ug/l

0.87

986

5268

Caries of dentine

171

1239

1.33

3.30

1.5

1.4

3.35

3.98

ug/l

0.30

142

1108

Abdominal and pelvic pain

999

4440

1.13

3.30

1.4

1.3

4.30

3.67

ug/l

0.67

892

4061

Viral infections characterized by skin and mucous membrane lesions

385

3192

1.21

3.26

1.5

1.4

3.76

3.69

ug/l

0.03

329

2878

Malignant neoplasm of endocrine gland

301

1.71

3.25

1.6

1.2

2.32

2.89

ug/l

0.48

267

201

1554

1.30

3.23

1.6

1.3

3.68

3.61

ug/l

0.03

178

1429

Other neurological diseases

259

2511

0.80

3.21

1.7

1.5

3.30

4.00

ug/l

0.50

205

2120

Malignant neoplasm of eye, brain and central nervous system

123

2.13

3.20

2.0

1.2

2.72

3.09

ug/l

0.21

112

Type 1 diabetes, wide definition, subgroup 1

138

1863

0.74

3.20

1.3

1.4

4.19

3.72

ug/l

0.42

127

1707

Injuries to the ankle and foot

925

7011

1.13

3.18

1.3

1.4

3.09

3.65

ug/l

2.79

849

6370

Viral warts, including avohilmo

295

2394

1.24

3.16

1.4

1.3

4.63

3.62

ug/l

0.44

272

2194

Hernia of abdominal wall, postoperative

591

1.48

3.15

2.7

1.2

2.13

2.96

ug/l

2.02

518

Paralytic ileus and intestinal obstruction

587

1.48

3.14

1.2

1.7

1.82

4.63

ug/l

2.29

469

Other embolism and thrombosis

389

1.60

3.12

1.5

1.6

2.70

4.10

ug/l

1.00

330

Presence of other functional implants

723

0.65

3.11

2.4

1.7

16.60

5.37

ug/l

0.42

492

Other obstetric trauma

141

1047

1.37

3.10

1.2

1.3

3.40

3.67

ug/l

0.25

135

974

Iron deficiency anaemia secondary to blood loss (chronic)

469

1.54

3.09

1.7

1.5

4.44

3.86

ug/l

0.09

389

Need for immunization against other single viral diseases

2.71

3.07

1.8

1.3

2.96

3.56

ug/l

0.28

Benign neoplasm of other and ill-defined parts of digestive system

430

1.56

3.07

1.5

1.6

3.41

4.41

ug/l

0.53

342

Coxarthrosis [arthrosis of hip](FG)

598

0.62

3.06

1.5

1.9

3.43

6.73

ug/l

0.87

348

Chronic periodontitis, complicated

133

1750

0.74

3.05

1.6

1.5

4.44

4.18

ug/l

0.05

100

1386

Other female pelvic inflammatory diseases

174

1331

1.31

3.05

1.4

4.52

3.56

ug/l

0.20

151

1161

Hallux valgus (acquired)

997

0.70

3.04

1.8

1.6

2.15

4.71

ug/l

1.94

757

Vulvovaginal ulceration/inflammation in other diseases

163

1241

1.33

3.02

1.4

1.3

2.62

3.46

ug/l

2.74

150

1149

Melanocytic naevi of other and unspecified parts of face

441

1.56

3.02

1.3

1.4

2.74

3.94

ug/l

1.06

403

Type 1 diabetes

154

2027

0.76

3.02

1.3

1.4

3.93

3.71

ug/l

0.19

141

1846

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

450

1.54

2.97

1.8

1.5

2.96

4.01

ug/l

0.83

396

Bacterial intestinal infections, IBD co-morbidities

104

736

1.42

2.97

1.6

1.5

3.64

3.85

ug/l

0.07

641

Other CVD

286

1.68

2.96

1.7

1.8

2.81

4.39

ug/l

0.84

223

Substance use, excluding alcohol

121

1646

0.73

2.96

1.4

5.87

3.51

ug/l

0.40

104

1509

Dorsalgia

1045

6169

0.90

2.95

1.3

1.4

3.36

3.57

ug/l

0.25

938

5663

Maternal care for known or suspected abnormality of pelvic organs

624

3665

1.16

2.94

1.3

3.38

3.10

ug/l

1.04

586

3344

Insulin, fast-acting or short human

169

2191

0.77

2.94

1.3

1.4

3.93

3.81

ug/l

0.10

148

1975

Other complications of surgical and medical care, not elsewhere classified

606

1.46

2.93

1.9

1.4

5.03

3.60

ug/l

0.38

539

Colon adenocarcinoma

3.25

2.93

2.0

1.2

5.31

3.18

ug/l

—

Other coagulation defects

607

1.46

2.92

1.7

1.4

3.06

3.93

ug/l

0.73

558

Haemangioma, any site

421

1.55

2.90

1.4

1.5

3.68

4.12

ug/l

0.15

369

Complications predominantly related to the puerperium

558

4841

1.16

2.89

1.3

3.28

3.32

ug/l

0.06

523

4454

Intestinal adhesions without obstruction

156

1.93

2.89

1.4

1.9

1.90

5.34

ug/l

1.07

119

Heart failure, not strict

126

1147

0.74

2.89

1.8

1.7

9.40

4.35

ug/l

0.29

843

Bipolar affective disorders

200

2526

0.79

2.85

1.2

1.3

2.89

3.58

ug/l

1.99

179

2343

Maternal care for cervical incompetence

490

1.51

2.83

1.2

1.4

4.26

3.44

ug/l

0.84

459

Insulin, fast-acting

169

2177

0.77

2.82

1.3

1.4

3.93

3.80

ug/l

0.11

148

1964

Carcinoma in situ of breast, intraductal

179

1.85

2.82

2.1

2.2

17.59

6.23

ug/l

0.32

119

Bacterial infection, other or unspecified

251

1706

1.24

2.81

1.6

1.5

3.19

4.05

ug/l

0.78

199

1448

Enterocolitis due to Clostridium difficile

314

1.63

2.81

1.8

1.5

2.34

3.92

ug/l

0.96

265

Alcohol dependence

721

0.61

2.80

1.2

1.4

3.28

3.82

ug/l

0.29

629

Disorders of lacrimal system

328

2680

1.21

2.80

1.3

1.5

2.55

3.94

ug/l

3.50

271

2296

Explicit Sepsis

274

2034

1.23

2.79

1.7

1.4

3.65

3.97

ug/l

0.21

223

1796

Motor disorders

151

1.95

2.79

1.7

1.6

5.55

6.60

ug/l

0.20

141

Malignant melanoma of skin

194

1.81

2.79

1.1

1.2

2.31

2.77

ug/l

0.48

166

Thrombocytopenia, unspecified

254

1.70

2.77

1.4

1.6

3.42

4.31

ug/l

0.38

225

Endometriosis in cutaneous scar

8.59

2.77

1.2

1.0

3.79

1.94

ug/l

—

Diseases of arteries, arterioles and capillaries

123

1215

0.74

2.76

1.8

1.5

2.84

4.25

ug/l

1.47

968

Other arthrosis

110

1011

0.73

2.76

1.6

2.00

4.75

ug/l

2.09

733

Acetic acid derivatives and related substances

317

1347

1.22

2.75

1.3

5.12

4.03

ug/l

0.39

298

1251

Excessive attrition of teeth

761

6682

1.13

2.75

1.4

1.3

3.49

3.57

ug/l

0.10

684

6063

ILD medications: immunosuppressive drugs

492

5160

0.86

2.75

1.4

2.83

3.72

ug/l

2.77

438

4598

Disorders of synovium and tendon

429

4259

0.85

2.74

1.4

3.06

3.54

ug/l

0.76

373

3819

Effects of foreign body entering through natural orifice

176

1369

1.29

2.74

1.4

3.59

4.11

ug/l

0.50

159

1245

Any death

658

0.66

2.73

1.8

1.9

4.61

4.80

ug/l

0.03

432

Leiomyosarcoma, including Hilmo

6.08

2.71

1.0

1.2

—

1.19

—

Injuries to the elbow and forearm

595

5819

0.87

2.69

1.4

3.20

3.90

ug/l

2.70

531

5234

Voice disturbances

176

1373

1.29

2.69

1.6

1.5

3.07

3.79

ug/l

0.44

147

1160

Dermatophytosis, including avohilmo

614

5276

1.14

2.66

1.4

2.93

3.54

ug/l

2.52

542

4733

Fenamates

191

1021

1.28

2.65

1.4

1.3

4.83

3.93

ug/l

0.17

175

939

Colonic or urogenital fistula

178

1394

1.28

2.64

1.3

1.4

2.83

3.70

ug/l

1.23

157

1215

Pseudohypoparathyroidism

8.05

2.63

1.6

1.3

2.63

5.89

ug/l

—

Specific developmental disorder of motor function

151

1.91

2.63

1.7

1.6

5.55

7.14

ug/l

0.32

142

Dental caries, including avohilmo

449

2683

0.86

2.62

1.5

1.4

3.88

3.79

ug/l

0.04

395

2375

Exposure to unspecified factor

936

7061

0.90

2.58

1.4

3.93

3.54

ug/l

0.40

847

6386

Melanocytic naevi, other sites/unspecified

640

1.42

2.58

1.4

2.58

3.91

ug/l

1.66

583

Other puerperal infections

264

2181

1.23

2.56

1.3

2.91

3.40

ug/l

1.25

248

2053

Other and unspecified tonsillitis

539

5121

0.87

2.56

1.3

3.18

3.46

ug/l

0.62

504

4832

Disorders of breast

553

5554

0.87

2.55

1.4

3.54

3.42

ug/l

0.05

473

4957

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

394

4541

0.85

2.53

1.3

3.00

3.36

ug/l

1.39

367

4226

Other postsurgical states

231

1.70

2.52

1.4

1.6

1.55

4.29

ug/l

1.73

202

Ventral hernia

701

1.39

2.51

3.1

1.5

3.18

4.40

ug/l

0.52

571

Abnormal findings on diagnostic imaging of other body structures

502

1.46

2.49

2.1

1.5

3.42

4.06

ug/l

0.23

421

Preterm labour and delivery

315

2644

1.20

2.48

1.4

3.68

3.45

ug/l

0.23

289

2305

Dislocation, sprain and strain of joints and ligaments of knee

592

6067

0.88

2.48

1.4

1.3

3.72

3.48

ug/l

0.28

528

5509

Abrasion of teeth

273

2261

1.21

2.47

1.3

1.5

2.85

3.71

ug/l

1.89

237

1925

Injuries to the thorax

155

1980

0.78

2.47

1.9

1.4

5.26

3.69

ug/l

0.33

137

1734

Erysipelas

117

1339

0.75

2.45

1.5

2.47

4.16

ug/l

2.41

1087

Right hemicolectomy

2.56

2.44

3.1

1.3

13.09

2.28

ug/l

—

Scabies, including avohilmo

145

1862

0.77

2.44

1.2

1.4

2.89

3.95

ug/l

2.68

134

1728

Anogenital herpesviral [herpes simplex] infection, including avohilmo

280

2337

1.21

2.42

1.3

3.44

3.61

ug/l

0.18

261

2200

Haemangioma and lymphangioma, any site

473

1.47

2.41

1.4

1.5

3.52

3.98

ug/l

0.18

418

Explicit Sepsis, including avohilmo

281

2117

1.20

2.41

1.7

1.4

3.62

3.95

ug/l

0.22

229

1871

Other skin changes

112

835

1.35

2.41

1.3

1.5

3.38

3.92

ug/l

0.29

729

Melanoma in situ of trunk

5.04

2.40

1.0

1.6

2.41

1.72

ug/l

—

Coagulation defects, purpura and other haemorrhagic conditions

171

1352

1.27

2.39

1.6

1.4

3.38

3.84

ug/l

0.47

155

1213

Autoimmune diseases related-to ILD

730

6810

0.89

2.38

1.3

1.4

2.95

3.60

ug/l

2.04

650

6140

Haemolytic anaemias

168

1.80

2.37

1.2

1.4

5.37

3.35

ug/l

1.01

149

General symptoms and signs

1239

5673

1.10

2.37

1.5

1.3

3.61

ug/l

0.00

1107

5175

Other problems related to primary support group, including family circumstances

221

1754

1.23

2.37

1.6

1.4

4.17

3.99

ug/l

0.12

205

1632

Candidiasis

156

1222

1.28

2.37

1.3

1.4

2.68

3.58

ug/l

2.18

144

1106

Cholecystectomy

367

3644

0.85

2.37

1.4

2.93

3.56

ug/l

1.14

290

3107

Pediculosis, acariasis and other infestations, including avohilmo

160

2020

0.79

2.35

1.2

1.4

2.91

3.85

ug/l

2.42

148

1865

Arthropathies

1136

6282

0.91

2.32

1.3

3.51

3.65

ug/l

0.16

1030

5794

Disorders of refraction and accommodation

374

3195

1.17

2.31

1.5

1.4

4.03

3.83

ug/l

0.19

342

2918

Benign neoplasm: Colon, unspecified

253

1.62

2.29

1.6

2.0

3.03

4.99

ug/l

0.62

167

Motor disorders, excluding more controls

153

1.81

2.28

1.7

1.5

5.55

6.91

ug/l

0.28

146

Atrophic disorders of skin

119

905

1.32

2.26

1.3

1.5

3.07

4.11

ug/l

0.95

770

Postpartum haemorrhage due to retained placenta

335

2861

1.18

2.25

1.3

3.26

3.77

ug/l

1.27

311

2684

Antihypertensive medication - note that there are other indications

1095

6257

0.91

2.25

1.4

1.3

3.18

3.54

ug/l

1.12

1017

5828

Embedded and impacted teeth

755

5517

1.12

2.21

1.3

3.55

3.57

ug/l

0.05

724

5255

Asthma (diagnoses ohter than nonallergic)

796

7113

0.90

2.20

1.4

3.33

3.64

ug/l

0.59

720

6432

Diabetic retinopathy, strict definition

780

0.69

2.19

1.3

1.4

3.93

4.85

ug/l

0.80

722

Astigmatism

585

1.39

2.17

1.6

1.4

4.35

4.39

ug/l

0.01

541

Other inflammation of vagina/vulva

639

1.38

2.16

1.3

2.66

3.27

ug/l

0.93

594

Medical observation and evaluation for suspected diseases and conditions

678

3092

1.12

2.13

1.4

1.3

3.28

3.98

ug/l

0.94

607

2824

Psoriatic arthropathies

411

0.56

2.13

1.1

1.4

2.90

3.75

ug/l

0.37

344

Melanocytic naevi of upper limb, including shoulder

190

1.71

2.12

1.3

1.4

4.37

2.97

ug/l

0.79

171

Malignant neoplasm of thyroid gland, including Hilmo

299

1.55

2.11

1.5

1.2

2.19

2.92

ug/l

0.77

264

Other bacterial diseases

527

3946

0.88

2.10

1.7

1.4

3.21

3.94

ug/l

1.10

410

3460

Urticaria and erythema

455

3990

1.14

2.10

1.3

1.4

2.89

3.68

ug/l

3.44

410

3626

Eating disorders

299

2544

1.18

2.10

1.4

1.3

3.93

3.60

ug/l

0.27

290

2415

Appendicitis, broad definition

618

6196

0.89

2.10

1.4

1.3

3.98

3.34

ug/l

0.38

545

5572

Localized swelling, mass and lump of skin and subcutaneous tissue

229

1900

1.21

2.09

1.5

1.4

2.95

3.81

ug/l

1.06

201

1679

Diseases of appendix

621

6201

0.89

2.09

1.4

1.3

3.96

3.34

ug/l

0.37

548

5576

Crossbite

101

700

1.34

2.09

1.7

1.4

4.75

4.90

ug/l

0.04

652

Gonarthrosis, primary, with knee surgery

398

0.61

2.08

3.3

2.4

12.26

13.76

ug/l

0.05

139

Ulcerative ileocolitis

261

1.59

2.07

1.4

2.33

3.37

ug/l

1.16

236

Codeine

1035

6105

0.91

2.07

1.4

1.3

3.49

3.53

ug/l

0.03

948

5596

Other cataract

577

0.68

2.06

2.1

1.9

19.18

4.16

ug/l

0.43

389

Maternal care for known or suspected disproportion

455

0.59

2.05

2.6

1.4

5.18

2.72

ug/l

0.44

390

Cardiomyopathy, other and unspecified

1.98

2.05

1.2

1.9

2.49

6.77

ug/l

0.75

Personal history of other diseases and conditions

230

1911

1.21

2.02

1.4

1.3

4.11

3.93

ug/l

0.10

216

1797

Falls/tendency to fall

1164

6327

0.92

2.01

1.4

1.3

3.29

3.63

ug/l

0.83

1038

5764

Other chronic obstructive pulmonary disease, including avohilmo

574

0.67

2.00

1.1

1.9

4.45

5.02

ug/l

0.15

387

Other and unspecified drugs and medicaments

476

1.42

2.00

1.5

1.4

2.57

3.88

ug/l

1.39

427

Oxicams

114

839

0.77

2.00

1.3

2.02

4.06

ug/l

2.06

763

Osteoporosis

405

1.43

2.00

1.9

2.0

3.60

5.53

ug/l

0.55

270

Eating disorder

292

2494

1.18

1.98

1.4

1.3

3.59

3.67

ug/l

0.07

283

2372

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

4.64

1.95

1.6

1.3

2.11

4.63

ug/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

275

3226

0.85

1.95

1.4

3.49

3.67

ug/l

0.14

234

2875

Acute alcohol intoxication

1282

0.76

1.95

1.2

1.4

3.08

3.84

ug/l

1.28

1173

Undescended testis, unilateral

4.60

1.95

2.0

1.1

9.13

24.25

ug/l

—

Misadventures to patients during surgical and medical care

709

1.33

1.94

1.5

1.4

2.16

3.75

ug/l

2.81

622

Major coronary heart disease event excluding revascularizations

356

0.63

1.94

2.2

2.3

2.30

7.48

ug/l

1.21

178

Fissure and fistula of anal and rectal regions

166

1347

1.24

1.92

1.3

1.4

2.83

3.99

ug/l

1.37

146

1184

Adalimumab

864

0.71

1.91

1.2

1.4

3.35

3.70

ug/l

0.31

786

Oxycodone

117

777

1.29

1.91

2.1

1.6

3.89

4.11

ug/l

0.05

585

Other osteochondrodysplasias

2.20

1.90

1.4

1.3

1.54

3.32

ug/l

2.09

Abnormal blood-pressure reading, without diagnosis

243

1.57

1.90

2.0

1.6

3.44

4.53

ug/l

0.38

212

Mycoses

229

1922

1.19

1.89

1.4

4.01

3.63

ug/l

0.10

201

1715

Diverticular disease of intestine

112

897

0.78

1.89

1.6

1.8

2.39

5.39

ug/l

1.68

606

Perioral dermatitis

285

1.53

1.87

1.3

1.4

3.15

3.00

ug/l

0.13

264

Viral warts

123

970

1.28

1.86

1.4

1.3

5.81

3.68

ug/l

0.37

110

898

Other or unspecified ileus, impaction or obstruction

341

1.47

1.85

1.2

1.7

1.91

5.65

ug/l

1.59

269

Psoriatic arthropathies, ICD10

393

0.58

1.85

1.1

1.6

2.90

3.98

ug/l

0.47

328

Acute alcohol intoxication, ICD10

1248

0.77

1.85

1.3

1.4

3.09

4.12

ug/l

1.54

1155

Other pleural conditions

1.98

1.84

2.0

1.8

2.23

4.72

ug/l

0.74

Accessory breast

2.07

1.84

1.1

1.2

3.96

3.21

ug/l

0.27

Acute appendicitis

585

6031

0.90

1.84

1.4

1.3

4.03

3.32

ug/l

0.40

519

5423

Malaise and fatigue

329

2985

0.87

1.84

1.6

1.4

3.24

3.86

ug/l

0.63

291

2674

Seborrhoeic keratosis

442

1.40

1.83

1.3

1.8

2.58

4.71

ug/l

0.82

306

Haemorrhoids and perianal venous thrombosis

190

1562

1.21

1.82

1.3

1.5

3.25

3.84

ug/l

0.60

168

1349

Bacterial pneumoniae

166

1776

0.82

1.81

1.6

1.5

2.80

4.04

ug/l

2.37

146

1572

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

690

0.69

1.79

1.3

3.47

3.53

ug/l

0.04

651

L04AX Other immunosuppressants

358

4085

0.87

1.79

1.4

2.87

3.75

ug/l

1.83

323

3578

Wide developmental disorders

531

0.65

1.78

1.5

1.4

2.82

4.63

ug/l

2.33

502

Cerebrovascular diseases

131

1136

0.80

1.78

1.8

1.7

3.89

5.19

ug/l

0.46

850

Exposure to other specified electric current

219

0.45

1.78

1.0

1.4

2.74

3.07

ug/l

—

201

KRA_PSY_EATING, excluding more controls

290

2483

1.17

1.77

1.4

1.3

3.60

3.55

ug/l

0.06

281

2373

Spondylosis

105

1050

0.78

1.76

1.7

3.45

4.65

ug/l

0.26

755

Emotional disorders and disorders of social functioning with onset specific to childhood

1239

0.77

1.76

1.5

1.4

4.00

4.27

ug/l

0.29

1187

Urticaria

395

3481

1.14

1.76

1.3

1.4

2.95

3.71

ug/l

2.69

362

3178

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

482

5323

0.89

1.74

1.4

1.3

3.35

3.43

ug/l

0.11

446

4957

Coxarthrosis, primary

503

0.68

1.73

2.5

2.1

3.45

9.73

ug/l

1.27

238

Diseases of pulp and periapical tissues and dental caries

430

2494

0.88

1.73

1.5

1.4

4.01

3.74

ug/l

0.15

376

2215

Symptoms and signs concerning food and fluid intake

592

1.34

1.72

1.3

1.4

4.63

4.48

ug/l

0.03

531

Cerebrovascular diseases (FINNGEN)

844

0.77

1.71

2.0

1.5

4.38

3.57

ug/l

0.26

681

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

348

1.45

1.71

1.4

6.08

3.94

ug/l

0.43

323

Diseases of the musculoskeletal system and connective tissue

807

4423

0.91

1.71

1.4

1.3

3.60

3.96

ug/l

0.34

743

4129

Benign neoplasm: Liver/bile ducts

187

1.62

1.70

1.3

1.4

3.17

2.59

ug/l

0.35

169

Follow-up care involving plastic surgery

179

1.63

1.70

1.3

1.5

1.56

4.44

ug/l

1.31

158

Other psoriatic arthropathies

382

0.60

1.68

1.1

1.5

2.90

4.02

ug/l

0.48

320

Open wound of wrist and hand

352

3868

0.88

1.68

1.4

1.3

3.46

3.61

ug/l

0.15

319

3564

Irritable bowel syndrome

318

2774

1.15

1.67

1.3

1.4

2.89

3.71

ug/l

2.30

290

2497

Myocardial infarction, strict

236

0.57

1.67

1.1

2.1

1.47

8.92

ug/l

—

119

Other disorders of central nervous system

2.13

1.67

1.5

2.21

3.34

ug/l

—

Other dorsopathies, not elsewhere classified

1104

6177

0.93

1.66

1.3

1.4

3.39

3.60

ug/l

0.27

1001

5671

Benign neoplasm: Brain, infratentorial

2.86

1.66

1.7

1.4

2.34

3.17

ug/l

—

Pain associated with micturition

693

1.30

1.66

1.3

1.5

2.97

3.72

ug/l

0.82

612

Iron deficiency

723

1.31

1.66

1.3

2.62

3.37

ug/l

1.69

684

Other specified/unspecified arthritis

151

1836

0.82

1.65

1.4

5.36

3.77

ug/l

0.65

135

1601

Injury, poisoning and certain other consequences of external causes

649

3585

0.91

1.65

1.4

1.3

4.03

3.76

ug/l

0.19

594

3290

Duodenal ulcer

2.03

1.64

1.2

1.8

2.40

3.32

ug/l

—

Covid-19 confirmed case

285

2467

1.16

1.63

1.4

3.09

3.64

ug/l

0.89

256

2230

Nonorganic sleeping disorders

307

2678

1.15

1.63

1.3

3.49

3.58

ug/l

0.07

278

2459

Coronary atherosclerosis

467

0.71

1.62

2.3

2.1

2.47

9.07

ug/l

1.54

251

Use of biperiden

133

0.37

1.61

1.0

1.6

3.29

3.67

ug/l

—

114

Stroke, including SAH

735

0.76

1.61

2.2

1.8

5.05

4.60

ug/l

0.09

525

Disorders of mineral metabolism

270

1.49

1.61

1.7

1.6

2.62

4.03

ug/l

0.61

227

Trigger finger

617

0.70

1.60

1.7

1.5

2.49

4.27

ug/l

1.18

503

Persistent mood disorders

126

1554

0.81

1.60

1.3

1.4

2.67

3.86

ug/l

2.75

111

1396

Injuries to the hip and thigh

178

1905

0.84

1.60

1.4

1.5

3.51

4.07

ug/l

0.33

155

1650

Thyroiditis, ILD-related definition

144

1180

1.23

1.60

1.5

1.4

3.63

3.83

ug/l

0.08

129

1065

Convalescence

279

1.48

1.59

1.6

2.76

4.58

ug/l

0.84

246

Emotional disorders starting during childhood or adolescence

1136

0.78

1.59

1.5

1.3

4.04

4.29

ug/l

0.23

1085

Vitamin D deficiency

144

1.69

1.59

1.9

1.3

3.00

3.12

ug/l

0.05

130

Extrapyramidal and movement disorders

162

1343

1.21

1.58

1.3

1.5

2.59

4.08

ug/l

2.21

137

1118

Arthropathic psoriasis

424

0.63

1.58

1.1

1.5

3.29

3.94

ug/l

0.26

356

Tooth agenesis EXCLUDE clefts and syndromes

656

1.31

1.58

1.4

4.28

3.98

ug/l

0.08

620

Thyrotoxicosis, other and/or unspecified

187

1573

1.19

1.57

1.3

1.4

2.40

3.78

ug/l

2.96

163

1392

Fracture of lower leg, including ankle

303

3398

0.87

1.57

1.6

1.4

4.28

3.91

ug/l

0.23

266

2978

Benign neoplasm: Colon

108

804

1.26

1.56

1.4

1.8

8.16

5.26

ug/l

0.23

553

Anomalies of dental arch relationship, including avohilmo

300

2369

1.15

1.56

1.5

1.3

3.83

3.97

ug/l

0.11

273

2200

Benign neoplasm: Liver

184

1.59

1.56

1.3

1.4

3.05

2.60

ug/l

0.25

166

Second line medication for Crohn's disease

393

4408

0.89

1.55

1.4

2.92

3.76

ug/l

1.94

357

3876

Nonorganic sleeping disorders, excluding more controls

307

2692

1.14

1.53

1.3

3.49

3.45

ug/l

0.03

278

2497

Hypermetropia

588

1.32

1.53

1.6

1.5

3.56

4.57

ug/l

0.91

542

Emotional disorders starting during childhood or adolecense, excluding more controls

1105

0.78

1.53

1.5

1.3

4.04

4.25

ug/l

0.19

1062

Bleeding

327

2605

0.88

1.52

1.4

1.5

3.79

4.27

ug/l

0.34

277

2210

Type 2 diabetes

816

5123

0.92

1.52

1.5

1.4

5.68

3.13

ug/l

2.84

734

4546

Ischaemic heart disease, wide definition

688

0.78

1.52

2.0

1.9

1.97

6.77

ug/l

2.02

416

Bacterial pneumonia, not elsewhere classified

156

1645

0.83

1.52

1.6

1.5

2.89

4.13

ug/l

2.11

136

1455

Cyst of kidney

1.83

1.51

1.1

1.6

3.25

2.93

ug/l

—

Childhood allergy (age < 16)

434

3981

0.89

1.51

1.3

4.17

3.92

ug/l

0.34

415

3846

Habit and impulse disorders

125

0.40

1.51

1.2

1.3

3.84

3.12

ug/l

—

114

Other reaction to severe stress, and adjustment disorders

580

5275

1.10

1.50

1.5

1.3

3.32

3.41

ug/l

0.09

534

4837

Dorsopathies

1144

6203

0.93

1.49

1.3

1.4

3.55

3.67

ug/l

0.14

1041

5695

Other diseases of blood and blood-forming organs

162

1.61

1.49

1.1

1.7

2.45

4.89

ug/l

0.80

136

Allergic urticaria

106

848

1.26

1.49

1.3

1.4

2.61

3.93

ug/l

2.62

777

Umbilical hernia

109

1352

0.80

1.48

1.2

1.4

2.72

3.51

ug/l

1.10

1208

Other viral diseases, not elsewhere classified, including avohilmo

363

3206

1.13

1.47

1.3

3.57

3.72

ug/l

0.23

327

2958

COPD

417

0.68

1.47

1.2

2.0

3.50

6.03

ug/l

0.74

280

Erosion of teeth , including avohilmo

380

3391

1.12

1.45

1.4

1.3

3.27

3.52

ug/l

0.30

352

3122

Other osteochondrodysplasias, including avohilmo

1.95

1.45

1.4

1.3

1.54

3.11

ug/l

1.86

Diseases of peritoneum

285

1.44

1.45

1.5

1.6

1.87

3.90

ug/l

1.40

239

Provisional assignment of new diseases of uncertain etiology

580

5243

1.10

1.45

1.4

1.3

3.17

3.52

ug/l

0.98

522

4797

Thyrotoxicosis with diffuse goitre

144

1194

1.21

1.44

1.3

1.4

2.32

3.55

ug/l

2.58

125

1058

All chronic kidney diseases

224

2072

0.86

1.44

1.7

1.4

4.99

3.84

ug/l

0.61

189

1821

Alcohol abuse, main dg, excluding more controls

968

0.77

1.44

1.3

2.87

3.92

ug/l

1.73

893

Problems related to lifestyle

1012

0.78

1.44

1.3

3.19

3.73

ug/l

0.59

947

Effects of heat and light

2.76

1.44

1.2

5.06

3.91

ug/l

—

Senile cataract

433

0.73

1.44

1.9

2.1

36.79

6.12

ug/l

0.44

222

Other arthritis (FG)

174

2056

0.84

1.44

1.4

5.21

3.80

ug/l

0.65

157

1778

Benign neoplasm: Rectum, anus and anal canal

244

1.48

1.44

2.0

1.8

2.39

4.49

ug/l

0.84

172

Congenital malformations and deformations of the musculoskeletal system

135

1108

1.22

1.43

1.5

1.4

3.68

4.07

ug/l

0.19

125

1043

Mental disorders, not otherwise specified

1032

0.78

1.43

1.6

1.3

2.73

3.92

ug/l

1.58

959

Fracture of rib(s), sternum and thoracic spine

809

0.75

1.43

2.1

1.5

8.84

3.88

ug/l

0.41

688

Codes for special purposes

580

5247

1.10

1.43

1.4

1.3

3.17

3.52

ug/l

0.98

522

4801

Other disorders of the musculoskeletal system and connective tissue

425

0.66

1.42

1.4

1.6

2.74

4.00

ug/l

0.73

348

Symptoms and signs involving the urinary system

365

3089

0.89

1.42

1.4

3.51

3.97

ug/l

0.42

318

2668

Other chronic obstructive pulmonary disease

388

0.67

1.42

1.2

2.1

3.81

6.30

ug/l

0.64

258

Desensitization to allergens

101

810

1.26

1.42

1.1

1.3

3.23

3.73

ug/l

0.46

765

Presence of other devices

637

0.72

1.41

1.9

1.5

3.47

4.55

ug/l

0.54

541

Seropositive rheumatoid arthritis, strict definition

577

0.71

1.41

1.2

1.5

3.35

3.75

ug/l

0.20

478

Alcohol abuse, main dg

964

0.78

1.40

1.3

1.4

2.87

3.79

ug/l

1.48

897

Obstructive hydrocephalus

2.19

1.40

1.8

1.2

3.45

3.50

ug/l

—

Complications of procedures, not elsewhere classified

730

5418

1.09

1.40

1.5

1.3

3.22

3.37

ug/l

0.16

622

4848

Bacterial infection, other or unspecified, including avohilmo

296

2131

1.14

1.40

1.5

3.19

3.90

ug/l

0.78

239

1844

Injuries to the wrist and hand

986

7004

0.93

1.40

1.4

3.44

3.61

ug/l

0.26

896

6335

Collagenous colitis

449

1.34

1.40

1.3

1.6

2.76

4.25

ug/l

1.24

381

Pulmonary heart disease

623

1.29

1.39

1.6

1.5

2.57

4.51

ug/l

1.27

488

Pulmonary embolism

623

1.29

1.39

1.6

1.5

2.57

4.51

ug/l

1.27

488

Psoriatic and enteropathic arthropathies

552

0.70

1.39

1.2

1.4

2.81

3.51

ug/l

0.52

471

Missing teeth due to accident, extraction or parodontitis

179

1879

0.85

1.39

1.7

1.5

3.22

4.29

ug/l

0.56

135

1514

Obesity and other hyperalimentation

783

6811

1.08

1.39

1.3

3.44

3.48

ug/l

0.07

712

6176

Exposure to other specified factors

773

7164

0.92

1.39

1.3

1.4

3.42

3.62

ug/l

0.32

713

6478

Covid-19 suspected case

305

2696

1.13

1.38

1.3

3.25

3.59

ug/l

0.72

275

2473

Sciatica+with lumbago

350

3474

0.89

1.38

1.4

3.04

3.54

ug/l

0.61

298

3065

Other special examinations and investigations of persons without complaint or reported diagnosis

666

3092

1.09

1.37

1.4

1.3

3.37

3.98

ug/l

0.73

595

2824

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

564

1.30

1.37

1.5

1.4

2.64

4.12

ug/l

1.74

508

Sleep disorders (combined)

1193

5840

1.07

1.37

1.3

1.4

3.31

3.65

ug/l

0.80

1085

5287

Other specified and unspecified strabismus

1.89

1.35

1.4

1.3

10.96

3.27

ug/l

0.49

Abnormal findings on antenatal screening of mother

240

2741

0.87

1.35

1.2

1.3

3.00

3.10

ug/l

0.25

223

2603

Obesity

781

6811

1.08

1.35

1.3

3.44

3.48

ug/l

0.06

710

6176

Organic, including symptomatic, mental disorders

453

0.73

1.34

2.5

1.9

2.85

5.64

ug/l

1.18

318

Nausea and vomiting

252

2148

1.15

1.34

1.6

1.3

3.46

3.70

ug/l

0.18

218

1978

Tooth eruption problems

401

3489

1.12

1.33

1.3

3.78

3.93

ug/l

0.23

389

3336

Implicit viral Sepsis

112

915

1.23

1.32

1.5

1.4

4.02

3.90

ug/l

0.06

827

Viral Sepsis

112

915

1.23

1.32

1.5

1.4

4.02

3.90

ug/l

0.06

827

Other specified/unspecified soft tissue disorders

160

1.57

1.31

1.7

1.6

2.48

4.93

ug/l

0.81

138

Episodal and paroxysmal disorders

1172

6325

0.94

1.31

1.4

3.55

3.68

ug/l

0.20

1071

5783

Accidents

880

4737

0.93

1.30

1.4

1.3

3.81

3.62

ug/l

0.17

791

4306

Restless leg syndrome

719

1.26

1.30

1.3

1.5

2.58

3.83

ug/l

1.60

622

COPD/asthma related infections

1012

5419

0.93

1.30

1.4

3.25

3.66

ug/l

1.07

893

4901

COPD/asthma/ILD related infections

1012

5419

0.93

1.30

1.4

3.25

3.66

ug/l

1.07

893

4901

Transient ischemic attack

599

0.76

1.29

2.3

1.8

2.24

5.09

ug/l

1.78

408

Lichen sclerosus et atrophicus

438

1.33

1.29

1.3

1.6

3.56

3.77

ug/l

0.10

351

Other medical care

243

1782

1.14

1.28

2.1

1.4

4.82

3.85

ug/l

0.26

194

1523

Polyneuropathies and other disorders of the peripheral nervous system

378

1.35

1.28

2.3

1.7

5.49

4.23

ug/l

0.20

298

Other symptoms and signs involving the urinary system

310

1.39

1.27

1.3

1.5

5.85

3.36

ug/l

0.41

267

Postdysenteric arthropathy

2.31

1.27

2.0

1.3

15.37

2.90

ug/l

—

Biological medication for rheuma

147

1738

0.84

1.27

1.2

1.4

3.01

3.77

ug/l

1.25

134

1571

External causes of morbidity and mortality

770

4161

0.93

1.27

1.4

1.3

3.97

3.68

ug/l

0.23

691

3821

COPD (mode)

286

0.65

1.27

1.1

2.0

3.69

7.50

ug/l

0.78

184

Wide developmental disorders, excluding more controls

481

0.70

1.26

1.5

1.3

2.82

4.67

ug/l

2.31

455

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

130

1087

1.20

1.25

1.3

3.71

3.14

ug/l

0.24

115

977

Disorders of continuity of bone

643

1.26

1.25

1.2

1.4

2.48

3.76

ug/l

1.93

574

Epilepsy

174

2020

0.86

1.25

1.3

1.4

2.99

4.11

ug/l

2.30

149

1814

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

137

1627

0.84

1.24

1.3

1.4

3.13

3.68

ug/l

0.73

115

1442

Primary gonarthrosis, bilateral

453

0.72

1.24

2.4

2.2

8.65

10.59

ug/l

0.09

197

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

355

1.36

1.23

1.5

2.17

3.84

ug/l

1.42

310

Melanocytic naevi of lower limb, including hip

330

1.37

1.23

1.4

2.60

3.01

ug/l

0.34

301

Other and unspecified nerve root and plexus disorders, also in other diseases

1089

0.81

1.23

1.4

4.54

3.63

ug/l

0.30

940

Other systemic involvement of connective tissue (FG)

140

1626

0.84

1.23

1.3

1.4

2.62

3.79

ug/l

2.07

116

1392

Placental disorders

189

1.52

1.22

1.1

1.4

3.10

2.89

ug/l

0.18

177

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

162

1375

1.18

1.22

1.4

3.52

4.39

ug/l

0.59

149

1282

Other disorders of fluid, electrolyte and acid-base balance

682

1.24

1.22

1.5

1.6

2.52

4.56

ug/l

1.60

536

Hypo-osmolality and hyponatraemia

268

1.41

1.22

1.3

1.8

3.27

6.25

ug/l

0.71

196

Symptoms and signs involving speech and voice

192

1660

1.16

1.22

1.6

1.4

3.10

3.67

ug/l

0.37

162

1396

Other external causes of accidental injury

883

4737

0.93

1.21

1.4

1.3

3.82

3.62

ug/l

0.18

793

4306

Antepartum haemorrhage, not elsewhere classified

209

1825

1.15

1.20

1.2

1.3

4.50

2.96

ug/l

0.50

190

1680

Other specified and unspecified disorders of eye and adnexa

164

1.53

1.20

1.3

1.6

1.53

3.57

ug/l

1.65

141

Single spontaneous delivery

476

2756

0.91

1.20

1.3

1.4

4.86

3.19

ug/l

2.59

445

2471

Recurrent aphthous stomatitis , including avohilmo

131

1100

1.19

1.20

1.5

1.4

4.85

3.89

ug/l

0.44

117

1005

Benign neoplasm: Skin of eyelid, including canthus

400

1.33

1.20

1.5

1.6

3.39

4.14

ug/l

0.32

315

Nontoxic multinodular goitre

558

1.27

1.19

1.3

1.8

2.21

4.57

ug/l

1.46

423

All dysplastic lesions of the vagina

181

1.50

1.19

1.6

1.5

2.02

4.32

ug/l

0.91

158

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

235

0.58

1.19

1.6

1.4

3.82

4.88

ug/l

0.50

219

COPD, early/later onset

381

0.70

1.18

1.2

1.9

3.81

6.06

ug/l

0.56

256

Colon adenocarcinoma, helper endpoint

1.88

1.18

2.0

2.4

5.31

8.80

ug/l

—

Chronic viral hepatitis

416

0.69

1.17

1.4

2.23

3.26

ug/l

1.64

386

Postpartum haemorrhage due to anatomy

374

3393

1.11

1.16

1.3

3.49

3.66

ug/l

0.32

348

3243

COPD, hospital admissions

381

0.71

1.16

1.2

1.9

3.81

6.06

ug/l

0.56

256

Malignant neoplasm of pancreas

0.00

1.16

0.0

1.1

—

3.33

—

Other symptoms and signs involving cognitive functions and awareness

126

1326

0.84

1.15

1.9

1.6

3.35

4.26

ug/l

0.57

1086

Phakomatoses, not elsewhere classified

1.87

1.14

2.2

1.5

2.25

3.23

ug/l

0.72

Explicit bacterial Sepsis, including avohilmo

430

1.31

1.14

2.0

1.4

2.97

4.32

ug/l

1.15

387

Paroxysmal tachycardia

139

1357

0.85

1.13

1.5

1.4

7.39

4.13

ug/l

0.30

117

1201

Phlebitis and thrombophlebitis (not including DVT)

109

905

1.21

1.13

1.7

1.4

2.43

3.96

ug/l

1.59

765

COPD, hospital admissions 1, only main diagnosis

265

0.65

1.13

1.2

1.8

4.21

6.57

ug/l

0.42

187

Other disorders of pigmentation

183

1.48

1.13

1.4

1.6

9.98

4.15

ug/l

0.46

159

Implicit viral Sepsis, including avohilmo

171

1473

1.16

1.13

1.5

1.4

3.70

4.24

ug/l

0.43

149

1309

Lesion of radial nerve

111

0.45

1.13

1.0

1.6

3.49

2.49

ug/l

—

Certain infectious and parasitic diseases, including avohilmo

740

3448

1.08

1.12

1.4

1.3

3.69

3.88

ug/l

0.13

652

3126

Mental and behavioural disorders due to opioids

400

0.69

1.12

1.3

1.2

2.37

3.34

ug/l

1.08

375

Infections of the skin and subcutaneous tissue

489

5231

0.92

1.11

1.4

3.07

3.70

ug/l

2.39

437

4753

Persons with potential health hazards related to communicable diseases

693

6400

1.08

1.11

1.3

3.29

3.48

ug/l

0.52

653

5965

Dental operations

305

1751

0.89

1.10

1.4

1.5

3.72

3.82

ug/l

0.04

259

1525

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

965

6474

0.94

1.10

1.6

1.3

3.76

3.54

ug/l

0.12

825

5886

Tumor necrosis factor alpha inhibitors

137

1604

0.85

1.10

1.2

1.4

3.04

3.82

ug/l

1.16

126

1461

Myocardial infarction

264

0.69

1.09

1.7

2.2

1.33

9.06

ug/l

1.65

133

Other viral diseases, not elsewhere classified

178

1542

1.15

1.09

1.4

3.56

4.17

ug/l

0.74

158

1400

Sequelae with surgical and medical care as external cause

791

1.22

1.09

1.4

1.5

4.55

3.93

ug/l

0.18

685

Other and unspecified diseases of blood and blood-forming organs

1.83

1.09

1.0

1.4

2.88

3.02

ug/l

—

Cardiomyopathy

226

1.42

1.09

1.7

2.26

4.85

ug/l

1.20

171

Thyroiditis

549

1.26

1.09

1.6

1.4

3.79

3.74

ug/l

0.01

495

COPD related to multimorbidity

217

0.62

1.09

1.0

2.0

5.65

8.24

ug/l

—

126

Abnormalities of forces of labour

131

1113

1.18

1.09

1.5

1.4

4.00

3.53

ug/l

0.18

115

967

Malignant neoplasm of skin, including Hilmo

539

1.22

1.08

1.4

1.2

2.70

2.69

ug/l

0.01

412

Benign neoplasm of brain and other parts of central nervous system

252

1.39

1.08

2.2

1.6

3.79

3.42

ug/l

0.10

223

Non-rheumatic valve diseases

837

0.83

1.08

1.4

1.6

2.93

4.86

ug/l

1.86

649

Other obstructed labour

103

857

1.21

1.08

1.2

1.3

7.11

3.64

ug/l

0.43

764

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

109

910

1.20

1.08

1.5

3.34

4.36

ug/l

0.96

817

Other inflammation of eyelid

747

1.22

1.08

1.6

1.5

4.81

3.79

ug/l

0.32

656

Superficial injury of thorax

806

0.79

1.08

1.3

1.4

2.82

3.71

ug/l

1.02

721

Excluding asthma or asthma-COPD overlap

779

4175

0.93

1.08

1.4

1.3

3.72

ug/l

0.00

690

3783

Dermatitis due to substances taken internally

382

1.32

1.07

1.4

5.48

4.22

ug/l

0.24

350

Malignant neoplasm of thyroid gland

278

1.37

1.07

1.4

1.2

1.97

2.89

ug/l

0.97

246

Other acute lower respiratory infections

389

4060

0.91

1.07

1.5

1.4

3.78

3.79

ug/l

0.01

356

3698

Myopia

204

1795

1.14

1.07

1.4

1.3

4.01

3.72

ug/l

0.19

188

1656

Disorders of ocular muscles, binocular movement, accommodation and refraction

588

5407

1.08

1.06

1.5

1.3

3.97

3.69

ug/l

0.32

534

4924

Ankyloglossia

252

0.62

1.06

1.4

3.37

4.78

ug/l

0.81

237

Depression or dysthymia

528

2655

1.09

1.06

1.4

3.56

3.99

ug/l

0.26

463

2365

Hypothyroidism due to medicaments and other exogenous substances

2.14

1.06

2.0

1.3

2.07

2.93

ug/l

—

Infections with a predominantly sexual mode of transmission

568

5256

1.08

1.06

1.3

2.92

3.24

ug/l

1.46

532

4875

Striking against or struck by other objects

272

3028

0.90

1.06

1.3

1.4

3.40

3.78

ug/l

0.63

254

2795

Stroke, excluding SAH

622

0.80

1.05

2.3

1.8

5.55

5.01

ug/l

0.09

429

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

117

986

1.19

1.05

1.5

3.20

4.23

ug/l

1.10

103

886

Psychotic depression

534

1.26

1.05

1.3

1.4

2.81

3.98

ug/l

1.33

489

Other and unspecified disorders of binocular movement

2.00

1.05

1.1

1.4

2.71

3.94

ug/l

—

Open bite

110

926

1.20

1.04

1.5

1.4

4.04

3.95

ug/l

0.03

105

875

Benign neoplasm: Short bones of lower limb

1.86

1.04

3.2

1.3

13.37

3.30

ug/l

0.47

Other and unspecified mood [affective] disorders

103

1226

0.84

1.03

1.5

1.3

3.35

4.03

ug/l

0.79

1157

Explicit bacterial Sepsis

420

1.29

1.02

2.0

1.4

3.01

4.34

ug/l

1.08

379

Other disorders of kidney and ureter

272

1.36

1.02

1.4

1.6

3.92

4.14

ug/l

0.06

220

Other extrapyramidal and movement disorders in other diseases

122

1036

1.18

1.02

1.3

1.5

2.60

3.98

ug/l

1.69

104

876

Superficial injury of lower leg

225

2529

0.89

1.02

1.3

1.4

3.50

3.68

ug/l

0.19

197

2314

Other disorders of breast

169

1475

1.15

1.01

1.4

4.94

3.65

ug/l

0.22

146

1309

Graves disease, strict definition

117

993

1.18

1.00

1.4

2.23

3.79

ug/l

2.82

107

893

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

152

1296

1.16

1.00

1.4

4.00

3.65

ug/l

0.18

138

1224

Internal derangement of knee

237

2626

0.89

1.00

1.4

3.10

3.76

ug/l

0.82

207

2315

Oral lichen planus, including avohilmo , including avohilmo

197

1.43

1.00

1.1

1.9

2.65

4.46

ug/l

0.60

153

Social phobias

132

1532

0.86

0.99

1.3

3.43

3.84

ug/l

0.56

121

1442

Phobic anxiety disorders

213

2389

0.89

0.99

1.3

3.40

3.74

ug/l

0.66

197

2253

Sequelae of external causes of morbidity and mortality

136

1169

1.17

0.99

1.4

4.17

4.29

ug/l

0.04

109

1018

Personal history of allergy to drugs, medicaments and biological substances

1.69

0.99

1.2

1.3

2.39

2.74

ug/l

0.19

Obesity, other/unspecified

428

3938

1.09

0.98

1.4

1.3

3.48

3.40

ug/l

0.08

392

3551

Syncope and collapse

264

2451

0.90

0.98

1.5

1.3

3.07

3.72

ug/l

1.55

230

2215

Malignant neoplasm of skin

447

1.23

0.98

1.3

1.1

2.55

2.76

ug/l

0.19

336

Inflammatory disease of uterus

265

2385

1.12

0.98

1.4

1.3

2.89

3.36

ug/l

1.57

245

2192

Drug-induced osteoporosis

2.19

0.98

3.8

1.1

1.85

3.87

ug/l

—

Other superficial mycoses, including avohilmo

154

1339

1.15

0.98

1.4

1.3

4.82

3.55

ug/l

0.28

149

1245

Viral hepatitis, IBD co-morbidity

481

0.75

0.98

1.3

2.76

3.84

ug/l

0.89

441

Bacterial pneumonia (organism specified)

182

1872

0.88

0.98

1.6

1.4

2.67

3.96

ug/l

2.76

161

1649

Soft tissue disorders

1165

6280

0.95

0.98

1.3

1.4

3.41

3.71

ug/l

0.41

1055

5761

Pulmonary heart disease, diseases of pulmonary circulation

692

1.21

0.98

1.6

2.66

4.67

ug/l

1.51

544

Ganglion

215

1911

1.13

0.97

1.4

3.28

3.61

ug/l

0.24

192

1700

Specific development disorders of scholastic skills

725

1.21

0.97

1.6

1.3

3.79

4.45

ug/l

0.50

688

Benign neoplasm of colon, rectum, anus and anal canal

137

996

1.16

0.96

1.6

1.8

6.84

4.75

ug/l

0.21

704

Other noninfective gastroenteritis and colitis

191

1685

1.13

0.96

1.3

1.4

4.46

4.18

ug/l

0.10

166

1505

Rosacea

117

997

1.18

0.96

1.2

1.4

2.71

3.58

ug/l

1.53

883

Symptoms and signs involving the nervous and musculoskeletal systems

377

4109

0.92

0.96

1.4

3.66

3.80

ug/l

0.10

322

3644

Impacted maxillary molar

193

1711

1.14

0.95

1.4

1.3

3.58

3.85

ug/l

0.42

188

1636

Focal epilepsy

106

1249

0.85

0.95

1.2

1.4

2.62

4.24

ug/l

3.00

1124

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

813

0.81

0.95

1.3

1.4

10.50

3.51

ug/l

0.55

725

Lesion of sciatic nerve

0.00

0.95

0.0

2.0

—

2.58

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.95

0.0

2.0

—

2.89

—

Care involving use of rehabilitation procedures

376

3685

0.92

0.95

1.7

1.4

3.25

3.89

ug/l

0.64

313

3211

Other predominantly sexually transmitted diseases, not elsewhere classified

314

2859

1.10

0.94

1.3

3.03

3.34

ug/l

0.73

296

2651

Benign neoplasm of breast

779

1.20

0.93

1.6

1.5

2.75

3.85

ug/l

1.46

678

Impacted teeth

578

4631

1.07

0.93

1.3

3.69

3.76

ug/l

0.14

553

4431

Rash and other nonspecific skin eruption

516

1.24

0.93

1.6

1.5

4.69

3.89

ug/l

0.27

456

1070

5712

0.95

0.93

1.4

3.25

3.64

ug/l

1.07

951

5147

Urinary track infection

1089

5177

1.05

0.93

1.4

3.23

3.50

ug/l

0.62

977

4705

Supplementary factors related to causes of morbidity and mortality classified elsewhere

217

2428

0.89

0.93

1.7

1.4

4.81

3.55

ug/l

0.38

195

2203

Gastroduodenal ulcer

337

1.30

0.93

1.4

1.8

2.36

5.39

ug/l

1.08

251

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

433

4003

1.09

0.92

1.3

3.23

3.44

ug/l

0.54

406

3756

Reactive arthropathies, FINNGEN

392

1.28

0.92

1.8

1.5

5.40

3.92

ug/l

0.29

352

Other infectious diseases, including avohilmo

392

1.28

0.92

1.7

1.4

2.47

3.35

ug/l

1.07

350

Valvular heart disease excluding rheumatic fever

102

860

0.85

0.92

1.4

1.6

2.81

5.00

ug/l

2.34

672

Other gastritis (incl. Duodenitis)

644

0.79

0.91

1.4

1.5

4.52

4.51

ug/l

0.00

535

Congenital malformations of the circulatory system

130

1090

1.16

0.91

1.5

1.4

5.68

4.47

ug/l

0.33

119

1002

Disorders of skin appendages

639

5958

1.07

0.91

1.3

3.32

3.60

ug/l

0.94

572

5459

Abnormal involuntary movements

717

1.20

0.91

1.4

1.5

2.97

3.97

ug/l

1.19

643

Other specified and unspecified personality disorders

939

0.83

0.91

1.3

1.4

3.55

4.01

ug/l

0.32

867

Nonsuppurative otitis media

439

4111

0.92

0.90

1.3

3.69

3.83

ug/l

0.33

421

3926

Myeloproliferative diseases (CML excluded)

118

1.53

0.90

1.1

1.9

2.73

5.88

ug/l

—

Biological medicines for asthma

170

0.58

0.90

1.1

1.5

3.38

2.78

ug/l

—

154

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

290

3188

0.91

0.90

1.3

3.01

3.62

ug/l

1.31

265

2922

Tobacco use

394

0.73

0.90

1.3

1.4

2.73

3.61

ug/l

0.96

363

Benign neoplasm: Rectum

193

1.40

0.90

2.1

2.0

2.01

5.12

ug/l

1.02

129

Myeloproliferative diseases

143

1.47

0.89

1.1

1.8

3.09

5.44

ug/l

0.55

111

Superficial injury of wrist and hand

229

2546

0.90

0.89

1.4

3.62

3.71

ug/l

0.07

214

2344

Diseases of salivary glands

268

2427

1.11

0.89

1.5

1.4

2.78

3.69

ug/l

2.31

232

2157

Unspecified misadventure during surgical and medical care

202

1.39

0.89

1.4

1.6

2.28

3.48

ug/l

0.76

174

Injury of muscle and tendon at wrist and hand level

552

0.78

0.89

1.3

1.4

2.58

3.81

ug/l

1.41

484

Other congenital malformations of tongue, mouth and pharynx

180

0.60

0.89

1.6

1.4

3.90

4.61

ug/l

0.25

168

Other disorders of conjunctiva

332

1.30

0.89

1.3

1.7

2.23

4.63

ug/l

1.70

264

Benign neoplasm of mouth and pharynx

341

1.29

0.88

1.4

1.6

1.94

3.98

ug/l

1.83

288

Other pulmonary diagnosis

786

4175

0.94

0.88

1.4

1.3

3.28

3.72

ug/l

0.81

698

3783

Asthma and allergy

250

2230

1.11

0.88

1.2

1.3

3.86

3.67

ug/l

0.13

234

2090

Bacterial, viral and other infectious agents

528

0.77

0.88

1.3

2.95

3.75

ug/l

0.73

485

Complications of surgical and medical care, not elsewhere classified

848

5974

0.95

0.87

1.6

1.3

3.33

3.40

ug/l

0.08

716

5382

Hypertrophic disorders of skin

612

1.22

0.87

1.2

1.4

3.54

3.86

ug/l

0.22

569

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

396

3659

1.09

0.87

1.3

3.06

3.38

ug/l

0.81

354

3403

Vitamin deficiency

246

1.35

0.87

1.8

1.4

3.06

3.48

ug/l

0.21

221

Vitamin deficiency, wide

246

1.35

0.87

1.8

1.4

3.06

3.48

ug/l

0.21

221

Nonischemic cardiomyopathy

111

1.53

0.87

1.2

1.8

1.50

6.17

ug/l

0.99

Other diseases of hard tissues of teeth

342

1618

1.10

0.87

1.5

1.4

3.82

4.08

ug/l

0.13

299

1415

Presence of cardiac and vascular implants and grafts

281

0.73

0.87

1.1

1.9

2.61

6.86

ug/l

1.09

188

Other hearing loss

513

1.23

0.86

1.6

3.16

4.89

ug/l

0.77

399

Diaphragmatic hernia

804

1.18

0.86

1.5

1.6

2.54

4.46

ug/l

1.70

603

Mucosal proctocolitis

118

1018

1.16

0.86

1.2

1.4

2.42

3.63

ug/l

2.95

106

937

Ankylosing spondylitis

425

0.75

0.86

1.1

1.4

3.71

3.75

ug/l

0.02

385

Visual impairment including blindness (binocular or monocular)

238

1.35

0.86

1.2

1.6

3.07

4.00

ug/l

0.32

205

Reactive arthropathies

450

1.25

0.86

1.8

1.4

5.05

3.85

ug/l

0.26

397

ILD differential diagnosis

785

4165

0.94

0.85

1.4

1.3

3.30

3.80

ug/l

0.91

695

3770

Acute appendicitis, no complications

505

5374

0.93

0.84

1.4

1.3

3.32

3.34

ug/l

0.02

452

4847

Streptococcal septicaemia, including avohilmo

230

1.35

0.84

2.5

1.6

2.90

3.39

ug/l

0.23

200

Other benign neoplasms of uterus

1.60

0.84

1.1

1.6

1.24

2.93

ug/l

—

Gestational [pregnancy-induced] hypertension

463

4957

0.93

0.84

1.3

4.03

3.05

ug/l

1.05

423

4546

Other and unspecified visual disturbances

633

1.20

0.83

1.7

1.5

2.85

4.10

ug/l

1.67

567

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

124

1422

0.87

0.83

1.4

1.3

3.19

3.91

ug/l

1.06

116

1323

Thyrotoxicosis

206

1849

1.12

0.83

1.3

1.4

2.42

3.61

ug/l

2.89

176

1616

Other diseases of the digestive system

101

863

1.17

0.83

1.3

1.5

3.00

4.11

ug/l

1.61

752

Dermatophytosis

461

1.24

0.83

1.5

1.6

2.57

4.29

ug/l

1.57

399

Any dementia

149

0.65

0.82

3.0

2.4

4.31

11.22

ug/l

—

Special screening examination for neoplasms

121

1.49

0.82

1.2

1.6

3.85

4.23

ug/l

0.09

Other and unspecified urticaria

225

2031

1.11

0.82

1.3

1.4

2.92

3.71

ug/l

1.86

209

1828

Chronic rhinitis, nasopharyngitis and pharyngitis

300

2745

1.09

0.82

1.4

2.76

3.72

ug/l

2.82

273

2432

Arthropathy in ulcerative colitis

1.66

0.82

1.2

2.42

2.85

ug/l

0.27

Dermatitis

461

4836

0.93

0.82

1.4

3.11

3.61

ug/l

0.77

405

4280

All influenza

164

1453

1.13

0.82

1.3

1.4

3.49

4.22

ug/l

0.94

143

1310

Venous thromboembolism

195

1680

1.12

0.82

1.8

1.5

2.51

3.82

ug/l

2.20

144

1365

Asthma and allergy, excluding more controls

250

2242

1.10

0.81

1.2

1.3

3.86

3.67

ug/l

0.13

234

2103

COPD differential diagnosis

787

4168

0.94

0.81

1.4

1.3

3.31

3.80

ug/l

0.91

698

3772

Soft tissue disorders related to use, overuse and pressure

982

0.84

0.81

1.5

1.6

4.39

4.19

ug/l

0.05

792

Mental and behavioural disorders due to tobacco

432

0.76

0.81

1.3

1.5

12.97

4.17

ug/l

0.38

381

Hypertrophic scar

563

1.21

0.81

1.2

1.4

3.37

3.97

ug/l

0.47

521

Follicular cysts of skin and subcutaneous tissue

105

903

1.16

0.81

1.3

1.4

2.92

4.06

ug/l

1.25

791

Nummular dermatitis

267

1.31

0.80

1.4

1.5

2.76

4.36

ug/l

0.83

230

Abnormal serum enzyme levels

481

1.22

0.80

1.5

5.70

4.09

ug/l

0.36

416

Hydronephrosis

445

1.24

0.80

2.0

1.4

2.74

4.22

ug/l

1.23

392

Retained placenta and membranes, without haemorrhage

132

1156

1.15

0.80

1.4

2.70

3.45

ug/l

1.03

118

1019

Certain conditions originating in the perinatal period

173

1368

1.13

0.80

1.4

4.59

4.40

ug/l

0.10

165

1305

Hyperkinetic disorders (excl. ADHD)

220

0.67

0.80

1.2

1.4

10.58

4.67

ug/l

0.39

205

Injury of eye and orbit

114

988

1.16

0.80

1.3

1.4

3.15

3.70

ug/l

0.79

105

908

Other enthesopathy of foot (+metatarsalgia)

692

1.19

0.79

1.3

1.5

2.41

3.66

ug/l

1.87

602

Fitting and adjustment of other devices

691

0.83

0.79

1.7

1.6

2.22

4.88

ug/l

2.56

539

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

126

1437

0.87

0.79

1.4

3.19

3.90

ug/l

1.06

117

1326

Fracture of shoulder and upper arm

156

1755

0.89

0.79

1.3

1.5

3.49

4.51

ug/l

1.45

134

1531

Secondary parkinsonism

0.00

0.79

0.0

1.6

—

3.30

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

0.79

0.0

1.6

—

3.56

—

Hyperhidrosis

393

1.26

0.79

1.3

1.4

3.12

3.74

ug/l

0.52

370

Other disorders of eyelid

104

844

1.16

0.79

1.2

1.8

1.90

4.49

ug/l

2.83

602

Purpura and other haemorrhagic conditions

720

1.18

0.79

1.7

1.4

3.69

3.77

ug/l

0.05

642

Flat foot [pes planus] (acquired)

396

0.76

0.79

1.3

1.5

3.05

5.35

ug/l

0.96

314

Post-traumatic stress disorder

179

1996

0.89

0.78

1.3

3.33

3.72

ug/l

0.59

163

1885

Secondary parkinsonism, excluding more controls

0.00

0.78

0.0

1.9

—

2.51

—

Smoking dependency

429

0.77

0.78

1.3

1.5

12.97

4.16

ug/l

0.38

379

Disorders of thyroid, IBD co-morbidities

257

1929

0.91

0.78

1.3

2.91

3.49

ug/l

0.52

229

1798

Cyst of Bartholin Gland

394

1.25

0.77

1.4

5.56

3.36

ug/l

0.33

359

Benign neoplasm of thyroid gland

116

1.47

0.74

1.4

1.5

1.73

3.76

ug/l

1.11

Fracture at wrist and hand level

232

2538

0.91

0.74

1.4

4.02

3.77

ug/l

0.14

209

2305

Azathioprine

132

1164

1.14

0.74

1.4

2.12

3.99

ug/l

4.48

126

1049

Acne

226

2466

0.91

0.74

1.3

3.34

3.90

ug/l

1.30

216

2357

Benign neoplasm: Sigmoid colon

201

1.34

0.74

1.7

1.9

24.26

5.06

ug/l

0.45

136

Delivery

559

2768

1.07

0.74

1.4

4.64

3.20

ug/l

2.46

518

2481

Supernumerary teeth EXCLUDE clefts and syndromes

1.64

0.74

3.0

1.5

3.39

3.60

ug/l

—

Deep bite

122

939

1.14

0.74

1.6

1.4

5.02

4.76

ug/l

0.09

108

875

ILD medications: azathioprine

132

1165

1.14

0.73

1.4

2.12

3.94

ug/l

4.34

126

1047

Opioids

1253

6208

1.04

0.73

1.4

1.3

3.35

3.55

ug/l

0.24

1152

5695

Other systemic involvement of connective tissue

143

1609

0.89

0.73

1.3

1.5

2.64

3.92

ug/l

2.30

119

1386

Acidosis

2.01

0.72

1.8

1.6

1.94

2.89

ug/l

—

Inflammatory disorders of breast

112

1277

0.87

0.72

1.4

2.93

3.85

ug/l

1.57

106

1198

Angina pectoris

327

0.79

0.72

1.4

2.3

1.24

8.27

ug/l

1.79

154

Granuloma annulare

110

0.54

0.72

1.2

1.4

3.67

2.75

ug/l

—

101

Ischaemic Stroke, excluding all haemorrhages

532

0.83

0.72

2.5

1.9

4.23

5.41

ug/l

0.27

358

Degeneration of macula and posterior pole

319

0.77

0.72

2.3

7.33

7.15

ug/l

0.02

164

Other viral diseases, including avohilmo

559

5221

1.06

0.71

1.3

3.54

3.64

ug/l

0.18

507

4837

L04AA Selective immunosuppressants

117

1331

0.88

0.71

1.4

3.32

3.73

ug/l

0.20

1155

Crohn disease (strict definition, require KELA, min 2 HDR)

588

0.81

0.71

1.3

1.4

2.89

3.92

ug/l

0.91

541

Benign neoplasm: Adrenal gland

134

1.42

0.71

1.3

1.9

1.64

5.78

ug/l

—

Convergent concomitant strabismus

563

1.20

0.71

1.5

1.4

3.37

4.02

ug/l

0.59

519

Benign neoplasm: Stomach

151

1.39

0.71

1.2

2.1

3.59

5.43

ug/l

0.35

109

Gout, FINNGEN

150

1.39

0.70

1.4

2.1

2.94

6.17

ug/l

0.75

Vasomotor and allergic rhinitis

512

4709

1.06

0.70

1.3

3.61

3.67

ug/l

0.06

467

4306

Pruritus

113

991

1.14

0.70

1.3

1.4

2.93

3.89

ug/l

0.73

898

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

125

1.44

0.70

1.2

1.8

7.96

4.46

ug/l

0.42

117

Nephropathy related operations

265

1.28

0.69

2.1

1.7

3.12

4.15

ug/l

0.37

229

Streptococcal septicaemia

221

1.31

0.69

2.6

1.6

2.96

3.49

ug/l

0.23

192

Fracture of forearm

406

3897

0.93

0.69

1.4

3.33

4.13

ug/l

2.01

363

3451

Demyelinating diseases of the central nervous system

888

0.85

0.68

1.2

1.4

2.37

3.58

ug/l

2.17

807

Type of accident

197

2168

0.91

0.68

1.8

1.4

4.87

3.58

ug/l

0.35

177

1959

Combinations of oral blood glucose lowering drugs

285

0.74

0.68

1.0

2.0

3.68

6.53

ug/l

0.46

185

Attention to artificial openings

1.60

0.68

1.3

1.6

2.91

3.69

ug/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

490

3066

1.06

0.68

1.4

1.3

2.96

3.96

ug/l

2.62

439

2802

Dermatographic urticaria

723

1.17

0.68

1.4

1.3

2.89

3.89

ug/l

1.16

663

L04AC Interleukin inhibitors

430

0.79

0.67

1.5

1.4

2.56

3.85

ug/l

1.05

388

Other maltreatment syndromes

168

0.65

0.67

1.5

1.3

1.66

2.95

ug/l

2.07

153

Juvenile osteochondrosis

366

1.24

0.67

1.2

1.4

3.57

3.29

ug/l

0.25

343

Pityriasis rosea

1.53

0.67

1.3

1.71

3.29

ug/l

1.68

Unstable angina pectoris

151

0.68

0.67

1.1

2.4

0.44

13.29

ug/l

—

Other benign neoplasms of connective and other soft tissue

429

1.21

0.67

1.5

2.94

4.20

ug/l

0.91

370

Benign neoplasm: Anus and anal canal

1.63

0.67

1.6

1.3

3.43

3.19

ug/l

—

Contact with and exposure to communicable diseases

626

5915

1.06

0.66

1.3

3.37

3.49

ug/l

0.28

590

5535

Other condition

950

0.86

0.66

1.5

1.4

3.97

3.89

ug/l

0.03

862

Other and unspecified disorders of vitreous body

644

1.17

0.66

1.3

2.1

2.53

7.18

ug/l

1.63

386

Other/unspecified reactive arthropathies

348

1.24

0.66

1.9

1.5

5.49

3.33

ug/l

0.38

313

Conjunctivitis (acute, non atopic)

305

2816

1.08

0.66

1.3

1.4

3.30

3.74

ug/l

0.53

273

2577

Crohn disease (strict definition, require KELA)

593

0.82

0.66

1.3

1.4

2.84

3.91

ug/l

0.96

545

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.79

0.66

1.8

1.6

2.08

2.34

ug/l

—

Fibromyalgia

906

0.86

0.66

1.3

1.4

2.43

3.41

ug/l

1.54

799

Contact with hypodermic needle

1.51

0.66

1.5

1.3

6.99

3.05

ug/l

0.44

COPD, hospital admission 2, with asthma infections

234

0.74

0.65

1.3

1.8

3.36

4.81

ug/l

0.38

167

Mental and behavioural disorders due to sedatives or hypnotics

439

0.79

0.65

1.5

1.4

2.92

3.40

ug/l

0.34

397

Disorders of iron metabolism

1.62

0.65

1.5

1.3

1.74

2.98

ug/l

—

Diseases of the respiratory system

679

3581

0.95

0.65

1.3

1.4

3.30

3.88

ug/l

1.09

609

3242

Fentanyl

128

1.40

0.65

1.2

1.9

1.61

3.87

ug/l

—

Coxarthrosis, primary, with hip surgery

324

0.77

0.64

3.2

2.4

3.93

9.15

ug/l

—

126

Stomatitis and related lesions

186

1691

1.10

0.64

1.4

4.32

3.75

ug/l

0.33

162

1528

Disorders in reading

234

1.30

0.64

1.5

1.3

3.19

4.28

ug/l

0.72

218

Sequelae of injuries, of poisoning and of other consequences of external causes

114

1286

0.89

0.63

1.4

2.78

3.79

ug/l

1.75

1130

Car occupant injured in other and unspecified transport accidents

203

2219

0.91

0.63

1.2

1.3

4.75

3.51

ug/l

0.39

195

2046

Benign neoplasm: Ascending colon

146

1.37

0.63

1.3

2.1

1.78

6.02

ug/l

1.06

Paracetamol or NSAID medication

219

1009

1.10

0.63

1.4

1.3

3.17

4.11

ug/l

2.44

205

953

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

622

0.83

0.63

1.3

1.4

2.71

3.86

ug/l

1.15

572

Asthma, hospital admission 2, infections

496

5114

0.94

0.63

1.4

3.59

3.83

ug/l

0.25

448

4590

Asthma-related infections

496

5114

0.94

0.63

1.4

3.59

3.83

ug/l

0.25

448

4590

Other viral hepatitis, including avohilmo

524

0.82

0.63

1.3

2.75

3.31

ug/l

0.57

487

Spondylopathies (FG)

103

1168

0.88

0.63

1.4

1.3

4.26

3.68

ug/l

0.18

1055

Crushed, pushed or stepped on by crowd or human stampede

783

0.85

0.62

1.8

1.3

3.40

3.64

ug/l

0.26

735

Trochanteric bursitis

513

0.82

0.62

1.6

1.7

2.90

4.48

ug/l

0.68

393

Personal history of risk-factors, not elsewhere classified

164

0.66

0.62

1.1

1.3

1.89

3.37

ug/l

2.25

154

All influenza (not pneumonia)

860

1.14

0.62

1.4

3.41

4.57

ug/l

1.11

782

Fracture of skull and facial bones

130

1162

1.12

0.62

2.0

1.4

3.84

3.57

ug/l

0.10

117

1039

Retinal breaks without detachment

279

1.26

0.62

1.6

1.8

2.55

4.80

ug/l

0.97

189

Etanercept

490

0.81

0.62

1.2

1.4

2.92

3.68

ug/l

0.50

445

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

159

1396

1.11

0.61

1.5

1.4

5.72

4.61

ug/l

0.43

146

1284

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

577

0.83

0.61

1.3

2.63

3.60

ug/l

0.93

522

Cellulitis

115

1293

0.89

0.61

1.3

1.4

3.17

4.24

ug/l

1.41

103

1158

Malignant neoplasm of bronchus and lung, including Hilmo

1.55

0.61

2.6

1.2

1.46

3.29

ug/l

—

Other disorders of amniotic fluid and membranes

360

3258

1.07

0.61

1.2

1.3

3.00

2.99

ug/l

0.02

334

3022

Focal epilepsy, mode (most common among epilepsy diagnosis)

1027

0.87

0.61

1.2

1.5

2.77

4.48

ug/l

2.45

922

Other viral hepatitis

489

0.82

0.61

1.3

2.88

3.14

ug/l

0.20

452

Obesity related asthma

168

1849

0.91

0.61

1.5

3.69

3.98

ug/l

0.14

143

1570

Spondyloarthritis

106

1196

0.88

0.60

1.4

1.3

4.22

3.75

ug/l

0.15

1076

Other disorders of veins

170

1839

0.91

0.60

1.7

1.5

2.52

3.97

ug/l

1.78

128

1486

Dysphagia

100

881

1.14

0.60

1.3

1.4

5.32

3.65

ug/l

0.29

760

Abnormal findings on diagnostic imaging of lung

736

1.15

0.60

1.9

1.7

2.74

4.36

ug/l

0.76

529

Cervicalgia

133

1193

1.12

0.60

1.4

1.5

2.85

3.75

ug/l

0.93

115

1033

GI-bleeding

862

1.14

0.60

1.3

1.5

3.14

4.11

ug/l

1.26

750

Vascular dementia

0.00

0.60

0.0

1.8

—

6.48

—

Pollen allergy

341

3148

1.07

0.59

1.3

3.86

3.83

ug/l

0.02

321

2944

Acute bronchitis

263

2779

0.93

0.59

1.5

1.4

3.73

3.87

ug/l

0.09

234

2500

Polyhydramnios

1075

0.88

0.59

1.3

2.80

3.06

ug/l

0.36

1003

Noninfectious colitis NAS

100

883

1.13

0.59

1.3

1.4

3.45

4.02

ug/l

0.21

788

Fall on same level involving ice and snow

388

4121

0.94

0.59

1.5

1.4

3.36

3.84

ug/l

0.75

341

3634

Heartburn

725

0.85

0.59

1.3

3.18

3.27

ug/l

0.08

656

Retinal detachments and breaks

603

1.16

0.58

2.0

1.8

12.22

5.04

ug/l

0.34

435

Combined immunodeficiencies

1.72

0.58

1.3

1.4

1.89

2.97

ug/l

—

Radial styloid tenosynovitis [de Quervain]

530

1.17

0.57

1.4

3.16

3.85

ug/l

0.42

482

Diseases of the eye and adnexa

1114

5379

1.04

0.57

1.3

3.44

3.50

ug/l

0.11

1018

4957

Multiple delivery

1031

0.88

0.57

1.9

1.4

4.38

2.50

ug/l

1.90

898

Puerperal sepsis

819

0.87

0.57

1.3

1.5

3.08

4.54

ug/l

1.02

689

Papulosquamous disorders

169

1851

0.91

0.57

1.3

1.5

2.98

3.92

ug/l

1.41

139

1570

Dementia

212

0.77

0.57

2.2

2.3

3.51

8.63

ug/l

0.75

116

Raynaud syndrome

807

0.87

0.56

1.4

3.30

3.69

ug/l

0.31

734

Atopic dermatitis, strict definition

497

5116

0.95

0.56

1.4

1.3

4.63

3.59

ug/l

1.23

456

4768

Other peripheral vertigo

286

0.77

0.56

2.4

1.7

3.35

3.96

ug/l

0.19

238

Iridocyclitis in diseases classified elsewhere

1.51

0.56

1.3

1.4

2.11

2.94

ug/l

0.76

Methotrexate

700

0.86

0.56

1.8

1.5

4.60

3.83

ug/l

0.15

593

Scoliosis

130

1172

1.11

0.56

1.4

3.21

3.90

ug/l

1.19

121

1102

Sulfasalazine

180

1964

0.92

0.56

1.2

1.4

3.15

3.75

ug/l

0.82

159

1711

Lesion of ulnar nerve

531

1.17

0.56

1.3

1.4

2.96

3.83

ug/l

0.68

452

Early onset COPD, excluding more controls

341

0.79

0.56

1.2

1.6

3.81

5.97

ug/l

0.54

256

Pain (limb, back, neck, head abdominally)

724

3468

1.05

0.56

1.4

1.3

4.18

3.89

ug/l

0.18

648

3179

Any reimbursement code in KELA

1027

4958

1.04

0.55

1.4

1.3

3.70

3.45

ug/l

0.28

913

4714

Mixed disorders of conduct and emotions, excluding more controls

525

0.83

0.55

1.2

1.3

3.10

3.83

ug/l

0.96

508

Metatarsalgia

625

1.15

0.55

1.3

1.4

2.55

3.70

ug/l

1.40

548

Otitis media, unspecified

180

1519

1.09

0.55

1.4

1.3

3.82

4.40

ug/l

0.96

168

1442

Unspecific neurodegenerative disorder

134

0.71

0.55

1.6

2.8

5.40

15.48

ug/l

—

Pregnancy hypertension

724

6200

1.04

0.55

1.4

1.3

3.68

3.31

ug/l

0.43

652

5633

Peritonsillar abscess

234

2521

0.93

0.55

1.3

3.21

3.42

ug/l

0.34

214

2325

Benign paroxysmal vertigo

123

1107

1.11

0.54

1.4

1.5

2.79

4.34

ug/l

1.70

101

899

False labour

674

4000

1.05

0.54

1.3

4.27

3.22

ug/l

1.37

632

3657

Viral hepatitis, including avohilmo

557

0.84

0.54

1.3

2.73

3.28

ug/l

0.61

515

Obesity due to excess calories

542

5686

0.95

0.54

1.3

3.43

3.36

ug/l

0.09

493

5166

Calculus of kidney and ureter

963

0.88

0.53

1.2

1.4

6.31

3.99

ug/l

0.51

835

Oter anti-inflammatory and antirheumatic agents, non-steroids

278

0.83

0.53

1.9

1.4

4.04

5.55

ug/l

0.19

220

Carbimazole or st.post thyroidectomy, condition for graves disease

178

1634

1.09

0.53

1.3

1.4

2.24

3.76

ug/l

3.61

151

1431

Other viral diseases

363

3410

1.06

0.53

1.3

3.53

3.81

ug/l

0.45

329

3161

Acne, including avohilmo

692

5368

1.05

0.53

1.3

3.72

3.54

ug/l

0.35

661

5137

Other specified and unspecified retinal disorders

1.43

0.53

1.7

1.5

8.37

2.73

ug/l

0.48

Use of pramipexole

516

1.16

0.52

1.4

1.6

2.09

4.82

ug/l

1.77

405

Prolonged pregnancy

446

3613

1.06

0.52

1.2

1.3

3.83

3.09

ug/l

2.88

422

3369

Previous suicide attempt

135

0.66

0.52

1.1

1.3

1.59

3.14

ug/l

—

125

Nontoxic goitre/thyroid nodule

122

1101

1.11

0.52

1.4

1.6

2.48

4.20

ug/l

1.84

861

Pre-eclampsia or poor fetal growth

622

5928

1.05

0.52

1.4

1.3

3.25

3.22

ug/l

0.05

560

5450

Carcinoma in situ of other and unspecified genital organs

1.45

0.52

1.7

1.5

4.10

2.67

ug/l

—

Bell's palsy

601

1.15

0.52

1.8

1.4

2.93

3.73

ug/l

0.67

537

Disorders of psychological development

189

1897

0.92

0.51

1.5

1.3

3.66

4.28

ug/l

0.89

181

1809

Impingement syndrome of shoulder

403

0.82

0.51

1.4

2.0

2.25

7.91

ug/l

1.40

266

Renal failure

637

0.87

0.51

1.9

1.6

3.14

4.80

ug/l

0.95

496

Bulimia nervosa (incl. atypical)

104

935

1.12

0.50

1.2

1.3

3.39

3.67

ug/l

0.24

880

severe traumatic brain injury, does not include concussion

416

1.18

0.50

1.3

1.6

3.36

4.00

ug/l

0.21

352

Left ventricular outflow tract obstruction (LVOTO), broad definition

306

1.21

0.50

1.3

1.6

6.95

4.55

ug/l

0.30

264

Viral hepatitis

509

0.84

0.50

1.3

2.84

3.13

ug/l

0.26

469

Other noninfective disorders of lymphatic vessels and lymph nodes

127

1.34

0.49

1.3

1.4

2.48

4.65

ug/l

0.53

108

Abnormalities of heart beat

281

2902

0.94

0.49

1.4

3.09

3.82

ug/l

1.67

244

2610

Heart failure and antihypertensive medication

254

0.82

0.49

1.6

1.7

44.36

5.26

ug/l

0.42

163

Infections, IBD-co-morbidities

126

802

1.11

0.49

1.4

3.41

4.23

ug/l

0.34

108

714

Other keratitis

108

973

1.11

0.49

1.4

1.3

2.64

3.90

ug/l

1.94

898

Early lumbar disc prolapse, operated

105

1165

0.90

0.49

1.4

1.3

6.13

3.15

ug/l

0.46

1074

Lichen simplex chronicus and prurigo

201

0.74

0.49

2.1

1.6

1.13

4.47

ug/l

—

172

Psoriasis vulgaris

840

1.12

0.49

1.3

1.5

3.09

3.72

ug/l

0.62

730

Sarcoidosis

353

1.19

0.49

1.7

1.5

2.07

3.56

ug/l

0.85

277

Congenital malformations of heart and great arteries

109

953

1.11

0.49

1.5

1.4

6.35

4.68

ug/l

0.41

100

879

Asthma, hospital admissions , main diagnosis only

790

7126

0.96

0.48

1.4

3.29

3.63

ug/l

0.74

714

6443

Other spirochaetal diseases

179

1653

1.08

0.48

1.7

1.4

3.46

3.90

ug/l

0.37

155

1391

Transport accidents

537

4673

0.96

0.48

1.3

3.78

3.62

ug/l

0.10

503

4273

Vitiligo

1.46

0.48

1.5

1.3

3.49

2.93

ug/l

0.22

Other joint disorders

1167

6276

0.97

0.48

1.3

3.51

3.64

ug/l

0.15

1055

5789

Other diseases of pleura

631

1.13

0.48

1.6

1.7

3.28

4.81

ug/l

0.65

486

Abnormal results of function studies

465

1.16

0.48

1.3

1.4

3.18

4.07

ug/l

0.69

416

Systemic connective tissue disorders

186

2008

0.93

0.48

1.3

1.5

2.45

3.79

ug/l

3.50

156

1721

DVT of lower extremities and pulmonary embolism

119

1074

1.10

0.48

1.5

1.6

2.31

4.35

ug/l

2.42

854

Herpesviral [herpes simplex] infections, including avohilmo

340

3215

1.06

0.47

1.2

1.3

3.13

3.36

ug/l

0.40

308

2943

Autoimmune hyperthyroidism

503

1.16

0.47

1.4

2.26

3.94

ug/l

2.07

450

Other/unspecified enthesopathies, not elsewhere classified

267

0.79

0.47

1.4

1.6

2.28

4.13

ug/l

0.80

224

Other and unspecified effects of external causes

306

3244

0.94

0.47

1.3

3.44

3.61

ug/l

0.16

285

2985

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

753

6288

1.04

0.47

1.4

1.3

4.22

3.27

ug/l

0.83

677

5692

Other disorders of skin and subcutaneous tissue, not elsewhere classified

550

1.15

0.47

1.5

2.89

3.70

ug/l

0.79

476

Aortic aneurysm

100

1.37

0.47

2.4

1.9

3.29

5.64

ug/l

—

Weight loss

476

1.16

0.46

1.6

1.5

6.88

3.77

ug/l

0.55

423

Urolithiasis

1004

0.90

0.46

1.3

1.4

6.22

3.95

ug/l

0.54

870

Intrahepatic Cholestasis of Pregnancy (ICP)

124

1358

0.91

0.46

1.4

1.3

3.19

3.65

ug/l

0.55

116

1259

In situ neoplasms

317

2994

1.06

0.46

1.3

1.4

5.26

3.31

ug/l

0.60

276

2682

Other diseases of anus and rectum

139

1268

1.09

0.46

1.5

3.12

4.27

ug/l

1.27

122

1079

Lyme disease, including avohilmo

175

1619

1.08

0.46

1.8

1.4

3.44

3.91

ug/l

0.39

151

1360

Lyme disease

175

1619

1.08

0.46

1.8

1.4

3.44

3.91

ug/l

0.39

151

1360

Hallux rigidus

209

1.25

0.46

1.4

2.2

1.96

8.73

ug/l

1.18

118

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

467

1.16

0.46

1.6

2.58

4.14

ug/l

1.31

381

Dipeptidyl peptidase 4 (DPP-4) inhibitors

572

0.88

0.46

1.7

1.9

2.40

5.51

ug/l

1.63

359

Myocardial infarction, without ST-elevation

159

0.74

0.46

2.3

0.42

11.41

ug/l

—

Sequelae of cerebrovascular disease

339

0.83

0.45

2.2

1.8

4.37

5.79

ug/l

0.20

248

Open wound of shoulder and upper arm

121

0.66

0.45

1.4

1.3

4.76

2.72

ug/l

—

109

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

477

2282

1.05

0.45

1.4

1.3

3.78

3.98

ug/l

0.12

434

2128

Other abnormal findings in urine

1.40

0.45

1.1

1.5

3.65

2.46

ug/l

—

Neurological diseases

1095

5667

0.97

0.45

1.4

1.3

3.60

3.69

ug/l

0.12

1001

5221

!Aliquae complicationes praecoces traumatis

175

0.74

0.44

1.3

1.5

2.17

3.19

ug/l

1.08

154

Early complications of trauma

175

0.74

0.44

1.3

1.5

2.17

3.19

ug/l

1.08

154

Other inflammation of eyelid, including avohilmo

598

5746

1.04

0.44

1.4

3.73

3.48

ug/l

0.32

550

5239

Acute sinusitis

599

5663

0.96

0.44

1.3

3.47

3.54

ug/l

0.07

538

5148

Benign neoplasm of urinary organs

1.40

0.44

2.5

2.0

2.54

4.36

ug/l

—

Dementia, including avohilmo

233

0.82

0.44

2.1

2.3

4.25

7.97

ug/l

0.55

129

Other diseases of pancreas

121

1.32

0.44

1.6

1.8

2.80

6.56

ug/l

—

Palatinal maxillary canine

131

0.68

0.44

1.1

1.5

2.77

3.72

ug/l

—

122

Acute laryngitis and tracheitis

196

1799

1.07

0.44

1.3

3.78

4.06

ug/l

0.22

185

1699

Acute and transient psychotic disorders

704

0.88

0.44

1.4

3.07

3.89

ug/l

0.60

636

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

130

1.31

0.44

1.0

1.8

2.83

5.83

ug/l

0.63

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

334

3394

0.95

0.44

1.3

1.4

3.14

3.73

ug/l

0.72

290

2988

Hypotension

238

1.22

0.43

1.4

1.7

2.89

4.10

ug/l

0.53

190

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

978

0.90

0.43

1.6

1.5

2.50

4.44

ug/l

1.72

757

Glucagon-like peptide-1 (GLP-1) analogues

978

0.90

0.43

1.6

1.5

2.50

4.44

ug/l

1.72

757

Other infectious diseases

275

1.20

0.43

1.9

1.5

2.10

3.27

ug/l

1.04

242

Certain infectious and parasitic diseases

1092

5306

1.03

0.43

1.4

1.3

3.62

3.71

ug/l

0.10

974

4850

Allergic rhinitis

467

4411

1.05

0.43

1.3

3.72

3.69

ug/l

0.02

434

4062

Spirochaetal infections, other/unspecified, including avohilmo

177

1645

1.08

0.43

1.8

1.4

3.44

3.89

ug/l

0.39

153

1385

Poor fetal growth

350

3329

1.05

0.43

1.3

3.09

3.32

ug/l

0.49

322

3141

Use of teriflunomide

0.65

0.43

1.2

1.3

4.18

2.90

ug/l

—

Coxibs

279

1378

1.06

0.43

1.3

4.74

4.03

ug/l

0.24

262

1280

Chronic sinusitis

359

3409

1.05

0.42

1.5

1.4

3.01

3.71

ug/l

0.94

310

3018

Excessive vomiting in pregnancy

159

1474

1.08

0.42

1.3

3.43

3.33

ug/l

0.12

148

1361

Primary coxarthrosis, bilateral

196

0.77

0.42

2.8

2.5

2.80

11.71

ug/l

—

Abnormal weight loss

359

1.17

0.42

1.3

1.6

2.70

4.12

ug/l

0.99

316

Mixed connective tissue disease

0.64

0.42

1.3

1.4

3.22

2.95

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

126

1371

0.92

0.42

1.4

1.3

3.19

3.64

ug/l

0.54

117

1261

Dialysis, with operation codes

276

1.20

0.42

1.9

1.6

3.17

4.24

ug/l

0.38

232

Unspecified privation

594

1.13

0.42

1.7

1.4

4.08

3.64

ug/l

0.14

536

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.36

0.42

1.5

1.3

3.49

3.19

ug/l

0.08

Lifestyle-related condition

1.39

0.41

1.6

1.3

1.72

2.93

ug/l

—

Other and unspecified vasculitis limited to skin

1.38

0.41

1.1

1.7

3.23

3.67

ug/l

—

Disease of hard tissues of teeth, NOS

326

1616

1.06

0.41

1.5

1.4

3.01

4.03

ug/l

0.88

280

1413

Visual disturbances

378

3603

1.05

0.41

1.5

1.4

3.00

3.84

ug/l

1.46

335

3203

Effects of other deprivation

0.00

0.41

0.0

1.0

—

4.10

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.41

0.0

1.1

—

2.88

—

Trichomoniasis

0.00

0.41

0.0

1.7

—

2.74

—

Diagnoses used for exclusion with ILD

576

1.13

0.41

2.1

1.5

2.85

3.84

ug/l

0.59

466

Anogenital herpesviral [herpes simplex] infection

122

1121

1.09

0.41

1.3

2.52

3.68

ug/l

2.33

113

1049

Other spirochaetal diseases, including avohilmo

182

1698

1.07

0.41

1.7

1.4

3.55

3.89

ug/l

0.27

158

1429

Other and unspecified rosacea

520

1.14

0.41

1.2

1.5

2.26

3.84

ug/l

1.83

458

Crystal arthropathies, rheuma endpoint

0.00

0.40

0.0

2.0

—

3.33

—

Dronedarone medication

0.00

0.40

0.0

1.9

—

4.26

—

Intracranial injury

473

4594

0.96

0.40

1.4

3.99

3.81

ug/l

0.10

429

4188

Anaemia in chronic diseases classified elsewhere

1.47

0.40

4.0

1.6

1.86

3.61

ug/l

—

Ethmoidectomy

720

0.89

0.40

1.5

1.4

2.56

3.72

ug/l

1.54

637

Eosinophilia

1.34

0.40

2.3

1.3

2.35

3.18

ug/l

—

Other sexually transmitted chlamydial diseases

162

1508

1.08

0.40

1.3

2.95

3.57

ug/l

1.28

156

1424

Focal epilepsy, strict definition

1034

0.91

0.40

1.2

1.5

2.66

4.49

ug/l

2.87

928

Other crystal arthropathies

0.00

0.40

0.0

1.6

—

1.40

—

Basal cell carcinoma, including Hilmo

294

1.15

0.40

1.4

1.1

3.22

2.46

ug/l

0.42

197

Peripheral artery disease

257

0.83

0.39

1.8

2.0

1.92

6.65

ug/l

1.20

174

Bitten or struck by other mammals

146

1354

1.08

0.39

1.4

1.3

3.70

3.84

ug/l

0.05

128

1248

Superficial injury of head

141

1520

0.93

0.39

1.2

1.4

3.41

3.73

ug/l

0.36

126

1358

Speech and linguistic disorders

144

1280

1.08

0.39

1.6

1.4

4.35

4.36

ug/l

0.01

138

1218

Dental pulpitis, including avohilmo

1078

6714

1.03

0.38

1.3

3.50

3.49

ug/l

0.01

987

6099

Deviated nasal septum

104

1135

0.91

0.38

1.2

1.4

3.00

4.01

ug/l

0.94

968

Contusion of toe(s) without damage to nail

298

1.18

0.38

1.5

1.4

2.84

3.46

ug/l

0.47

274

Aortic valve malfunction, age under 60 years

233

1.20

0.38

1.2

1.6

4.07

4.83

ug/l

0.22

193

Calcific tendinitis of shoulder

159

0.75

0.38

1.2

1.8

1.94

4.92

ug/l

—

123

Other diseases of liver

703

1.11

0.38

1.3

1.5

3.52

3.91

ug/l

0.24

585

Infection due to other mycobacteria, including avohilmo

1.39

0.38

1.4

1.6

0.33

3.68

ug/l

—

Atopic dermatitis, strict definition with reimbursement

519

5176

0.96

0.38

1.4

1.3

4.48

3.55

ug/l

1.13

475

4810

Early onset COPD

323

0.84

0.38

1.2

1.7

3.81

4.60

ug/l

0.22

240

Conduction disorders

608

0.90

0.37

1.6

1.5

2.70

5.46

ug/l

2.20

489

Neonatal jaundice from other and unspecified causes

109

0.71

0.37

1.0

1.9

23.10

6.15

ug/l

—

102

Use of peginterferon beta-1a

1.30

0.37

1.1

1.3

2.99

2.77

ug/l

—

Ulcerative rectosigmoiditis

524

1.13

0.37

1.2

1.4

2.52

3.91

ug/l

1.63

475

Nontoxic diffuse goitre

107

1.31

0.37

1.4

1.8

2.74

3.48

ug/l

—

Atrial fibrillation and flutter

408

0.88

0.37

1.9

1.6

2.41

4.58

ug/l

1.55

289

Psoriasis

128

1381

0.93

0.36

1.3

1.4

3.20

3.72

ug/l

0.55

107

1197

Acute epiglottitis

1.27

0.36

1.2

1.6

1.50

2.30

ug/l

—

Later onset COPD, excluding more controls

0.63

0.36

1.0

3.3

—

38.13

—

Hepatic failure, not elsewhere classified

1.27

0.36

1.1

1.5

5.66

3.14

ug/l

—

Rheumatism, unspecified

513

0.88

0.36

1.2

1.7

2.66

4.52

ug/l

0.98

397

Other acute viral hepatitis

0.65

0.36

1.0

1.2

5.14

3.28

ug/l

—

Early lumbar disc prolapse operation

106

1151

0.92

0.36

1.4

1.3

6.10

3.35

ug/l

0.42

1057

Other Crohn's disease

576

0.88

0.36

1.4

1.3

2.26

3.90

ug/l

2.36

531

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

319

1.16

0.36

1.4

3.34

3.12

ug/l

0.12

288

Polycystic kidney disease

1.32

0.35

1.8

1.4

5.68

2.78

ug/l

1.14

Acute renal failure

288

0.83

0.35

1.9

1.8

4.20

4.24

ug/l

0.01

228

Visual disturbances and blindness

396

3795

1.04

0.35

1.5

1.4

3.04

3.87

ug/l

1.51

350

3374

Fracture of lumbar spine and pelvis

734

1.10

0.35

1.8

1.5

2.55

3.69

ug/l

1.85

631

Chronic hepatitis NAS

1.40

0.35

1.5

1.3

3.64

3.25

ug/l

—

Benign neoplasm: Lip

1.40

0.35

1.2

1.4

2.34

3.75

ug/l

—

Migraine without aura and triptan purchases

344

3293

1.05

0.35

1.4

1.3

3.25

3.46

ug/l

0.24

321

3053

Other and unspecified injuries of wrist and hand

341

0.85

0.35

1.3

1.4

2.77

3.65

ug/l

0.99

310

Fibroblastic disorders

554

0.88

0.35

1.5

1.6

2.81

4.33

ug/l

0.85

439

Other and unspecified acne

189

0.79

0.35

1.3

3.56

3.17

ug/l

0.14

178

Somatoform disorder

155

1450

1.07

0.35

1.5

1.3

4.26

3.71

ug/l

0.18

130

1292

Implicit bacterial Sepsis, including avohilmo

107

965

0.92

0.34

1.8

1.6

3.55

4.36

ug/l

0.41

802

Ulcerative colitis, NAS

111

1025

1.08

0.34

1.2

1.4

2.58

4.12

ug/l

2.63

106

935

Crowding of teeth, including avohilmo

172

1515

0.94

0.34

1.4

4.40

4.31

ug/l

0.04

158

1446

Lateral epicondylitis

532

0.88

0.34

1.1

1.6

2.21

3.62

ug/l

1.21

421

Undetermined asthma

856

0.91

0.34

1.4

2.60

3.88

ug/l

2.43

764

Pedal cyclist injured in noncollision transport accidents

815

0.91

0.34

1.2

1.4

2.91

3.83

ug/l

1.42

751

Fracture of foot, except ankle

225

2374

0.95

0.34

1.2

1.4

3.18

3.74

ug/l

1.28

207

2160

Diseases of the ear and mastoid process

1237

6342

0.98

0.34

1.4

1.3

3.50

3.54

ug/l

0.04

1129

5746

Glaucoma

101

931

0.92

0.34

1.9

1.7

4.94

5.33

ug/l

0.07

667

FESS (DNB20)

710

0.90

0.34

1.5

1.4

2.56

3.74

ug/l

1.57

629

Medial epicondylitis

127

1.26

0.33

1.6

1.8

1.93

5.51

ug/l

1.05

110

Ascites

100

1.30

0.33

2.6

1.5

2.50

2.55

ug/l

—

Nonalcoholic fatty liver disease

387

1.14

0.33

1.4

1.5

3.84

4.31

ug/l

0.18

325

Bacterial, viral and other infectious agents, including avohilmo

625

0.89

0.33

1.3

2.82

3.70

ug/l

1.12

576

Open wound of head

251

2477

0.95

0.33

1.4

3.09

3.86

ug/l

1.87

223

2183

Perforation of tympanic membrane

596

1.11

0.33

1.4

2.37

3.90

ug/l

2.34

538

Benign neoplasm: Cerebral meninges

188

0.80

0.33

2.6

2.0

1.07

4.93

ug/l

—

135

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

558

5689

0.97

0.33

1.3

2.94

3.65

ug/l

4.49

512

5264

Viral conjunctivitis

173

1.22

0.33

1.3

1.5

3.45

2.77

ug/l

0.22

157

Oral leukoplakia, including avohilmo

1.31

0.33

1.0

1.5

2.72

2.99

ug/l

—

Other follicular disorders

729

0.90

0.33

1.3

1.4

2.70

3.49

ug/l

0.90

680

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

219

1.19

0.33

1.3

1.6

2.36

4.23

ug/l

0.75

179

Diseases of arteries, arterioles and capillaries (FINNGEN)

286

0.87

0.33

2.2

1.7

2.39

4.85

ug/l

1.05

202

Undetermined asthma, excluding more controls

853

0.91

0.32

1.4

2.60

4.35

ug/l

2.18

766

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

318

1.12

0.32

1.6

1.1

3.26

2.49

ug/l

0.45

215

IBD patients in KELA-register

200

2112

0.95

0.32

1.3

1.4

2.52

3.63

ug/l

3.79

187

1923

Unspecified fall

336

3437

0.96

0.32

1.3

1.4

3.11

4.05

ug/l

3.41

300

3083

Leisure time condition

121

1299

0.93

0.32

2.1

1.4

5.36

3.71

ug/l

0.26

107

1179

Symptoms and signs involving the skin and subcutaneous tissue

650

5954

1.03

0.32

1.4

3.08

3.57

ug/l

1.21

567

5325

Other diseases of upper respiratory tract

1011

5395

0.98

0.32

1.4

3.39

3.74

ug/l

0.75

919

4872

Keratitis

269

2567

1.05

0.32

1.3

1.4

3.24

3.61

ug/l

0.30

234

2301

Thyroiditis, unspecified

101

1.29

0.32

2.8

1.6

9.89

2.69

ug/l

0.38

Parapsoriasis

110

1.28

0.32

1.4

1.3

1.91

3.26

ug/l

1.46

Inflammatory bowel disease, strict (require KELA)

200

2111

0.95

0.32

1.3

1.4

2.52

3.65

ug/l

3.83

187

1912

Other and unspecified mononeuropathies of upper limb

119

1.26

0.32

2.1

1.5

10.04

2.62

ug/l

0.50

103

Pain in thoracic spine

124

1156

1.07

0.31

1.3

1.4

2.74

3.43

ug/l

0.77

107

1021

Abnormal findings on examination of blood, without diagnosis

165

1585

0.94

0.31

1.3

1.4

3.98

3.77

ug/l

0.09

141

1379

Mixed disorders of conduct and emotions

495

0.88

0.31

1.2

1.3

3.10

3.84

ug/l

0.97

474

Cerebral aneurysm, nonruptured

202

1.19

0.31

1.4

1.7

2.36

4.48

ug/l

0.78

154

Presbyopia

156

1.22

0.31

3.2

1.9

8.46

5.62

ug/l

—

106

Cramp and spasm

296

1.15

0.30

1.1

1.4

2.99

4.18

ug/l

0.65

270

Stenosis and insufficiency of lacrimal passages

343

1.14

0.30

1.2

1.7

3.54

4.04

ug/l

0.19

288

Cardiomyopathy (excluding other)

120

1.25

0.30

1.0

1.6

1.71

6.29

ug/l

—

Heart failure and coronary heart disease

168

0.83

0.29

1.5

2.6

1.09

11.75

ug/l

—

Persons encountering health services for specific procedures, not carried out

745

1.09

0.29

1.2

1.4

3.09

4.11

ug/l

1.45

692

Biguanides

719

4222

1.03

0.29

1.4

6.12

3.28

ug/l

2.80

652

3682

Embedded teeth, including avohilmo

199

1892

1.05

0.29

1.3

3.02

3.71

ug/l

1.84

193

1794

Gastric ulcer

250

1.16

0.29

1.5

1.8

2.39

4.29

ug/l

0.88

192

Other specified/unspecified systemic involvement of connective tissue

292

0.85

0.29

1.2

1.5

2.92

3.83

ug/l

0.39

255

436

4472

0.97

0.29

1.4

3.72

3.81

ug/l

0.07

394

4051

0.73

0.29

1.1

2.8

—

32.24

—

Congenital malformations of the respiratory system

1.23

0.29

1.3

1.5

8.47

3.73

ug/l

—

Injury of muscle and tendon at hip and thigh level

392

1.12

0.29

1.7

1.5

3.91

4.28

ug/l

0.15

331

Neurological diseases, wide definition

526

2559

1.03

0.28

1.4

1.3

3.91

3.71

ug/l

0.12

492

2402

Other epidermal thickening

204

1.18

0.28

2.4

1.5

8.29

2.94

ug/l

0.43

183

Crohn disease

117

1095

1.07

0.28

1.3

1.4

2.48

3.78

ug/l

2.77

110

1000

Ménière disease

223

1.17

0.28

1.5

1.7

2.48

4.36

ug/l

0.68

177

Exposure to smoke, fire and flames

1.28

0.28

1.2

1.3

2.42

3.19

ug/l

0.93

Vasculitis limited to skin, not elsewhere classified

1.29

0.28

1.1

1.6

3.23

3.61

ug/l

—

Acute suppurative otitis media

482

4631

0.97

0.28

1.3

4.32

3.55

ug/l

0.56

448

4374

Dilated cardiomyopathy

1.29

0.28

1.0

2.0

1.52

4.50

ug/l

—

Assault

116

1238

0.94

0.28

1.3

3.27

3.79

ug/l

0.51

1158

Use of fingolimod

116

0.77

0.28

1.3

1.2

1.43

2.68

ug/l

—

105

Other factor of the environment

1.27

0.28

1.6

1.2

1.72

3.15

ug/l

—

Gastrointestinal diseases

885

4540

0.98

0.27

1.4

1.3

3.89

3.64

ug/l

0.21

798

4235

Localized scleroderma [morphea]

1.25

0.27

1.5

1.4

3.17

2.59

ug/l

—

122

1.24

0.27

1.6

1.3

2.39

3.30

ug/l

0.85

112

Congenital malformations of the respiratory system, including avohilmo

1.23

0.27

1.3

1.4

8.07

3.62

ug/l

—

Speech therapy

896

0.93

0.27

1.3

1.5

2.01

3.76

ug/l

3.97

738

Retinal detachment with retinal break

168

1.19

0.27

2.0

42.31

4.96

ug/l

0.43

121

Oedema, not elsewhere classified

166

1537

1.06

0.27

1.3

1.4

3.11

3.65

ug/l

0.54

147

1318

Other malignant neoplasms of skin (=non-melanoma skin cancer)

286

1.11

0.27

1.5

1.1

2.82

2.45

ug/l

0.19

193

Non-allergic asthma (mode), excluding more controls

137

1280

1.06

0.27

1.5

1.4

3.14

4.34

ug/l

1.70

120

1150

Hypothyroidism, drug reimbursement

156

1150

0.95

0.27

1.3

1.2

2.31

3.02

ug/l

3.00

131

1076

Asthma, including avohilmo

1238

6684

1.02

0.26

1.3

1.4

3.22

3.65

ug/l

1.47

1130

6047

Bacterial Sepsis

133

1166

0.94

0.26

1.9

1.5

3.48

4.49

ug/l

0.66

102

994

Symptoms and signs involving the circulatory and respiratory systems

1207

6164

0.98

0.26

1.3

3.16

3.67

ug/l

1.80

1100

5636

Spondylolisthesis/Spondylolysis

573

0.91

0.26

1.5

1.7

3.20

4.52

ug/l

0.59

448

Unspecified lump in breast

119

1118

1.07

0.26

1.4

1.5

2.86

3.73

ug/l

1.10

953

Childhood asthma (age<16)

359

2902

0.96

0.26

1.3

3.51

3.67

ug/l

0.29

340

2795

Nonsuppurative otitis media, including avohilmo

575

5105

0.97

0.26

1.3

3.54

3.59

ug/l

0.12

550

4815

Type 2 diabetes, definitions combined, including avohilmo

763

4516

0.98

0.26

1.5

1.4

5.85

3.18

ug/l

2.73

685

3964

Childhood asthma (age<16), excluding more controls

359

2901

0.96

0.26

1.3

3.51

3.67

ug/l

0.28

340

2795

Viral and other specified intestinal infections, including avohilmo

490

4579

1.03

0.26

1.3

3.44

3.82

ug/l

1.12

463

4319

Distal bite

443

0.89

0.26

1.6

1.5

4.62

5.10

ug/l

0.18

412

Open wound of lower leg

925

0.93

0.26

1.2

1.4

3.97

3.72

ug/l

0.14

848

Trigeminal neuralgia

278

0.86

0.26

1.6

2.52

4.35

ug/l

0.88

241

Sicca syndrome [Sjögren]

331

0.88

0.26

1.4

1.7

2.41

4.27

ug/l

1.07

268

Migraine with aura

452

4655

0.97

0.26

1.3

3.16

3.51

ug/l

0.92

420

4305

Other appendicitis

424

1.11

0.26

1.2

1.5

3.28

3.58

ug/l

0.20

377

Maternal care for other conditions predominantly related to pregnancy

451

4528

0.97

0.26

1.3

3.84

3.14

ug/l

0.49

415

4170

Other pulmonary heart/vessel disease

0.67

0.26

1.0

1.6

3.46

3.15

ug/l

—

Non-allergic asthma (mode)

137

1282

1.06

0.26

1.5

1.4

3.14

4.33

ug/l

1.67

120

1149

Other and unspecified dermatitis

405

4180

0.97

0.26

1.4

3.09

3.70

ug/l

0.87

358

3697

Injury of muscle and tendon at shoulder and upper arm level

572

0.91

0.26

1.3

1.7

2.14

4.80

ug/l

1.72

420

Excessive earwax

313

2732

1.04

0.26

1.3

1.5

3.32

4.19

ug/l

1.42

254

2359

Migraine without aura

420

4071

1.03

0.26

1.4

1.3

3.45

3.50

ug/l

0.05

390

3765

Heterophoria

877

1.07

0.26

1.3

1.4

4.58

4.05

ug/l

0.17

817

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.25

0.25

1.3

1.4

3.67

3.08

ug/l

—

Benign neoplasm of meninges

203

0.84

0.25

2.4

1.9

1.26

4.76

ug/l

—

145

Noninfective enteritis and colitis

391

3780

1.03

0.25

1.3

1.4

3.49

3.83

ug/l

0.28

353

3412

Anorexia

123

1.23

0.25

2.4

1.3

16.25

2.96

ug/l

0.81

108

Plantar fascial fibromatosis

446

0.90

0.25

1.6

1.5

2.98

3.70

ug/l

0.48

367

Other and unspecified vascular occlusions

1.23

0.25

4.3

1.9

3.53

7.34

ug/l

—

Osteopathies and chondropathies

328

2892

1.04

0.25

1.5

3.32

4.09

ug/l

0.80

279

2500

Asthma (only as main-diagnosis), excluding more controls

730

4131

0.98

0.25

1.4

1.3

2.95

3.57

ug/l

3.24

662

3754

Pre-eclampsia or eclampsia

309

2982

1.04

0.25

1.5

1.3

3.30

3.18

ug/l

0.18

275

2681

Other symptoms and signs involving the circulatory and respiratory systems

349

1.12

0.25

1.3

1.5

2.21

4.26

ug/l

1.79

311

Hidradenitis suppurativa

455

0.90

0.24

1.2

1.4

3.06

3.49

ug/l

0.28

423

Atherosclerosis, excluding cerebral and coronary sclerosis

159

0.84

0.24

2.0

2.5

0.53

10.47

ug/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

198

1.16

0.24

3.0

1.4

3.37

3.18

ug/l

0.11

178

Viral and other specified intestinal infections

363

3429

1.03

0.24

1.3

3.73

4.02

ug/l

0.55

343

3270

Functional dyspepsia

177

1855

0.95

0.24

1.4

5.55

3.56

ug/l

0.49

155

1609

Other benign neoplasms of skin

178

1698

1.05

0.24

1.5

2.78

3.84

ug/l

1.58

151

1439

Disorders of vitreous body

116

1039

1.06

0.24

1.2

1.8

2.97

5.24

ug/l

1.35

741

Glaucoma suspect

753

1.08

0.24

1.7

5.15

4.43

ug/l

0.13

550

Disorders of optic nerve and visual pathways

812

1.07

0.24

1.4

2.35

3.78

ug/l

2.66

744

Convulsions, not elsewhere classified

200

2063

0.96

0.24

1.3

3.28

3.86

ug/l

1.28

183

1925

Disorders of parathyroid gland

355

1.11

0.24

2.2

1.8

2.58

5.49

ug/l

0.98

252

Amputation

0.73

0.24

1.8

1.6

2.03

3.28

ug/l

—

Other contact dermatitis

631

0.92

0.24

1.3

1.4

2.62

3.74

ug/l

1.31

574

Lichen ruber planus, wide definition including periferal and oral lichen planus

677

1.08

0.23

1.3

1.6

2.81

4.68

ug/l

1.33

532

Deforming dorsopathies

212

2032

1.04

0.23

1.4

3.15

3.92

ug/l

1.48

181

1808

Other sexually transmitted chlamydial diseases, including avohilmo

271

2614

1.04

0.23

1.3

3.12

3.65

ug/l

1.76

261

2498

Other mosquito-borne viral fevers, including avohilmo

1.32

0.23

1.2

1.5

1.68

2.75

ug/l

—

Basal cell carcinoma

271

1.11

0.23

1.5

1.1

2.81

2.49

ug/l

0.15

182

Heart failure, strict

366

0.91

0.23

2.2

2.1

25.51

6.64

ug/l

0.35

217

Burn and corrosion of head and neck

1.24

0.23

1.2

3.16

3.40

ug/l

0.10

Migraine without aura, drug-induced

0.77

0.22

4.4

1.2

3.07

2.77

ug/l

—

Other congenital malformations of face and neck

274

0.87

0.22

1.2

1.4

3.68

3.11

ug/l

0.40

255

Congenital varicose veins

1.26

0.22

1.4

1.2

2.46

3.67

ug/l

—

Myalgia

242

2512

0.96

0.22

1.5

1.4

3.43

3.57

ug/l

0.09

223

2274

Peripheral artery operations in Hilmo

0.74

0.22

1.7

1.5

2.44

3.23

ug/l

—

Benign thyroid growths and nodules

142

1255

1.05

0.22

1.4

1.6

2.42

4.64

ug/l

2.11

103

1004

Disorders of sclera, cornea, iris and ciliary body

413

4016

1.03

0.22

1.4

3.53

3.65

ug/l

0.09

364

3560

Contact with venomous snakes and lizards

1.22

0.22

1.4

1.3

2.60

3.45

ug/l

—

Impetigo

472

0.91

0.22

1.6

1.4

3.29

3.93

ug/l

0.23

439

Other infestations, including avohilmo

1.22

0.22

3.2

1.4

2.11

2.51

ug/l

—

All-cause Heart Failure

358

0.91

0.22

2.2

2.1

25.51

6.72

ug/l

0.35

212

Induced delusional disorder

0.00

0.22

0.0

1.0

—

4.91

—

Congenital edentulism

0.00

0.21

0.0

1.2

—

2.75

—

Cerebral cysts

526

1.09

0.21

1.6

1.4

2.92

3.54

ug/l

0.56

487

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

836

5740

0.98

0.21

1.6

1.4

3.53

3.58

ug/l

0.05

718

5135

Lesion of lateral popliteal nerve

163

1.17

0.21

1.4

1.6

2.21

3.31

ug/l

0.68

141

Injury of blood vessels of thorax

0.00

0.21

0.0

1.3

—

3.30

—

Juvenile dermatomyositis

0.00

0.21

0.0

1.2

—

3.94

—

Apocrine sweat disorders, other sweat gland disorders

0.00

0.21

0.0

1.1

—

5.08

—

Polydactyly

0.00

0.21

0.0

1.3

—

4.83

—

Open wound of forearm

658

0.93

0.21

1.2

1.4

3.40

3.74

ug/l

0.23

611

Neuroendocrine tumor and carcinoma of pancreas

0.00

0.21

0.0

1.0

—

4.66

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

0.21

0.0

1.3

—

Alzheimer’s disease (Early onset)

0.00

0.21

0.0

2.8

—

4.55

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

296

1.12

0.21

1.5

2.96

3.99

ug/l

0.44

258

Gout

156

1.16

0.21

1.4

2.2

2.94

10.48

ug/l

1.03

Other specified and unspecified disorders of choroid

0.00

0.21

0.0

1.2

—

4.29

—

0.00

0.21

0.0

1.1

—

2.98

—

Contact with machinery

177

0.85

0.21

2.1

1.3

1.36

2.96

ug/l

4.14

153

DVT of lower extremities

479

1.09

0.20

1.2

1.5

1.93

3.92

ug/l

2.24

402

Hypothyroidism, autoimmune, DX-based

1.26

0.20

1.2

1.4

1.85

3.29

ug/l

—

Abscess of Bartholin gland

374

1.10

0.20

1.8

1.3

2.28

3.51

ug/l

1.70

344

Cystic disease of liver

0.00

0.20

0.0

1.4

—

1.22

—

Lesion of femoral nerve

0.00

0.20

0.0

1.9

—

0.64

—

Guillain-Barre syndrome

1.25

0.20

1.0

1.4

2.01

2.94

ug/l

—

Traumatic subarachnoid haemorrhage

1.25

0.20

1.3

1.6

2.47

2.87

ug/l

—

Hyperparathyroidism

258

0.88

0.20

2.9

2.0

2.05

4.82

ug/l

1.14

173

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

500

0.92

0.20

1.5

1.4

3.30

3.65

ug/l

0.24

470

Retinal vascular occlusion

108

1.20

0.20

4.3

1.7

3.67

5.69

ug/l

0.31

Implicit bacterial Sepsis

765

0.94

0.20

1.9

1.6

3.72

4.71

ug/l

0.40

631

Multiple gestation

166

1593

1.04

0.20

1.6

1.3

3.77

3.04

ug/l

0.92

157

1443

Asthma-related pneumonia or sepsis

173

1795

0.96

0.20

1.4

1.5

3.50

4.19

ug/l

0.42

151

1564

Asthma, hospital admissions 3, pneumonia

173

1795

0.96

0.20

1.4

1.5

3.50

4.19

ug/l

0.42

151

1564

Panic disorder

262

2705

0.97

0.19

1.4

1.3

3.82

3.63

ug/l

0.23

241

2551

Brachial plexus disorders

830

1.06

0.19

1.4

2.47

3.87

ug/l

1.62

746

Otitis externa

179

1721

1.04

0.19

1.5

1.4

3.50

3.81

ug/l

0.36

158

1540

Other diseases of arteries and capillaries

279

1.11

0.19

1.2

1.6

2.92

4.04

ug/l

0.49

242

Vasomotor rhinitis (mode)

333

0.90

0.19

1.1

1.5

1.47

4.02

ug/l

2.65

289

Secondary hypertension

266

0.89

0.19

1.6

1.4

4.43

4.75

ug/l

0.08

231

Benign neoplasm: Caecum

118

1.19

0.19

1.2

2.1

1.36

6.95

ug/l

—

Pacemaker

319

0.90

0.19

1.4

1.9

2.29

4.27

ug/l

0.94

240

Divergent concomitant strabismus

472

1.08

0.19

1.4

1.5

2.54

4.09

ug/l

1.32

423

Sequelae of injuries of lower limb

478

0.92

0.19

1.7

1.4

2.14

3.77

ug/l

2.14

426

Asthma-related pneumonia

172

1782

0.96

0.19

1.4

1.5

3.48

4.20

ug/l

0.44

150

1551

Pneumonia derived septicemia

156

1.16

0.18

1.2

1.4

3.99

3.41

ug/l

0.36

141

Lichen planus

280

0.89

0.18

1.0

1.7

2.30

4.35

ug/l

1.09

207

Retinal vascular disorders

109

1.19

0.18

4.3

1.7

3.67

5.61

ug/l

0.30

Ulcerative colitis

196

1891

1.04

0.18

1.2

1.4

2.54

3.70

ug/l

3.46

180

1703

Hypokalaemia

357

1.09

0.18

1.4

1.5

1.96

4.02

ug/l

1.68

288

Nontraumatic intracranial haemmorrhage

227

0.88

0.18

1.2

1.8

7.18

4.49

ug/l

0.20

168

Other specified/unspecified hearing loss

204

1.13

0.18

1.2

1.8

3.22

4.58

ug/l

0.30

166

Herpesviral [herpes simplex] infections

853

1.06

0.18

1.3

1.4

2.34

3.95

ug/l

3.58

767

Other and unspecified corneal deformities and disorders

121

0.83

0.18

1.2

1.5

3.02

2.87

ug/l

—

104

LSIL lesion of the cervix uteri, vagina or vulva

240

2327

1.03

0.18

1.4

1.3

2.77

3.35

ug/l

1.39

215

2122

Glomerulonephritis

348

1.09

0.17

2.3

1.5

9.38

3.99

ug/l

0.52

306

Other obstructive and reflux uropathy

416

1.08

0.17

1.3

5.09

3.30

ug/l

0.89

387

Monoamine oxidase A inhibitors

387

1.09

0.17

1.7

1.5

3.06

4.57

ug/l

0.76

307

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

141

1312

1.04

0.17

1.5

1.4

5.63

4.46

ug/l

0.40

128

1211

Other antidepressants

959

4968

0.98

0.17

1.3

1.4

3.39

3.71

ug/l

0.60

856

4507

Diplopia

591

1.07

0.17

1.6

1.5

4.31

3.86

ug/l

0.09

516

Nontoxic single thyroid nodule

320

1.09

0.17

1.2

1.6

2.22

3.86

ug/l

0.96

270

Hypertrophy of breast in women and men

156

1620

0.96

0.17

1.3

1.4

2.22

3.73

ug/l

4.28

125

1398

Pre-eclampsia

299

2913

1.03

0.16

1.5

1.3

3.33

3.17

ug/l

0.26

269

2624

Other protozoal intestinal diseases

101

1.19

0.16

1.7

1.2

2.79

2.75

ug/l

0.02

Generalized anxiety disorder

343

3343

1.03

0.16

1.3

3.18

3.61

ug/l

1.15

320

3155

Asthma (only as main-diagnosis)

730

4148

0.98

0.16

1.4

1.3

2.95

3.72

ug/l

3.02

662

3760

Heart failure,strict

360

0.93

0.16

2.2

2.1

25.51

6.71

ug/l

0.35

215

Asthma (mode)

806

4165

1.02

0.16

1.4

1.3

2.92

3.80

ug/l

3.49

736

3770

Impacted cerumen

298

0.91

0.16

1.2

1.6

2.72

3.89

ug/l

0.63

252

HSIL lesion of the cervix uteri, vagina or vulva

406

4148

0.98

0.16

1.3

3.53

3.10

ug/l

0.23

372

3830

Other/unspecified enthesopathies of lower limb, excluding foot

453

0.93

0.16

1.3

1.4

2.71

3.84

ug/l

0.93

402

HSIL lesion of the cervix uteri

394

4026

0.98

0.16

1.3

3.57

3.10

ug/l

0.25

363

3730

Unspecified haematuria

811

0.95

0.16

1.6

1.5

3.97

4.47

ug/l

0.17

683

Cough

303

2756

1.03

0.16

1.5

1.4

4.61

4.38

ug/l

0.11

263

2428

Superficial injury of forearm

102

1067

0.96

0.16

1.3

2.78

4.04

ug/l

2.25

997

Gingivitis and periodontal diseases

821

4173

1.02

0.16

1.4

3.46

3.73

ug/l

0.30

726

3698

Disorders of vestibular function (Vertigo)

197

1858

1.03

0.16

1.6

1.5

3.01

3.90

ug/l

1.27

160

1520

Lung diseases due to external agents

206

1.12

0.16

2.9

1.6

4.76

4.52

ug/l

0.04

171

Postprocedural disorders of nervous system

944

0.95

0.15

1.5

1.3

4.54

3.88

ug/l

0.18

874

Hypertrophy of breast

156

1616

0.96

0.15

1.3

1.4

2.22

3.71

ug/l

4.19

125

1396

Budesonide

122

1172

1.04

0.15

1.3

1.4

2.49

3.83

ug/l

2.41

114

1052

Prepatellar bursitis

1.15

0.15

1.0

1.8

3.32

4.94

ug/l

—

Pedestrian injured in collision with pedal cycle

140

0.86

0.15

1.5

1.4

3.53

2.91

ug/l

0.18

127

Polyuria

663

1.06

0.15

1.3

1.5

2.74

3.84

ug/l

1.32

571

Other acute skin changes due to ultraviolet radiation

1.10

0.15

1.2

1.5

1.94

2.99

ug/l

—

Nystagmus and other irregular eye movements

0.79

0.14

1.4

2.55

3.20

ug/l

—

Disorders of vitreous body and globe

118

1072

1.04

0.14

1.3

1.8

2.98

5.13

ug/l

1.31

771

Other specified disorders of muscle

0.79

0.14

3.0

1.5

2.98

3.19

ug/l

—

Macular pucker

0.80

0.14

3.1

2.8

—

10.66

ug/l

—

Other diseases of lip and oral mucosa

281

2744

1.02

0.14

1.3

1.4

2.68

3.85

ug/l

3.95

238

2385

Other sleep disorders

792

1.05

0.14

1.4

2.81

3.94

ug/l

1.59

713

Acne vulgaris

182

1871

0.97

0.14

1.3

3.41

3.88

ug/l

0.85

173

1787

Other peripheral vascular diseases

460

0.93

0.14

1.4

3.05

3.13

ug/l

0.05

407

Other and unspecified injuries of neck

0.82

0.14

1.1

1.4

1.91

3.19

ug/l

—

Other functional intestinal disorders

308

2735

1.02

0.14

1.4

1.5

3.08

4.37

ug/l

2.52

268

2408

Infections specific to the perinatal period

0.83

0.14

1.5

1.8

2.50

5.70

ug/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

143

1383

1.03

0.13

1.2

1.4

2.48

3.83

ug/l

3.31

131

1259

Speech and linguistic disorders, excluding more controls

138

1251

1.04

0.13

1.5

1.3

3.78

4.10

ug/l

0.33

133

1199

Otitis externa, unspecified

929

0.96

0.13

1.4

3.63

3.83

ug/l

0.15

842

Disturbances of skin sensation

286

2925

0.98

0.13

1.4

2.95

3.37

ug/l

0.92

254

2650

Toxic effects of substances chiefly nonmedicinal as to source

939

0.96

0.13

1.5

1.4

2.98

3.94

ug/l

1.68

875

Other assisted single delivery

325

1.08

0.13

1.3

1.2

4.56

2.37

ug/l

1.67

299

Atopic conjunctivitis

422

1.07

0.13

1.1

1.4

5.48

3.78

ug/l

0.36

385

Anterior Iridocyclitis

109

1049

1.04

0.13

1.6

1.4

4.71

3.47

ug/l

0.49

923

General examination and investigation of persons without complaint and reported diagnosis

605

3092

1.02

0.13

1.4

1.3

3.94

3.98

ug/l

0.02

544

2824

Injuries to the abdomen, lower back, lumbar spine and pelvis

297

2864

1.02

0.13

1.4

3.05

3.72

ug/l

1.81

266

2601

Allergic asthma (mode), excluding more controls

351

3358

1.02

0.13

1.3

3.58

3.66

ug/l

0.07

324

3116

Post-traumatic wound infection, not elsewhere classified

107

0.84

0.13

1.3

1.5

1.73

3.15

ug/l

—

Eustachian salpingitis and obstruction

775

1.05

0.13

1.2

1.3

2.82

2.95

ug/l

0.11

700

Other (not insulin) diabetes medications

761

4523

0.99

0.13

1.4

5.95

3.20

ug/l

2.87

684

3967

Glomerular diseases

683

0.95

0.13

1.9

1.4

6.81

3.57

ug/l

0.55

604

Hypermobility syndrome

866

0.96

0.13

1.3

1.4

2.53

3.81

ug/l

2.35

809

Acute pharyngitis

240

2432

0.98

0.12

1.4

1.3

3.21

3.93

ug/l

1.37

220

2317

Benign neoplasm: Skin of other and unspecified parts of face

345

1.07

0.12

1.6

1.5

1.90

4.01

ug/l

2.02

295

Adverse effects, not elsewhere classified

231

2255

1.02

0.12

1.3

1.4

3.52

3.68

ug/l

0.11

215

2059

Allergic asthma (mode)

351

3360

1.02

0.12

1.3

3.58

3.66

ug/l

0.07

324

3113

Deep bite that required surgery

123

1.14

0.12

1.1

1.4

4.35

2.86

ug/l

0.57

112

Carcinoma in situ of cervix uteri

244

2496

0.98

0.12

1.2

1.3

4.10

3.37

ug/l

0.25

228

2352

Mouth breathing

146

1503

0.97

0.12

1.2

1.5

3.31

4.32

ug/l

0.95

124

1286

D07AA Corticosteroids, weak (group I)

188

1927

0.97

0.12

1.4

3.82

3.97

ug/l

0.09

176

1786

Psychiatric diseases

878

4343

1.01

0.12

1.4

1.3

3.67

3.73

ug/l

0.04

787

3890

Allergic contact dermatitis

132

1363

0.97

0.12

1.3

2.81

3.64

ug/l

1.33

113

1224

Other enthesopathies

159

1636

0.97

0.12

1.3

1.5

2.34

4.05

ug/l

2.43

129

1358

Superficial injury of shoulder and upper arm

794

0.96

0.12

1.2

1.4

2.89

3.69

ug/l

1.09

724

Vitamin B12 deficiency anaemia

152

1.12

0.12

1.4

1.7

2.55

5.28

ug/l

0.74

116

Corneal ulcer

137

1328

1.03

0.12

1.3

1.4

3.98

3.68

ug/l

0.12

116

1192

Tinnitus

102

983

1.04

0.12

1.4

1.5

2.59

4.28

ug/l

1.74

828

Spinal stenosis

442

0.95

0.12

1.8

2.1

1.27

8.58

ug/l

1.89

250

Benign neoplasm: Skin, unspecified

168

0.89

0.11

1.4

1.6

4.12

3.61

ug/l

0.12

148

Algoneurodystrophy

259

1.08

0.11

1.4

1.5

2.83

4.12

ug/l

0.61

234

Other/unspecified synovitis and tenosynovitis

670

0.95

0.11

1.3

1.4

2.82

3.75

ug/l

0.94

587

Suppurative and unspecified otitis media

626

5612

0.99

0.11

1.3

4.14

3.45

ug/l

0.69

583

5272

Diseases of the digestive system

214

2171

0.98

0.11

1.3

1.5

2.96

3.99

ug/l

2.35

190

1910

AV-block

187

0.91

0.11

2.1

1.7

2.11

5.39

ug/l

1.30

141

Other disorders of patella

153

1571

0.97

0.11

1.4

1.3

3.07

3.45

ug/l

0.21

136

1398

Superficial injury of ankle and foot

163

1589

1.03

0.10

1.4

2.96

4.11

ug/l

2.56

151

1482

Type 2 diabetes, strict (exclude DM1)

757

4352

1.01

0.10

1.5

1.4

5.82

3.22

ug/l

2.57

679

3802

Benign neoplasm of eye and adnexa

338

1.07

0.10

1.3

1.6

2.68

4.13

ug/l

0.82

277

Diseases of liver

120

1164

1.03

0.10

1.4

1.5

3.18

3.85

ug/l

0.57

968

Injury of muscle and tendon at lower leg level

485

0.95

0.10

1.3

1.4

2.27

3.50

ug/l

1.32

420

Strabismus

243

2472

0.98

0.10

1.4

4.12

3.84

ug/l

0.16

220

2245

Persistent delusional disorders

202

1.09

0.10

3.0

1.6

3.02

4.44

ug/l

0.49

170

Congenital malformations of the nervous system

280

1.07

0.10

1.5

1.4

4.01

3.09

ug/l

0.60

258

Sequelae of infectious and parasitic diseases, including avohilmo

249

0.92

0.10

1.3

1.5

1.68

3.48

ug/l

1.42

214

Superficial injury of abdomen, lower back and pelvis

150

1462

1.03

0.10

1.2

1.4

3.03

3.89

ug/l

1.61

142

1349

Anti-inflammatory and antirheumatic products, non-steroids

293

1447

1.02

0.10

1.4

1.3

3.39

4.39

ug/l

1.35

271

1342

Use of amantadine

1.14

0.10

1.0

1.2

1.43

2.96

ug/l

—

Atrial fibrillation and flutter with reimbursement

144

0.92

0.10

2.8

2.1

1.67

8.22

ug/l

—

Late syphilis, including avohilmo

1.11

0.10

1.6

1.4

2.39

3.15

ug/l

—

Acute and subacute iridocyclitis

103

999

1.03

0.09

1.6

1.4

4.82

3.48

ug/l

0.50

874

Inflammatory bowel disease

263

2584

1.02

0.09

1.2

1.4

2.62

3.60

ug/l

3.51

243

2338

Diseases of the skin and subcutaneous tissue

1012

5120

0.99

0.09

1.4

3.32

3.64

ug/l

0.69

904

4662

LSIL lesion of the cervix uteri

220

2159

1.02

0.09

1.4

1.3

2.71

3.42

ug/l

1.83

202

1985

Other diseases of gallbladder

1.13

0.09

1.1

1.7

2.92

4.12

ug/l

—

Acute pancreatitis

502

0.96

0.08

1.7

1.6

2.45

3.97

ug/l

1.49

422

Other hammer toe(s) (acquired)

203

1.07

0.08

2.6

2.3

2.53

10.28

ug/l

1.06

Cauda equina syndrome

1.07

0.08

1.3

1.2

2.40

2.61

ug/l

—

Twin gestation

159

1556

1.02

0.08

1.6

1.3

3.78

3.06

ug/l

0.86

150

1410

Type 2 diabetes, definitions combined

755

4349

1.01

0.08

1.5

1.4

5.82

3.22

ug/l

2.58

679

3803

Congenital malformations of anterior segment of eye

1.04

0.08

3.3

1.3

2.50

2.73

ug/l

—

Whooping cough

0.82

0.08

1.0

1.3

2.38

3.41

ug/l

—

Later onset COPD

0.82

0.08

1.0

3.3

—

5.98

—

Chronic laryngitis and laryngotracheitis

538

1.04

0.08

1.7

1.5

1.95

3.76

ug/l

2.03

436

Narcolepsy and cataplexy

0.79

0.08

1.2

1.3

2.98

3.28

ug/l

—

Coeliac disease

947

0.97

0.08

1.2

1.5

2.75

3.81

ug/l

1.88

850

Glucosamine medication

280

1.05

0.08

2.5

2.8

5.50

15.77

ug/l

0.70

Heart failure and bmi 25plus

151

0.93

0.08

2.8

2.5

0.59

3.25

ug/l

5.76

Transient synovitis

1.10

0.08

1.1

1.4

2.55

4.00

ug/l

—

Cervicobrachial syndrome

134

1371

0.98

0.08

1.4

1.5

2.58

3.73

ug/l

1.87

112

1178

Acute otitis externa, noninfective

1.09

0.08

1.7

1.4

3.82

3.00

ug/l

—

Other strabismus

227

2299

0.98

0.08

1.4

4.28

3.86

ug/l

0.24

206

2096

Cardiodefibrillation

174

0.92

0.08

1.4

2.3

2.69

10.35

ug/l

—

Other specified/unspecified inflammatory spondylopathies

401

1.05

0.08

1.6

1.4

6.17

3.96

ug/l

0.30

369

Other and unspecified disorders of psychological development

109

0.89

0.08

1.4

1.5

4.06

5.63

ug/l

—

102

Sequelae of infectious and parasitic diseases

246

0.93

0.08

1.3

1.5

1.68

3.47

ug/l

1.38

211

Iridocyclitis

126

1231

1.02

0.08

1.6

1.4

4.35

3.74

ug/l

0.23

110

1079

Pleural effusion

166

1.08

0.07

1.3

1.9

3.66

5.19

ug/l

0.29

121

Inguinal hernia, bilateral

0.81

0.07

1.0

1.4

10.69

2.94

ug/l

—

Inguinal or femoral hernia, bilateral

0.81

0.07

1.0

1.4

10.69

2.94

ug/l

—

Toxic effect of carbon monoxide

0.80

0.07

1.2

1.4

2.35

3.04

ug/l

—

Eosinophilic disease (BM)

1.08

0.07

2.3

1.6

2.35

3.11

ug/l

—

Fall on and from stairs and steps

157

1601

0.98

0.07

1.4

3.01

4.05

ug/l

1.56

139

1414

All dysplastic lesions of the cervix uteri

554

5503

0.99

0.07

1.3

3.33

3.08

ug/l

0.17

512

5076

Migraine with aura and triptan purchases

329

3249

1.01

0.07

1.3

3.18

3.48

ug/l

0.61

311

3018

Abscess of anal and rectal regions

422

1.04

0.07

1.3

1.4

2.06

3.87

ug/l

2.21

383

Faecal incontinence

245

1.06

0.07

1.3

1.4

2.88

2.97

ug/l

0.04

195

Diseases of oral cavity, salivary glands and jaws

310

1618

0.99

0.07

1.4

3.99

4.08

ug/l

0.03

269

1415

Dislocation, sprain and strain of joints and ligaments at neck level

203

1998

1.02

0.07

1.3

3.15

3.68

ug/l

0.94

184

1851

Conotruncal defects

122

0.90

0.07

1.1

1.4

11.08

4.25

ug/l

0.32

111

Cardiomyopathies, Primary/intrinsic

118

1.10

0.07

1.0

1.6

1.67

6.39

ug/l

—

Assault by bodily force

709

1.03

0.07

1.3

3.71

3.46

ug/l

0.18

665

Blepharochalasis

387

0.96

0.07

1.1

2.2

1.62

5.91

ug/l

1.43

214

Venous complications and haemorrhoids in the puerperium

0.88

0.07

1.6

1.4

8.08

3.03

ug/l

—

Carcinoma in situ of cervix uteri, endocervix

173

0.92

0.07

1.3

1.4

2.86

2.43

ug/l

0.23

156

Benign lipomatous neoplasm

967

1.02

0.06

1.4

1.6

2.81

3.98

ug/l

1.13

786

Acute pancreatitis (for exclusion)

498

0.96

0.06

1.7

1.5

2.45

3.89

ug/l

1.36

417

Other respiratory disorders and diseases

315

0.95

0.06

1.6

1.7

4.92

4.52

ug/l

0.06

250

Other diseases of the respiratory system

315

0.95

0.06

1.6

1.7

4.91

4.52

ug/l

0.06

250

Enteropathic arthropathies

148

1.08

0.06

1.3

1.6

2.71

3.83

ug/l

0.62

129

Abnormal findings on diagnostic imaging of central nervous system

335

0.95

0.06

1.3

1.5

2.77

4.21

ug/l

0.94

305

Chronic kidney disease

398

1.04

0.06

1.8

1.7

2.95

4.18

ug/l

0.67

311

Acute appendicitis, with complications

780

1.03

0.06

1.5

1.4

8.83

3.32

ug/l

0.51

665

Persons encountering health services for examination and investigation

621

3092

1.01

0.05

1.5

1.3

4.00

3.98

ug/l

0.01

562

2824

Hyperlipidaemia, other/unspecified

400

0.97

0.05

2.1

2.0

2.28

6.37

ug/l

1.56

254

Obsessive-compulsive disorder

136

1381

0.98

0.05

1.3

3.32

3.76

ug/l

0.58

131

1300

Ptosis of eyelid

218

1.06

0.05

1.4

1.9

2.15

4.71

ug/l

0.98

163

215

0.94

0.05

1.5

1.7

9.66

5.67

ug/l

0.38

200

Pedal cyclist injured in transport accident

190

1876

1.01

0.05

1.3

1.4

2.80

3.77

ug/l

2.85

178

1711

Cerebral palsy and other paralytic syndromes

565

1.03

0.04

1.6

1.5

4.27

4.18

ug/l

0.02

505

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

140

0.93

0.04

2.5

1.4

3.71

3.59

ug/l

0.05

130

Chronic gastritis

506

1.03

0.04

1.7

1.9

5.46

4.90

ug/l

0.08

370

Other and unspecified psoriasis

219

1.05

0.04

1.2

1.6

2.95

4.30

ug/l

0.46

188

Polyarthritis, unspecified

150

0.93

0.04

1.4

1.6

2.16

5.38

ug/l

1.10

130

Other disorders of cornea

312

0.96

0.04

1.2

1.6

2.22

4.06

ug/l

1.20

266

Benign mammary dysplasia

675

1.02

0.04

1.9

1.5

10.53

3.90

ug/l

0.49

560

Subjective visual disturbances

190

1880

1.01

0.04

1.4

2.80

3.86

ug/l

2.04

164

1671

Other disorders of eye and adnexa

122

1203

1.01

0.04

1.6

1.4

3.95

3.83

ug/l

0.04

109

1080

258

0.96

0.03

1.5

1.6

8.43

5.46

ug/l

0.34

241

Diseases of external ear

213

2150

0.99

0.03

1.4

3.37

3.97

ug/l

0.86

186

1910

Other specified/unspecified bacterial intestinal infections

240

1.04

0.03

1.3

1.6

6.93

3.36

ug/l

0.46

209

Adjustment and management of implanted device

250

0.96

0.03

2.0

1.7

3.45

4.67

ug/l

0.35

200

Hernia of abdominal wall

194

1958

0.99

0.03

2.2

1.4

2.90

3.53

ug/l

0.64

152

1690

Diseases of inner ear

219

2112

0.99

0.03

1.6

1.5

2.95

4.08

ug/l

1.52

178

1732

Other/unspecified soft tissue disorders related to use, overuse and pressure

159

0.94

0.03

1.9

1.5

9.25

4.92

ug/l

0.30

143

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

250

2157

1.01

0.03

1.7

1.5

3.09

4.15

ug/l

1.09

186

1767

Chalazion

787

1.02

0.03

1.2

1.4

2.97

4.01

ug/l

0.99

715

Aneurysms, operations, SAH

320

1.03

0.03

1.3

1.7

2.20

4.32

ug/l

1.22

240

Ocular pain

792

0.98

0.03

1.3

1.4

3.18

3.69

ug/l

0.50

723

Other disorders of skin and subcutaneous tissue

431

3618

1.00

0.02

1.4

3.74

3.66

ug/l

0.05

363

3121

Ulcerative colitis (strict definition, require KELA)

143

1416

1.01

0.02

1.2

1.4

2.48

3.81

ug/l

3.32

131

1289

Other/unspecified dorsalgia

303

3008

0.99

0.02

1.4

2.79

3.71

ug/l

2.29

264

2694

Other fall from one level to another

196

1973

0.99

0.02

1.6

1.4

3.62

4.06

ug/l

0.58

179

1834

Ventricular septal defect, a heart condition

221

1.04

0.02

1.5

2.94

4.37

ug/l

1.48

202

Disorders of calcium metabolism

182

1.04

0.02

1.9

1.7

1.82

4.87

ug/l

1.25

149

Burns and corrosions of external body surface, specified by site

750

1.01

0.02

1.5

1.4

3.63

3.87

ug/l

0.14

694

Nail disorders

481

1.02

0.02

1.2

1.4

3.05

3.81

ug/l

0.56

433

Other headache syndromes

443

4430

1.00

0.02

1.3

1.4

2.79

3.67

ug/l

3.21

391

3981

Congenital musculoskeletal deformities of head, face, spine and chest

1.08

0.02

1.3

1.4

12.86

4.16

ug/l

—

Enthesopathies of lower limb, excluding foot

138

1369

1.01

0.02

1.2

1.5

2.63

3.75

ug/l

1.81

114

1178

Other shoulder lesions

641

1.01

0.01

1.5

1.4

2.43

3.69

ug/l

1.70

566

5-aminosalicylic acid

183

1819

1.01

0.01

1.2

1.4

2.53

3.66

ug/l

3.44

169

1640

First line medication for Crohn's disease

1223

6586

1.00

0.01

1.5

1.3

2.79

3.74

ug/l

5.28

1081

6029

Retention of urine

662

0.99

0.01

1.3

1.5

2.82

4.01

ug/l

1.36

576

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

173

1.04

0.01

1.1

1.6

3.02

4.19

ug/l

0.30

140

All dysplastic lesions of the vulva

223

1.03

0.01

1.7

3.14

4.85

ug/l

0.51

189

Non-ischemic cardiomyopathy

248

1.02

0.01

1.8

2.0

36.21

7.28

ug/l

0.37

158

Achilles tendinitis

333

1.02

0.01

1.3

1.6

2.62

3.96

ug/l

0.78

264

All dysplastic lesions of the cervix uteri, vagina or vulva

581

5654

1.00

0.01

1.4

1.3

3.28

3.11

ug/l

0.12

530

5180

Diarrhoea and gastroenteritis of presumed infectious origin

729

6493

1.00

0.01

1.4

1.3

3.12

3.53

ug/l

1.09

647

5937

Other osteochondropathies

393

1.02

0.01

1.5

1.4

2.88

3.26

ug/l

0.22

352

Lung cancer and mesothelioma

107

0.95

0.01

2.5

2.6

2.17

15.99

ug/l

—

Asthma, excluding more controls

804

4131

1.00

0.01

1.4

1.3

2.92

3.57

ug/l

3.61

736

3754

Injuries to the neck

251

2502

1.00

0.01

1.3

1.4

3.17

3.58

ug/l

0.76

227

2305

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

104

1.06

0.01

1.3

1.4

3.01

2.67

ug/l

0.23

Other and unspecified intracranial injuries

116

0.95

0.00

1.3

1.5

2.76

3.26

ug/l

0.27

102

Other blood glucose lowering drugs, excl. Insulins

126

0.95

0.00

1.2

2.3

0.92

7.24

ug/l

—

300

1.02

0.00

1.3

2.3

4.64

8.03

ug/l

0.39

161

Chronic pancreatitis

144

1.04

0.00

1.5

2.0

3.10

5.67

ug/l

—

109

Viral haemorrhagic fevers, not elsewhere classified/unspecified

264

1.02

0.00

1.6

1.4

3.38

3.24

ug/l

0.05

231

Lichen planus, including avohilmo

526

0.99

0.00

1.3

1.6

2.83

5.03

ug/l

1.17

409

Viral pneumonia

664

1.01

0.00

1.4

1.5

3.10

4.34

ug/l

0.73

594

Propionic acid derivatives

287

1447

1.00

0.00

1.4

1.3

3.22

4.39

ug/l

1.74

265

1342

Ulcerative colitis (strict definition, all Crohn cases excluded)

117

1164

1.01

0.00

1.2

1.4

2.58

3.80

ug/l

2.25

108

1067

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

148

1486

1.00

0.00

1.2

1.4

2.45

3.73

ug/l

3.34

135

1351

Selective serotonin reuptake inhibitors

959

4987

1.00

0.00

1.3

1.4

3.27

3.79

ug/l

1.46

880

4523

Asthma

804

4148

1.00

0.00

1.4

1.3

2.92

3.72

ug/l

3.27

736

3760

Primary open-angle glaucoma, strict

163

0.98

0.00

3.8

2.2

3.35

12.29

ug/l

—

Adhesive capsulitis of shoulder

397

1.01

0.00

1.1

1.8

2.13

4.88

ug/l

1.13

289

Other and unspecified polyneuropathies, also in other diseases

294

0.99

0.00

1.6

1.7

1.76

3.87

ug/l

1.19

224

Any mental disorder

1005

5034

1.00

0.00

1.4

1.3

3.66

3.64

ug/l

0.02

901

4519

Radiculopathy

434

0.99

0.00

1.2

1.6

1.99

3.69

ug/l

1.62

350

Spirochaetal infections, other/unspecified

308

1.01

0.00

1.7

1.6

4.49

4.04

ug/l

0.09

257

Primary open-angle glaucoma

196

0.98

0.00

3.7

2.2

2.88

11.34

ug/l

—

Other CVD (FINNGEN)

216

0.99

0.00

1.4

1.7

2.89

5.11

ug/l

0.96

179

Gluteal tendinitis

175

0.97

0.00

1.2

1.7

2.24

4.60

ug/l

0.69

142

Vestibular neuronitis

265

1.02

0.00

3.0

1.6

4.22

4.66

ug/l

0.12

221

Helminthiases, including avohilmo

604

0.99

0.00

1.2

1.3

2.74

3.31

ug/l

0.71

563

Patent foramen ovale

110

1.00

0.00

1.7

1.5

24.19

4.35

ug/l

0.71

Neuralgia and neuritis, unspecified

251

1.00

0.00

1.6

1.5

17.00

4.27

ug/l

0.41

223

Skin changes due to chronic exposure to nonionizing radiation

205

1.02

0.00

1.1

2.6

10.48

11.67

ug/l

—

Continuous positive airway pressure

289

1.01

0.00

1.4

1.7

5.70

7.93

ug/l

0.31

205

Dependent personality disorder

1.04

0.00

1.2

1.4

1.35

2.90

ug/l

—

Cervical disc disorders

989

1.00

0.00

1.4

1.7

1.64

4.77

ug/l

2.72

745

Torticollis

136

1.03

0.00

1.1

1.5

2.88

2.92

ug/l

0.01

124

Primary hyperparathyroidism

176

1.02

0.00

3.2

1.9

1.86

5.52

ug/l

—

119

Cervicocranial syndrome

646

1.01

0.00

1.8

1.4

2.86

3.80

ug/l

0.78

561

Respiratory distress of newborn

106

0.96

0.00

2.5

1.9

7.94

6.18

ug/l

0.20

Pain, not elsewhere classified

247

2473

1.00

0.00

1.4

1.3

2.97

3.44

ug/l

0.96

223

2236

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.01

0.00

1.3

1.4

12.86

4.28

ug/l

—

Chondropathies

117

1172

1.00

0.00

1.4

3.18

4.02

ug/l

1.05

108

1062

Vocal cord dysfunction

101

890

1.00

0.00

1.4

3.62

3.65

ug/l

0.01

770

Other disorders of bone

151

1508

1.00

0.00

1.3

1.4

3.02

3.74

ug/l

1.16

134

1351

Open bite that required surgery (Lefort1 or BSSO)

159

1.01

0.00

1.2

1.3

3.26

3.29

ug/l

0.01

146

Cutaneous abscess, furuncle and carbuncle

216

2158

1.00

0.00

1.3

1.4

2.73

3.66

ug/l

2.83

188

1959

Other bursopathies

361

1.00

0.00

1.3

1.5

2.50

4.09

ug/l

1.10

293

Overexertion and strenuous or repetitive movements

551

1.00

0.00

1.9

1.4

3.03

3.75

ug/l

0.61

500

Other and unspecified injuries of lower leg

716

1.01

0.00

1.2

1.4

2.97

3.79

ug/l

1.19

664

Cardiac murmurs and other cardiac sounds

105

1043

0.99

0.00

1.4

4.11

4.81

ug/l

0.61

100

965

Infectious mononucleosis

163

1629

1.00

0.00

1.3

3.70

3.82

ug/l

0.09

153

1548

Infectious mononucleosis, including avohilmo

163

1629

1.00

0.00

1.3

3.70

3.82

ug/l

0.09

153

1548

Burns and corrosions

981

1.00

0.00

1.4

3.55

4.25

ug/l

0.53

905

Other abnormal findings of blood chemistry

248

1.01

0.00

1.4

1.98

2.66

ug/l

1.07

224

LSIL lesion of the vulva

137

1.02

0.00

1.9

1.8

3.96

4.49

ug/l

—

110

Non-selective monoamine reuptake inhibitors

126

1204

1.00

0.00

1.3

1.6

2.51

4.92

ug/l

2.17

946

Pneumococcal septicemia

157

1.02

0.00

1.1

1.4

4.04

3.22

ug/l

0.49

139

Fracture of femur

365

0.99

0.00

1.7

1.8

2.37

4.22

ug/l

1.38

286

Other dialysis

0.86

0.00

1.8

1.5

0.96

3.65

ug/l

—

Periodic paralysis

0.00

0.0

1.3

—

1.45

—

APECED

0.00

0.0

1.0

—

3.82

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.0

1.3

—

1.34

—

Poisoning by medicine, drug-induced

0.86

0.00

1.2

1.3

3.32

3.08

ug/l

—

Exposure to sunlight

0.00

0.0

1.4

—

1.85

—

Exposure to ignition of highly flammable material

0.00

0.0

1.1

—

3.82

—

Fetal blood loss

0.00

0.0

2.0

—

5.54

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

1.2

—

1.59

—

Defect, injury or illness of chest

0.00

-0.00

0.0

1.4

—

1.62

—

1.00

-0.00

1.1

3.0

—

24.27

—

Environmental-pollution-related condition

0.00

-0.00

0.0

1.4

—

3.44

—

Malignant neoplasm of accessory sinuses, including Hilmo

0.00

-0.00

0.0

1.1

—

2.15

—

Diphyllobothriasis and sparganosis, including avohilmo

0.00

-0.00

0.0

1.0

—

3.29

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.2

—

6.98

—

Dislocations, sprains and strains involving multiple body regions

0.00

-0.00

0.0

1.5

—

1.51

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.0

—

6.20

—

Leprosy [Hansen's disease], including avohilmo

0.00

-0.00

0.0

1.4

—

6.02

—

Degeneration of iris and ciliary body

0.00

-0.00

0.0

1.5

—

3.28

—

Methaemoglobinaemia

0.00

-0.00

0.0

1.0

—

7.45

—

Other immunodeficiencies

0.94

-0.00

1.8

1.3

1.27

3.19

ug/l

—

Benign neoplasm: Tongue

0.98

-0.00

1.3

1.4

1.00

3.05

ug/l

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.3

—

1.67

—

Tuberculosis of nervous system

0.00

-0.00

0.0

1.0

—

6.30

—

Brain mixed glioma, helper endpoint

0.00

-0.00

0.0

1.0

—

3.56

—

Small plaque parapsoriasis

0.00

-0.00

0.0

1.3

—

3.69

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.4

—

4.70

—

Tuberculosis of nervous system, including avohilmo

0.00

-0.00

0.0

1.0

—

6.30

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.3

—

3.21

—

Polypectomy (DHB20)

140

1.00

-0.00

1.4

1.5

4.86

3.81

ug/l

0.26

117

Hookworm diseases

0.00

-0.00

0.0

1.0

—

5.01

—

Femoral hernia, unilateral

0.98

-0.00

1.4

1.5

1.57

3.15

ug/l

—

Torsion of testis

0.00

-0.00

0.0

1.2

—

21.96

—

Other and unspecified vaccines and biological substances

0.91

-0.00

1.0

1.2

1.79

3.11

ug/l

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

2.52

—

CR(E)ST syndrome

0.98

-0.00

1.0

1.4

1.58

3.02

ug/l

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.0

—

3.34

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.0

—

3.19

—

Pityriasis alba

0.00

-0.00

0.0

1.0

—

5.68

—

Other localized connective tissue disorders

0.99

-0.00

1.4

3.16

2.92

ug/l

—

Other and unspecified pemphigus

0.00

-0.00

0.0

1.0

—

3.54

—

Osteochondrosis of ankle, juvenile

0.91

-0.00

1.2

1.4

4.69

3.46

ug/l

—

Malignant neoplasm of accessory sinuses

0.00

-0.00

0.0

1.2

—

2.48

—

Inguinal of femoral hernia, unilateral

0.98

-0.00

1.4

1.5

1.57

3.15

ug/l

—

Other injuries of upper limb, level unspecified

0.99

-0.00

1.6

1.4

7.42

3.42

ug/l

—

Brain glioblastoma

0.00

-0.00

0.0

1.0

—

2.80

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.0

—

3.79

—

Disorders of urea cycle metabolism

0.00

-0.00

0.0

1.0

—

1.58

—

Inguinal hernia, unilateral

0.98

-0.00

1.4

1.5

1.57

3.15

ug/l

—

Preparatory care for dialysis

0.94

-0.00

3.8

1.4

1.95

3.25

ug/l

—

Evidence of alcohol involvement determined by level of intoxication

0.95

-0.00

1.2

1.3

6.87

3.05

ug/l

—

Thoracic root disorders

0.00

-0.00

0.0

1.8

—

1.31

—

Psoriasis (vulgaris), strict definition

120

1.00

-0.00

1.8

1.4

2.21

2.99

ug/l

—

105

Other conjunctival vascular disorders and cysts

0.93

-0.00

1.2

1.5

1.50

3.45

ug/l

—

Migraine with aura, drug-induced

0.89

-0.00

1.4

1.3

6.48

2.68

ug/l

—

Corrosions classified according to extent of body surface involved

0.00

-0.00

0.0

1.0

—

2.11

—

Other disorders of iris and ciliary body

0.96

-0.00

1.6

2.28

3.59

ug/l

—

Complications specific to multiple gestation

0.96

-0.00

1.3

1.5

2.15

2.70

ug/l

—

Other conditions related to polyarteritis nodosa

0.00

-0.00

0.0

1.1

—

3.36

—

Disorder of bilirubin metabolism, other/unspecified

0.00

-0.00

0.0

1.4

—

2.34

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

0.00

-0.00

0.0

1.4

—

1.91

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.0

—

7.95

—

Disorder of mineral metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

3.93

—

Obstructed labour due to maternal pelvic abnormality

610

1.00

-0.00

2.0

1.6

2.44

3.57

ug/l

0.99

452

Hookworm diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

4.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS